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ABSTRACT 
 
ERIN E. MILNER: Lasonolide A: Synthetic Explorations 
(Under the direction of Dr. M. Crimmins) 
 
 
 First isolated in 1984 from the marine sponge Forcepia trilabis, lasonolide 
A was found to inhibit A-549 human lung carcinoma cells and P-388 murine 
leukemia cell lines among others. This cytotoxic natural product was chosen 
because of its biological activity and challenging polyketide structure. Interesting 
structural features include two cis-2,6-substituted tetrahydropyran rings 
integrated into the highly unsaturated macrolide structure, and a quaternary 
stereogenic center at C22. Construction of the A-ring showcases a novel zinc 
triflate-mediated asymmetric alkynylzinc addition hetero-Michael reaction, which 
was developed to selectively form the 2,6-cis tetrahydropyran motif. To assemble 
the B-ring, alternate carbon nucleophiles were explored to displace the N-acyl 
thioimide auxiliary and prepare β-ketonitrile and β-ketoester moieties. Coupling of 
the three fragments via olefination, esterification, and metathesis strategies is 
also outlined.  
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CHAPTER 1 
 
LASONOLIDES A-G: ISOLATION, STRUCTURAL ELUCIDATION, AND 
BIOLOGICAL ACTIVITY 
 
1.1  Marine Macrolide Overview 
 
Marine organisms have proven to be a beneficial source of secondary 
metabolites with unique biological activities and have shown promise as 
chemotherapeutic agents. Unfortunately, one factor impeding the large-scale 
isolation of these secondary metabolites for clinical development is their low natural 
abundance. Current efforts in the synthetic organic chemistry community are 
focused on generating quantities of material for further therapeutic evaluation, as 
well as more accurate structural elucidation. Thus, the synthesis of natural products 
has sparked the development of new and innovative methodologies and 
retrosynthetic strategies. 
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1.2  Isolation, Structural Elucidation, and Biological Activity 
 
Lasonolide A (1-1 originally proposed) was isolated in 1994 by McConnell and 
coworkers from the shallow water Caribbean marine sponge Forcepia trilabis.1 The 
red-orange sponge was collected in 1992 by a dive team from the Harbor Branch 
Oceanographic Institute (HBOI) approximately 100 nautical miles southwest of 
Sanibel Island, Florida. Due to the abundance of Forcepia trilabis in the region, it has 
been termed “Forcepia-land” by researchers at HBOI.2 This species of sponge is 
unusual since it prefers the sandy bottom at a depth of approximately 230 feet. 
Extensive solvent partitioning of the bioactive extract allowed for the isolation of 
pale orange oil (reported [α]20D = +24.1). The extract was discovered to inhibit the in 
vitro proliferation of A-549 human lung adenocarcinoma cell lines (IC50 = 40 ng/mL) 
and inhibit cell adhesion in the EL-4.IL2 cell line (IC50 = 19 ng/mL), which is a 
response correlating to signal transduction activity.3 In addition, the extract is a 
potent cytotoxin against P-388 murine leukemia cell lines (IC50 = 2 ng/mL). The 
sponge metabolite responsible for the biological activity was aptly named lasonolide, 
a term derived from the Philippine word lason which translates to poison or toxin. 
The molecular formula was reported as C41H60O9 based on HRFABMS [(M + H)+ m/z 
697.4243] and key absorption peaks in the IR spectrum at 1736 and 1690 cm-1 
indicated a conjugated ester. After employing extensive 1H, 13C, DEPT, HMBC, and 
ROESY NMR analysis, McConnell and coworkers proposed structure 1-1 (Figure 
1.2.1) for the lasonopyran skeleton, with the specific stereochemistry at C28 still 
unclear.  
 3 
The lasonopyran skeletal structure 1-2, common to several related lasonolides, 
has since been revised based on the total synthesis of lasonolide A by Lee and 
coworkers (Section 2.1); correcting for the configuration about the C17-C18 and 
C25-C26 olefins, as well as elucidating the previously unknown stereochemistry at 
C28. Interesting structural features include two cis-2,6-substituted tetrahydropyran 
rings integrated into the macrolide structure, a quaternary stereogenic center at C22, 
and a highly unsaturated macrolide.  
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Figure 1.2.1. Originally Proposed and Revised Lasonopyran Skeletons 
 
 The related lasonolides A – G (1-3 – 1-9), isolated from Forcepia trilabis, 
possess the same C1-C28 polyketide, but exhibit differing side chain moieties (Table 
1.2.1.). Interestingly, lasonolide C 1-5 was isolated as a white powder, while 
lasonolides D – G (1-6 – 1-9) were isolated as oils.  
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Table 1.2.1. Lasonolides A-G (1-3 – 1-9) 
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Despite the structural similarities of the lasonolides, all show significantly reduced 
toxicity in relation to lasonolide A.4 The biological activities of lasonolides C-G 
toward human pancreatic carcinoma (PANC-1), human breast cell lines (NCI/ADR-
RES, formally MCF-7/ADR), and human lung carcinoma (A549) are shown in Table 
1.2.2. Lasonolide C (1-5), the closest structural analogue to lasonolide A (1-3), is 
4.5-fold less active in the PANC-1 cell line, 2-fold less active in the NCI/ADR-RES 
line, and 15-fold less active in the A-549 cell line. Hydrolysis to the carboxylic acid 
(1-8) results in a >175-fold reduction in activity compared to lasonolide A (1-3). 
 5 
Although each compound contains identical lasonopyran skeletal structures the 
cytotoxicity profile varies dramatically, illustrating the biological importance of the 
side chain moiety. 
 
Table 1.2.2. Bioactivities of Lasonolides A (1-3) and C-G (1-5 – 1-9) 
 
Compound 
PANC-1  
(IC50 µM) 
NCI/ADR-RES  
(IC50 µM) 
A-549 
(IC50 µM) 
lasonolide A (1-3) 0.089 0.49 0.0086 
lasonolide C (1-5) 0.38 1.12 0.13 
lasonolide D (1-6) 4.89 > 9 4.50 
lasonolide E (1-7) 0.57 > 8 0.31 
lasonolide F (1-8) 15.6 > 9 > 9 
lasonolide G (1-9) > 6 > 6 > 6 
 
  
 
 
CHAPTER 2 
 
STUDIES DIRECTED TOWARD THE SYNTHESIS OF  
LASONOLIDE A: LITERATURE REVIEW 
 
2.1  Lee’s Total Synthesis and Structural Revision of Lasonolide A5 
 
2.1.1 Retrosynthetic Analysis 
 
To ascertain the unknown stereochemistry of the C28 hydroxyl group, a strategy 
was devised whereby the side chain could be coupled with the lasonopyran skeleton 
towards the end of the synthesis (Scheme 2.1.1). Retrosynthetically, the C17-C18 
cis-alkene and the C2-C5 diene were envisioned to be accessible using Wittig 
olefination and Stille-type reaction conditions, respectively. With this strategy, each 
prepared enantiomer of the side chain could be appended late stage with a Julia-
Kocienski protocol to give the trans-olefin. The Lee group chose an innovative 
radical cyclization of the (bromomethyl)silyloxy-substituted β-alkoxyacrylate 2-3 to 
fashion the quaternary center at C22 of the A-ring, while β-alkoxyacrylate 2-5 was 
utilized to form tetrahydropyran ring B.  
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Scheme 2.1.1. Lee’s Retrosynthetic Analysis Based on Originally Proposed 1-1 
 
2.1.2 First Generation Synthesis 
 
The assembly of the A-Ring fragment began with commercially available ethyl L-
malate 2-6, which was subjected to reduction and subsequent protection as the 
benzyl ether (Scheme 2.1.2). Formation of the corresponding Weinreb amide and 
Grignard addition provided enone 2-8. A three step sequence afforded alcohol 2-9, 
which was subsequently added to ethyl propiolate. Further PMB-deprotection and 
silylation provided the critical bromomethyl(dimethyl)silyl intermediate 2-3. Bicyclic 
product 2-11 was formed as a single diastereomer via a tandem 6-endo, 6-exo 
radical cyclization based on conditions developed in the Lee laboratory.6  
 
 8 
HO CO2Et
EtO2C
HO OBn
OPMB
Me
HO
EtO2C
OBn
O
Si O
Me
H
OBn
Me Me
ethyl L-malate
1. BH3   SMe2, NaBH4, 
2. Bu2SnO,BnBr
    72% (2 steps)
1. MeNH(OMe)  HCl, Me3Al
2.CH2CH(Me)MgBr
   57% (2 steps)
2-6 2-7
2-9
2-8
1.                        , NMM
2. DDQ, 97% (2 steps)
BrCH2SiMe2Cl
Et3N
n-Bu3SnH, AIBN
80% (2 steps)
2-3
2-11
EtO2C
H H
HC CCO2Et
HO OBn
O
Me
1. Et3B, NaBH4
2. (p-MeO)PhCH(OMe)2, CSA
3. DIBAL-H, 90% (3 steps)
2-10
A
O
O
CO2Et
Si OBn
Me 22
19
Br
Me Me
O
OH
CO2Et
OBn
Me 22
19
22
19
 
Scheme 2.1.2. Lee’s Synthesis of the A-Ring  
 
Reduction of the ester, protection as the pivaloate derivative, and Tomao 
oxidation allowed for conversion to diol 2-12 (Scheme 2.1.3). The diol was bis-TBS 
protected, followed by removal of the primary silyl ether to provide alcohol 2-13. 
Selenoxide elimination, osmium tetroxide dihydroxylation/sodium periodate 
cleavage, and sodium borohydride reduction sequence was utilized to afford lower 
homologue 2-14. Cleavage of the silyl ether and protection of the resultant diol as 
the acetonide, followed by cleavage of the benzyl ether and subsequent oxidation of 
the primary alcohol provided aldehyde 2-15. 
 
 9 
1. LiBH4
2. PivCl, DMAP, pyridine
3. H2O2, KF, KHCO3
    76% (3 steps)
O
OH
Me
H
OBnPivO
HO
2-12
1. TBSOTf, 2,6-lutidine
2. CSA, MeOH
     96% (2 steps)
O
OTBS
Me
H
OBnPivO
HO
1. (o-NO2)PhSeCN, PBu3, H2O2
2. OsO4, NMO; NaIO4
3. NaBH4, EtOH, 85% (3 steps)
O
HO OTBS
Me
H
OBnPivO
1. HCl, MeOH
2. Me2C(OMe)2, CSA
3. H2, Pd(OH)2/C, MeOH
4. SO3  pyridine, Et3N
    80% (4 steps)
O
O O
Me
H
PivO
O
Me Me
2-13
2-142-15
O
Si O
Me
H
OBn
Me Me
2-11
EtO2C
H H
HH
HH
H H H H
A
A
 
Scheme 2.1.3. Lee’s Synthesis of the A-Ring Coupling Partner 2-15 
 
Towards the preparation of the B-ring fragment, β-hydroxyenone 2-17 was 
generated via reaction of the Z-boron enolate of Evans imide 2-16 and 
benzyloxyacetaldehyde (Scheme 2.1.4). The imide was converted to the 
corresponding Weinreb amide, which was reacted with vinyl magnesium bromide to 
provide enone 2-17. Chelation controlled reduction of the hydroxyl lactone, 
benzylidine formation of the resultant diol, and reduction of the benzylidine with 
DIBAL-H provided olefin 2-18. Oxidative cleavage of the terminal olefin, reduction of 
the resultant aldehyde, and protection as its TBS ether afforded alcohol 2-19. 
Extension to β-alkoxyacrylate 2-20 was achieved via reaction of the secondary 
alcohol with ethyl propiolate and 2-step conversion of the primary TBS ether to the 
corresponding primary bromide. Radical cyclization employing n-Bu3SnH delivered 
tetrahydropyran 2-21. 
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Scheme 2.1.4. Lee’s Synthesis of the B-Ring 
 
A five-step sequence involving removal of the benzyl ethers via hydrogenation, 
protection of the resultant alcohols as the corresponding silyl ethers, reduction of the 
ester to the aldehyde, and elaboration of the aldehyde via Takai olefination afforded 
vinyl iodide 2-22 (Scheme 2.1.5). Selective deprotection of the primary TBS ether 2-
22 and oxidation to the resultant aldehyde allowed for conversion to trisubstituted 
olefin 2-24 via the Z-selective Still-Gennari olefination protocol. Reduction of the 
resultant ester produced an allylic alcohol, which was oxidized to the aldehyde. 
Subsequent Julia-Julia coupling of the aldehyde with sulfone 2-25 provided diene 2-
26 with good E-selectivity. Phosphonium salt 2-27 was formed through a standard 
three step sequence.  
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Scheme 2.1.5. Lee’s Synthesis of the B-Ring Coupling Partner 2-27 
 
Wittig olefination of phosphonium salt 2-27 with aldehyde 2-15 was employed to 
obtain the coupled product solely as the C17-C18 cis isomer (Scheme 2.1.6). 
Hydrolysis of the acetonide and selective protection of the primary alcohol provided 
unmasked secondary alcohol 2-29, which underwent an esterification to install the 
diene. Unfortunately, in the synthesis of unsaturated ester 2-31 a 
stereorandomization problem resulted in a 2:1 E:Z ratio. The desired E-olefin (2-31) 
was subjected to an intramolecular Stille coupling to provide macrolactone 2-32.  
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Scheme 2.1.6. Lee’s Synthesis of Macrolactone 2-32 
 
To circumvent the stereorandomization issue encountered, they reversed the 
order of the key steps to form the macrolactone (Scheme 2.1.7). First, a Stille 
reaction was performed involving vinyl iodide 2-29 and acid 2-30 to give dienoic acid 
2-33, which underwent intramolecular lactonization under standard Yamaguchi 
conditions to afford macrolactone 2-32.7 The pivaloate was selectively removed by a 
Super-Hydride reduction followed by oxidation of the alcohol to give aldehyde 2-34.  
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Scheme 2.1.7. Lee’s Revised Approach to Macrolactone 2-32 
 
Commercially available malic acid was used to obtain the stereocenter in the side 
chain moiety (Scheme 2.1.8). As the configuration at C28 was unknown at the time, 
both enantiomers were subjected to the same protocol to give both desired 
configurational isomers: L-malic acid (2-38) was utilized to give the S-configuration, 
while D-malic acid was utilized to give the R-configuration. Synthesis of S-C28 is 
outlined below. Selective ketal formation followed by borane reduction to the primary 
alcohol and ensuing protection as the silyl ether provided ketal 2-39. The sodium 
alkoxide of 2-37, made in six steps from commercially available diol 2-35, opened 
the lactone of 2-39 to provide the ester. This intermediate was converted to alcohol 
2-40 by silylation of the secondary alcohol followed by selective cleavage of the 
primary alcohol. Mitsunobu reaction with tetrazole derivative 2-41 provided the 
sulfide, which was oxidized to sulfone 2-42.  
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Scheme 2.1.8. Lee’s synthesis of Side-Chain Coupling Partner 2-42  
 
Sulfoxide 2-42, and its corresponding enantiomer ent 2-42, were coupled with 
aldehyde 2-34 via a Kocienski-Julia olefination (Scheme 2.1.9).8 However, it was 
apparent upon evaluation of the NMR spectra obtained from 1-1 (28S) and 1-1 (28R) 
that neither matched that of the natural product.  
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Scheme 2.1.9. Completion of Lasonolide A (Originally Proposed Structure)  
 
2.1.3 Structural Revision 
 
In light of these results, Lee and coworkers subsequently undertook the synthetic 
challenge to obtain several stereoisomers of lasonolide A (Scheme 2.1.10). Based 
on a similar issue encountered in their synthesis of ambruticin, they decided to 
construct the C17-C18 trans-olefin. The NMR spectra of 2-43 (28S) and 2-44 (28R) 
were comparable to the natural product, but discrepancies in the vinylic region 
persisted. Hence they decided to install the C25-C26 cis-olefin, leading to structures 
1-3 (28R) and 2-45 (28S). Although the NMR spectrum of 1-3 matched that of the 
natural product, the optical rotation was opposite the value reported (incorrectly) by 
McConnell and coworkers (Section 1.2). With the correct structure known, Lee and 
coworkers constructed enantiomeric 1-3 (ent 1-3), which was identical to the natural 
product in both NMR data and the optical rotation value reported by McConnell. To 
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preclude any uncertainty regarding the structure, stereoisomers 2-46 and 2-47 were 
also constructed, but the NMR spectrums did not match the natural product. The Lee 
laboratory subjected all of the isomers to a series of biological assays (Section 
2.1.4), thereby determining that (-)-lasonolide A is indeed the most biologically active 
enantiomer (Table 2.1.1). The work of Lee elucidated the correct structure and 
optical rotation ([α]20D = -24.1), while the structure (1-1) and optical rotation ([α]20D = 
+24.1) reported by McConnell and coworkers were found to be in error.  
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Figure 2.1.1. Lasonolide A: Stereoisomers Prepared by Lee 
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2.1.4 Biological Evaluation and Synthesis of Lasonolide A Analogues 
 
  Lee and coworkers later reported the preparation of four analogs (Figure 
2.1.2).9 In derivative 2-48, the macrolactone is missing a methyl group at C10. 
Furthermore, homologue 2-49 was chosen due to the ease of preparation from 2-12, 
and side-chain derivatives 1-7 and 2-50 were assembled for a similar reason. 
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Figure 2.1.2. Synthesis and Evaluation of (-)-Lasonolide A Analogues 
 
The biological activities corresponding to the compounds in Figure 2.1.1 and 
Figure 2.1.2 toward human lung adenocarcinoma (A-549 and NCI-H460) and colon 
cancer (HCT-116) are shown in Table 2.1.1. In particular, it was determined that the 
R-configuration at C28 is vital to the activity when compared with its diastereomer 2-
45. The researchers describe the C25-C26 cis-olefin as “important,” and the C17-
C18 trans-olefin as “essential,” while 10-desmethyllasonolide A 2-47 and lasonolide 
homologue 2-48 exhibit reduced activity when compared to 1-3 (Figure 2.1.2). 
Furthermore, the A-549 cell line activity of lasonolide E (1-7) reported by Wright and 
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coworkers (IC50 = 0.31 µM)10 differs from the value reported by Lee and coworkers 
(IC50 = 0.007 µM).11 
 
Table 2.1.1. Bioactivities for Lasonolide A and Related Compounds 
Figure Compound A 549 HCT-116 NCI-H460 
2.1.1 1-1 (28S) > 10 5 5 
 
1-3 (28R) 0.015 < 0.003 < 0.003 
 
ent 1-3 (28S) 6 3 2 
 
2-43 (28S) 3.2 0.1 0.04 
 
2-44 (28R) 2 0.04 0.02 
 
2-45 (28S) 0.05 0.009 < 0.003  
 
2-46 (28R) > 10 > 10 > 10 
2.1.2 2-48 (28R) 0.100 0.045 0.065 
 
2-49 (28R) 0.800 1.800 1.000 
 
1-7 (28R) 0.007 0.100 0.015 
 
2-50 (28R) 0.390 0.190 0.170 
 
 
2.2  Kang’s Total Synthesis of (+)-Lasonolide A12 
 
From a retrosynthetic perspective, Kang and coworkers envisioned three 
disconnections as shown in Figure 2.2.1. Similar to the Lee laboratory, the C25-C26 
olefin would be formed utilizing a Wittig olefination, while the C14-C15 and C17-C18 
alkenes would be fashioned via Julia olefination conditions. A Horner-Emmons 
protocol would install the C2-C3 olefin of the conjugated diene.  
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Figure 2.2.1. Kang’s Retrosynthetic Analysis of (+)-Lasonolide A 
 
The construction of cis-2,6-disubstituted tetrahydropyran ring A began with 
known alcohol 2-51,13 which was oxidized to the aldehyde and reacted with 
allylboronate (R,R)-2-52 reported by Roush (Scheme 2.1.12).14 Next, they were able 
to differentiate between the two hydroxyl methyl groups of the 1,3-dioxane in 2-53 
through treatment with benzaldehyde and trifluoroacetic acid. The result was a 5:1 
separable mixture of benzylidine 2-54 and its diastereomeric acetal with 82% yield 
reported after several recycles of the undesired benzylidine diastereomer. Oxidation 
of primary alcohol 2-54 followed by allylation with (S,S)-2-52 led to homo-allylic 
alcohol 2-55. Iodoetherification of 2-55 afforded a 27:1 product ratio in favor of cis-
2,6-disubstituted tetrahydropyran 2-56 in excellent yield. 
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Scheme 2.2.1. Kang’s Synthesis of A-Ring Fragment 2-56 
 
The resultant iodide 2-56 was then converted to the benzoate moiety, and 
ozonolysis with a reductive workup gave the primary alcohol (Scheme 2.2.2). The 
benzylidine group was cleaved via hydrogenolysis to give triol 2-57. A selective 
protection of the two primary alcohols with TBSCl was followed by protection of the 
secondary alcohol with TESOTf. Further hydrolysis of the benzoate group and 
oxidation provided aldehyde 2-58 suited for the impending Julia coupling.  
 
 21 
1. BzONa, NMP, 100%
2. O3, NaBH4, 96%
3. H2, Pd/C, 89%
HO
O
OHHO
A
OBz
25
Me
HH
18
1. TBSCl, imidazole, 95%
2. TESOTf, 2,6-lutidine, 98%
3. K2CO3, MeOH, 91%
4. Dess-Martin periodinane
1. 2-32, DEAD, Ph3P, 81% 
2. (NH4)6Mo7O24   4H2O, H2O2
3. 2-60, DEAD, Ph3P, 75% (2 steps)
TBSO
O
OTESTBSO
OMe
HH
S
S
N
N N
N
NS
Ph
OO
OH
OH N
N
N N
Ph
SH
HS N
S
1. 2-61, KHMDS
    95%, 31:1cis:trans
2. (NH4)6Mo7O24    4H2O, H2O2
3. p-TsOH    H2O
4. TBSCl, imidazole
    88% (2 steps)
TBSO
O
OHTBSO
Me
HH
S
O
O
N
S
2-58
2-32
2-61
2-57
2-60 2-62
2-59
O
I
HH
O O
Me
Ph
2-56
Scheme 2.2.2. Kang’s Synthesis of A-Ring Coupling Partner 2-62 
 
The Julia olefination coupling partner was prepared from the reaction of 1,3-
propanediol 2-59 with 1-phenyl-1-H-tetrazole-5-thiol 2-32 using the protocol of 
Mitsunobu. Oxidation of the sulfide to the sulfone was followed by another 
Mitsunobu reaction with benzothiazole-2-thiol 2-60 to give thiazolethiol 2-61, which 
was coupled with aldehyde 2-59 under Julia-Kocienski conditions to afford the C25-
C26 olefin (31:1 trans:cis). Oxidation of the sulfide to the sulfone, cleavage of the 
silyl ether, and selective protection of the primary alcohols provided fragment 2-62. 
The synthesis of cis-2,6-disubstituted tetrahydropyran B began with the 
protection of known alcohol 2-63 (Scheme 2.2.3).15 Oxidative cleavage of the olefin 
afforded the aldehyde, which was reacted under asymmetric Brown allylation 
conditions.16 Alkene 2-64 was subjected to oxidative cleavage and subsequent 
conversion to the α,β-unsaturated ester. The secondary alcohol was protected as 
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the TIPS ether and DDQ was used to remove both the benzyl and p-methoxybenzyl 
moieties to afford diol 2-65. 
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Scheme 2.2.3. Kang’s Synthesis of B-Ring Coupling Partner 2-67 
 
A hydride-mediated intramolecular Michael addition of enoate 2-65 afforded the 
cis-2,6-disubstituted tetrahydropyran as a single diastereomer. Reduction of the 
ester was followed by homologation to the α,β-unsaturated ester via Horner-
Wadsworth-Emmons conditions. Subsequent reduction of the ester and protection 
as the silyl ether afforded B-ring precurser 2-66. The primary alcohol was oxidized 
and converted to the trisubstituted olefin via the Still-Gennari procedure.17 The 
secondary alcohol was desilylated and protected as the TBS ether. The methyl ester 
was subsequently reduced to aldehyde 2-67 in preparation for the Julia-Julia 
olefination. 
To prepare the side-chain, known acetonide 2-6818 was reacted with alcohol 2-30 
through an acid-mediated transesterification. The secondary alcohol was protected 
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as the silyl ether and exposure of the bromide to triphenylphosphine led to 
phosphonium salt 2-69.  
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Scheme 2.2.4. Kang’s Synthesis of Side Chain 2-69 
 
To complete the synthesis, the anion of sulfone 2-62 was reacted with aldehyde 
2-67 via a Julia-KoKocienski coupling reaction (Scheme 2.1.14). Formation of the 
phophonoacetate was followed by deprotection of the allylic alcohol provided 
Horner-Emmons precursor 2-70. Selective oxidation of the allylic alcohol with 
manganese dioxide followed by potassium carbonate mediated cyclization supplied 
macrolactone 2-71. The primary alcohol was oxidized to the aldehyde and reacted 
with phosphonium salt 2-69 via a Wittig olefination. Global deprotection gave (+)-
lasonolide A in 26 steps and 7.4% overall yield.  
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Scheme 2.2.5. Kang’s Synthesis (+)-Lasonolide A ent 1-3 
 
2.3  Shishido’s Total Synthesis of (+)-Lasonolide A19 
 
 Shishido and coworkers envisioned lasonolide to arise from a cross metathesis 
and macrolactonization to form the 20-membered polyene macrolide, while the side 
chain would be appended using the Wittig conditions reported by the Lee laboratory 
(Figure 2.3.1).  
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Figure 2.3.1. Shishido’s Retrosynthetic Analysis of (+)-Lasonolide A  
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 Tetrahydropyran 2-78 was prepared in thirteen steps from lactone 2.73 
(Scheme 2.3.1).20 Following protection of the secondary alcohol as the silyl ether, 
addition of benzyloxymethyl anion gave the lactol, which was reduced with boron 
trifluoride etherate and triethylsilane to provide cis-2,6-disubstituted tetrahydropyran 
2-74 as a single diastereomer.21 Removal of the benzyl group and subsequent 
oxidation allowed for homologation to trisubstituted olefin 2-75 with excellent 
diastereoselectivity. Reduction of the ester, oxidation of the resultant allylic alcohol, 
and elongation produced conjugated ester 2-76. Another reduction and installation of 
the terminal halide set the stage for a Stille coupling to provide skipped triene 2-78 
after removal of the primary silyl ether. 22  
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Scheme 2.3.1. Shishido’s Synthesis of cis-2,6-disubstituted Tetrahydropyran B 2-78 
 
 The synthesis of A-ring fragment 2-85 began with known enone 2-79 
(Scheme 2.3.2).23 Conjugate addition with lithium dimethylcuprate, subsequent 
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oxidation of the silyl enol ether, and copper catalyzed conjugate addition of vinyl 
magnesium bromide provided ketone 2-80.24 Ozonolysis of the terminal alkene with 
reductive workup gave the corresponding diol, which was selectively protected as 
the primary silyl ether. Further oxidation of the secondary alcohol and treatment with 
p-toluenesulfonylhydrazine provided hydrazone 2-81.  
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Scheme 2.3.2. Shishido’s Synthesis of cis-2,6-Disubstituted Tetrahydropyran A 2-85 
 
 A Bamford-Stevens reaction25 then provided the internal olefin. Epoxidation of 
alkene 2-81 with methyl(trifluoromethyl)-dioxirane 2-82, followed by reduction of the 
benzyl ether provided alcohol 2-83 in 90% de. The primary halide was formed and 
subsequently reduced with an ethanolic zinc suspension to provide hemiacetal 2-84. 
Conversion to the α,β-unsaturated ester and subsequent intramolecular Michael 
addition furnished the cis-2,6-disubstituted tetrahydropyran in 14:1 dr. Lithium 
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aluminum hydride reduction of the epoxy-hemiacetal provided a triol, which was 
selectively protected as the acetonide and corresponding silyl ethers (2-85).  
 The 20-membered macrolide backbone was constructed with a cross 
metathesis and macrolactonization strategy (Scheme 2.1.18). The cross metathesis 
between olefins 2-78 and 2-85 was achieved through the use of a mixture of Grubbs 
first generation (G1) catalyst 2-86 and Grubbs second generation (G2) catalyst 2-87 
to provide 70% of triene 2-88 and 19% of homodimer 2-89.26 With macrolide 
precursor 2-88 in hand, the primary alcohol was oxidized and homologation provided 
the extended diene. Removal of the acetonide gave the diol and hydrolysis afforded 
the dienoic acid. After protection of the primary alcohol, macrolactone 2-90 was 
formed under Yamaguchi conditions.27 Desilylation of both primary alcohols and 
subsequent oxidation of the least sterically hindered alcohol to the aldehyde set the 
stage for a Wittig olefination with phosphonium salt 2-91. Global deprotection 
concluded the enantiocontrolled total synthesis of (+)-lasonolide A (ent 1-3). 
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Scheme 2.3.4. Shishido’s Synthesis (+)-Lasonolide A ent 1-3 
 
2.4  Beck and Hoffmann’s Synthesis of the B-Ring (C1-C16 Segment)28 
 
The enantioselective synthesis of the C1-C16 segment of the originally proposed 
structure of lasonolide A was reported in 1999 by Beck and Hoffmann (Figure 2.4.1).  
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Figure 2.4.1. C11-C16 Segment Targeted by Beck and Hoffmann 
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The synthesis of the B-ring fragment began with racemic 2α-methyl-8-
oxabicyclo[3.2.1]oct-6-en-3-one (rac 2-92), which had been previously employed in 
their synthesis of the C29-C37 segment of spongistatin.29 A samarium iodide 
reduction of rac-2-92 afforded the equatorial alcohol, which was protected as the 
benzyl ether (Scheme 2.4.1). Easily separable regioisomers (-)-2-93 and desired (+)-
2-94 were obtained after hydroboration of the olefin and oxidation of the resulting 
secondary alcohol. The authors note that this step provides an opportunity for an 
“early racemic switch, [which] has been defined as the development in single-
enantiomer form of a drug that was first approved as a racemate.”30 The silyl enol 
ether, formed from ketone (+)-2-94, was ozonolyzed and the resulting aldehyde-acid 
was converted to cis-2,6-disubstituted tetrahydropyran 2-95 by esterification of the 
acid and reduction of the aldehyde.  
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Scheme 2.4.1. Beck and Hoffmann’s Synthesis of B-Ring 2-97 
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Protection of the primary alcohol 2-95 as the silyl ether, adjustment of the ester 
oxidation state to an aldehyde by reduction to the alcohol and reoxidation, and 
subsequent olefination afforded trisubstituted olefin 2-96 with high Z-selectivity. 
Reduction of the ester, oxidation of the resultant primary alcohol to the aldehyde, 
further extension utilizing Horner-Wadsworth-Emmons conditions, and subsequent 
reduction afforded diene 2-97.  
Allylic alcohol 2-97 was protected as the 2-(trimethylsilyl)ethoxymethyl (SEM) 
ether. Upon selective deprotection of the primary TBDPS ether, the alcohol was 
converted to the triflate to undergo nucleophillic substitution and deliver nitrile 2-98. 
Reduction of nitrile 2-98 and ensuing hydrolysis allowed for conversion to the 
aldehyde, which was subjected to a (E,E)-selective Horner-Wadsworth-Emmons 
reaction to give B-ring polyene 2-99.  
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Scheme 2.4.2. Beck and Hoffmann’s Synthesis of B-Ring 2-99 
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2.5  Rychnovsky’s Synthesis of the A-Ring (C18-C25 Segment)31 
 
 In order to showcase the 2-oxonia-Cope Prins cascade reported by Dalgard 
and Rychnovsky,32 the A-ring (C18-C25 segment) of (-)-lasonolide A was targeted 
(Figure 2.5.1).  
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Figure 2.5.1. A-Ring (C18-C25) Segment Targeted by Dalgard and Rychnovsky 
 
The proposed 2-oxonia-Cope Prins cyclization, shown in Scheme 2.5.1, is based 
on a tandem oxacarbenium ion reaction. Mixed acetal 2-100 could be reacted with a 
Lewis acid to form oxacarbenium ion 2-101, allowing for a stereospecific 2-oxonia 
Cope rearrangement to form oxacarbenium ion 2-102. The authors propose that 
upon bond rotation, transition state 2-103 could allow for cyclization of the chair 
conformer to yield 2-104. Further hydrolysis would provide cis-2,6-disubstituted 
tetrahydropyrans 2-105, like that of the A-ring of lasonolide. 
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Scheme 2.5.1. Proposed Mechanism of the 2-Oxonia-Cope Prins Cyclization 
 
Application of the proposed 2-oxonia-Cope Prins cyclization began with optically 
active alcohol 2-106 as shown in Scheme 2.5.2. DCC-Mediated esterification led to 
2-107, which upon enolization was subjected to an aldol reaction with aldehyde 2-
108. An in situ Lewis acid-mediated cyclization led to 1,3-dioxane 2-109, which was 
oxidized to the corresponding sulfoxide and subsequent elimination afforded olefin 
2-110. A 2-step deconjugation followed by reductive acylation afforded mixed acetal 
2-112. Oxacarbenium ion formation and in situ hydride reduction supplied cis-2,6-
disubstituted tetrahydropyran 2-113. 
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Scheme 2.5.2. A-Ring (C18-C25) Segment Targeted by Dalgard and Rychnovsky 
 
2.6  Gujar’s Synthesis of the A and B-Rings33 
 
Gujar and coworkers utilized a different approach and prepared the A and B-
rings of lasonolide A from sugar derivatives. The stereochemistry of the C18-C23 A-
ring segment corresponds to (-)-lasonolide A, while the C7-C16 B-Ring segment 
corresponds to (+)-lasonolide A (Figure 2.1.6). 
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Figure 2.6.1. A-Ring (C18-C23) and B-Ring (C7-C16) Segments Targeted by Gujar and Coworkers 
 
 34 
The synthesis of the A-ring (C18-C23) began with known methyl-3-O-benzyl-4,6-
O-isopropylidene-α-D-glucopyranoside 2-116 (Scheme 2.6.1).34 Oxidation of the 
secondary alcohol and subsequent two-carbon extension led to unsaturated ester 2-
117. Reduction of the ester was followed by a Simmons-Smith reaction, and the 
stereoisomeric cyclopropane derivates 2-118 and 2-119 were separated via 
chromatography. Oxidation of the alcohol was followed by hydrogenation to induce 
regiocontrolled ring cleavage.  
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Scheme 2.6.1. A-Ring (C18-C23) Segment Targeted by Gujar and Coworkers 
 
The aldehyde was transformed into the corresponding hydrazone, which was 
heated under Bamford-Stevens conditions (Scheme 2.6.2). The benzyl group was 
removed under dissolving metal conditions, and the free alcohol was protected to 
provide mesylate 2-121. Acetonide removal followed by primary alcohol protection 
and elimination delivered epoxide 2-122. Lithium aluminum hydride regioselectively 
opened the epoxide, and the resultant alcohol was acylated to supply 3-O-acetyl 
derivative 2-123. Oxidative cleavage of the olefin was then followed by reduction to 
afford alcohol 2-114.  
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Scheme 2.6.2. A-Ring (C18-C23) Segment Targeted by Gujar and Coworkers 
 
Efforts directed toward the C7-C16 segment began with methyl 2,3,4-tri-O-acetyl-
α-D-mannopyranoside 2-124 (Scheme 2.6.3). Oxidation and reduction was followed 
by a Simmons-Smith cyclopropanation to yield a racemic mixture of diastereomers 
2-125 and 2-126, which were separable via chromatography. Cyclopropane 2-126 
was converted to the 6-bromo-derivative and the ring was subsequently opened 
under radical conditions to give both pyranose derivative 2-127 and seven-
membered ring 2-128. The mixture of 2-127 and 2-128 was subjected to 
hydroboration-oxidation conditions and following silyl protection, ring ethers 2-129 
and 2-130 were separated via column chromatography.  
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Scheme 2.6.3. B-Ring (C7-C16) Segment Targeted by Gujar and Coworkers 
 
With 2-130 in hand, the acetates were removed, followed by treatment of the diol 
with p-anisaldehyde dimethylacetal under acidic conditions to yield PMP-acetal 2-
131 (Scheme 2.6.4). Regioselective reduction of the acetal followed by acylation and 
Barton deoxygenation afforded 2-deoxy pyranoside 2-132. Silyl deprotection, Swern 
oxidation, and homologation gave trisubstituted alkene 2-133. Conversion of the 
ester to the aldehyde was followed by a second Wittig olefination to afford α,β-
unsaturated ester 2-115. 
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Scheme 2.6.4. B-Ring (C7-C16) Segment Targeted by Gujar and Coworkers 
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2.7  Jennings’ Synthesis of the B-Ring (C1-C14 Segment)35 
 
Jennings and coworkers constructed the B-ring of (-)-lasonolide A through a 
Molander-Reformatsky samarium iodide-mediated intramolecular aldol reaction 
(Figure 2.7.1).36  
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Figure 2.7.1. B-Ring (C1-C14 Segment) Targeted by Jennings and Coworkers 
 
Known α,β-acetylenic ester 2-134 was reacted with lithium dimethylcuprate to 
form the trisubstituted olefin (Scheme 2.7.1). Reduction of the ester to the alcohol 
and oxidation led to aldehyde 2-135. The Z-boron enolate of 2-136 was reacted with 
aldehyde 2-135 utilizing Evans’ conditions to provide syn-aldol adduct 2-137. 
Removal of the chiral auxiliary was followed by selective silylation of the primary 
alcohol and acylation of the secondary alcohol with bromoacetyl bromide provided 
bromo-acetate 2-138. Selective removal of the t-butyldimethylsilyl ether and 
oxidation of the alcohol with Dess-Martin periodinane was followed by an 
intramolecular Molander-Reformatsky samarium iodide-mediated cyclization to 
stereoselectively provide lactone 2-139. Addition of allyl magnesium bromide to 
lactone 2-139 provided the lactol, which was reduced with triethylsilane to provide 
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the 2.6-cis-tetrahydropyran. Cross-metathesis with acrolein and subsequent 
extension to diene 2-140 completed the synthesis of the C1-C14 B-ring segment. 
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Scheme 2.7.1. B-Ring (C1-C14 Segment) Targeted by Jennings and Coworkers 
 
2.8  Hart’s Synthesis of the A and B-Rings37 
 
Hart, Patterson, and Unch have reported their collaborative efforts in 
synthesizing the A and B-Rings of (+)-lasonolide A (Figure 2.1.8). Their approach 
involved a cycloetherification reaction of bis-homoallylic alcohols in the key step.  
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Figure 2.8.1. A and B-Rings of (+)-lasonolide A Targeted by Hart and Coworkers 
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Commercially available diacetone glucose 2-141 was oxidized and converted to 
the corresponding nitroalkane. Addition of dimethylcuprate and oxidation to the 
carboxylic acid with ozone set the stage for a reduction with lithium aluminum 
hydride. Protection as a benzyl ether then provided 2-142. Selective hydrolysis and 
reaction with triphenylphosphine-iodine provided the mono-substituted olefin. 
Hydroboration-oxidation followed by benzyl protection gave acetonide 2-143, which 
underwent hydrolysis and Wittig olefination with (2-furyl)methylidenetriphenyl 
phosphorane to provide 2-144. The trans olefin proceeded through a three-step 
sequence involving phenylselenenyl chloride, reduction of the selenide, and 
protection as the pivaloate to give cis-2,6-disubstituted tetrahydropyran 2-145. 
Oxidative degradation of the furan via ozonolysis, reduction of the carboxylic acid to 
the primary alcohol, and silylation set the stage for reduction of the pivaloate and 
hydrogenolysis to give triol 2-146. Protection of the primary alcohol as the pivaloate 
and protection of the diol as the acetonide, followed by deprotection of the silyl ether 
provided A-ring fragment 2-147. 
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Scheme 2.8.2. A-Ring of (+)-lasonolide A Targeted by Hart and Coworkers 
 
The synthesis of the B-ring was initiated with the scandium triflate enolate of 
thiazolidinethione 2-148. Reaction of E,E-5-(4-methoxyphenyl)penta-2,4-dienal 2-
149 with the enolate of 2-148 gave syn-aldol adduct 2-150.38 Displacement of the 
auxiliary with Weinreb’s amide, silylation of the secondary alcohol, and treatment 
with benzyloxymethyllithium afforded ketone 2-151. Removal of the silyl ether and 
reduction with zinc borohydride39 provided diol 2-152 as a 4:1 mixture of 
diastereomers and treatment with phenylselenyl chloride initiated cyclization to the 
cis-2,6-disubstituted tetrahydropyran.40 Etherification of the secondary alcohol was 
followed by formation of diastereoselective bromohydrins. Finally, oxidation with 
Dess-Martin periodinane was followed by Bayer-Villiger reaction to give the desired 
B-ring fragment.  
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Scheme 2.8.3. B-Ring of (+)-lasonolide A Targeted by Hart and Coworkers 
  
 
 
CHAPTER 3 
 
STUDIES DIRECTED TOWARD THE TOTAL SYNTHESIS  
OF (-)-LASONOLIDE A 
 
3.1 Retrosynthetic Analysis 
 
When lasonolide A was first examined in the laboratory of M. T. Crimmins, (+)-
lasonolide A (ent 1-3) was presumed to be the biologically active natural product. As 
shown in Figure 3.1.1, projected disconnections partition the molecule into three 
components: two substituted tetrahydropyran segments (C1-C14 and C15-C25) and 
the side-chain extending from C26-C35. The macrolide could be assembled using a 
Julia olefination to install the trans C14-C15 alkene, a Stille-type protocol to form the 
C3-C4 bond, and a Yamaguchi lactonization. The side chain would be appended 
utilizing a Wittig olefination to form the cis geometry of the C25-C26 alkene. This 
strategy provided several options for constructing the molecule from the key 
fragments.  
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Figure 3.1.1. Preliminary Disconnections to Construct (+)-Lasonolide A 
 
3.2 A-Ring: Synthesis of the C15-C25 Segment  
 
The preliminary retrosynthesis of the C15-C25 fragment of (+)-lasonolide A 
(Scheme 3.2.1) was based on the ring closing metathesis of intermediate 3-3, which 
would be prepared from aldol adduct 3-4.41  
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Scheme 3.2.1. Retrosynthetic Analysis of C15-C25 Segment of (+)-Lasonolide A 
 
3.2.1 Frater-Seebach Alkylation via Syn Aldol Intermediate 
 
The formation of aldol adduct 3-4 was based on previous studies in the Crimmins 
laboratory.42 As shown in Scheme 3.2.2, N-acyl thiazolidinethione 3-5 allows access 
to either Evans or non-Evans syn aldol products by altering the stoichiometry of the 
base. When employing one equivalent of amine base, it is believed that non-Evans 
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syn aldol product 3-7 is formed via transition state 3-6, wherein the sulfur atom of the 
thiazolidinethione is chelated to the titanium atom. In this highly rigid arrangement, 
the chlorotitanium enolate forms a new C-C bond with the aldehyde opposite to the 
large R group of the chiral auxiliary.  
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Scheme 3.2.2. Asymmetric Aldol Addition of Thiazolidinethione Propionate 
 
On the other hand, by employing one equivalent each of amine base and an 
unreactive coordinating ligand such as N-methylpyrrolidinone (NMP, 3-10), dipole-
minimized transition state 3-8 predominates.  N-Methylpyrrolidinone coordinates to 
the metal center and occupies the open coordination sites available on titanium, 
which leads to Evans syn aldol adduct 3-9.  
Based on these earlier studies, a previous graduate student, M. Stanton, began 
the synthesis of the C15-C25 fragment of (+)-lasonolide A with the installation of the 
C21-C22 propionate subunit via an Evans syn aldol reaction (Scheme 3.2.2). The 
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chlorotitanium enolate of acyl thiazolidinethione 3-5 was treated with aldehyde 3-15 
(prepared in two steps from allyl bromide) providing syn aldol product 3-12 in 
excellent yield and diastereoselectivity.  
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Scheme 3.2.2. Evans syn Aldol Involving 3-butenal 
 
After exchange of the N-acyl thioimide for the corresponding methyl ester,43 the 
quaternary center was installed through a Frater-Seebach alkylation44 (Scheme 
3.2.3). Benzyl ether 3-16 was obtained in modest yield as a single diastereomer 
using a chelation controlled alkylation with the lithium enolate of ester 3-4 and 
benzyloxymethyl chloride (BOMCl = BnOCH2Cl). Ozonolysis of the alkene followed 
by reductive workup and protection of the resultant alcohol provided 3-17. The ring 
closing metathesis strategy was reliant on divinyl carbinol 3-18, which would be 
transformed to tetrahydropyran 3-2. Numerous conditions were tested by Stanton, 
but protection of the secondary alcohol to provide divinyl carbinol 3-18 was not 
achieved.45  
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Scheme 3.2.3. Divinyl Carbinol Approach 
 
3.2.2 Iterative Aldol Approach 
 
A second approach for the construction of tetrahydropyran 3-2 involved an 
asymmetric intramolecular Michael reaction of α,β-unsaturated ester 3-24. As shown 
in Scheme 3.2.4, the chlorotitanium enolate of thiazolidinethione acetate 3-19 was 
reacted with acrolein to afford the desired diastereomer in modest yield and 
stereoselectivity. After protection of the secondary alcohol and reduction of the N-
acyl thioimide to the aldehyde, a propionate aldol was utilized to form 3-21. 
Exchange of the N-acyl thioimide for the corresponding methyl ester set the stage 
for a chelation-controlled stereoselective alkylation with the lithium enolate of ester 
3-22. However, the alkylation failed despite investigating a variety of conditions.  
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Scheme 3.2.4. Iterative Asymmetric Aldol Approach 
 
3.2.3 Reductive Elimination Approach 
 
As shown in Scheme 3.2.5, the enantiomer of 3-4 was subjected to the same 
Frater-Seebach conditions utilized to form benzyl ether 3-16 and subsequently 
protected to yield intermediate 3-25. After exploring numerous cross-metathesis 
conditions involving allyl acetate, the desired trans olefin was prepared using 
Grubbs’ third generation catalyst. Removal of the acetate group was followed by 
epoxidation under Sharpless conditions.46 However, further attempts to form the 
alkyl bromide and trigger reductive elimination led to poor results.  
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Scheme 3.2.5. Reductive Elimination Investigation 
 
3.2.4 Organozinc Approach  
 
 In an attempt to successfully obtain allylic alcohol 3-28, alkene 3-25 was 
subjected to ozonolysis conditions. The resultant aldehyde 3-29 was treated with 
various organozinc reagents to give the corresponding vinyl alcohol with high 
stereoselectivity. Unfortunately, employing zinc bromide and vinyllithium in the 
presence of (+)-NME led to elimination product 3-30, as did divinyl zinc following the 
Oppolzer’s protocol.47 After a literature search for a mild alternative, the asymmetric 
acetylene addition reported by Carreira was tested.48 Fortunately, alcohol formation 
followed by in situ cyclization to the corresponding lactone 3-33 occurred in 62% 
yield as a single diastereomer. The installed alkyne would be employed as an olefin 
surrogate and could be later reduced to the desired trans alkene. 
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Scheme 3.2.6. Employing Organozinc Reagents 
 
Lactone 3-33 was reduced to provide hemi-acetal 3-34, which was subjected to a 
variety conditions in an effort to execute a diastereoselective addition to the 
oxacarbenium ion to yield 2,6-cis tetrahydropyran 3.35. However, these attempts 
never came to fruition. 
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Scheme 3.2.7. Conversion to 2,6-cis Tetrahydropyran 3.35 
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3.2.5 Tandem Zinc Acetylide Addition 1,4-Conjugate Addition 
 
Based on the successful chelation controlled alkylation with the lithium enolate of 
ester 3-4, which provided benzyl ether 3-16 (Scheme 3.2.3), the enantiomer of 3-16 
was synthesized and protected to yield silyl ether 3-36. As shown in Scheme 3.2.8, 
the methyl ester was reduced to aldehyde 3-37 and converted to the α,β-
unsaturated ester via a Horner-Wadsworth-Emmons olefination. Oxidative cleavage 
of the terminal alkene then delivered aldehyde 3-39, which was subjected to a zinc 
triflate-mediated asymmetric alkynylzinc addition. It was discovered that heating the 
reaction initiated an in situ 1,4-conjugate addition, which gave 2,6-cis 
tetrahydropyran 3-40. Upon a literature review, this appears to be the first example 
of a zinc acetylene addition tandem 1,4-conjugate addition and this sequence will be 
discussed further in section 3.2.6. 
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Scheme 3.2.8. Zinc Acetylene Addition Tandem 1,4-conjugate Addition  
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3.2.6 Completion of the C15-C25 Segment of (-)-lasonolide A 
 
Wittig Olefination
Julia-Julia Olefination
Yamaguchi 
Lactonization
O
OMe
Me O
OHO O
OH
A
B
O
OH
Me
Me
Me
H
H H
H
H22
10
28
26
25
(-)-lasonolide A
[α]20D = -24.1
1-3   (28R) shown
14
 
Figure 3.2.1. (-)-Lasonolide A: Projected Disconnections 
 
As discussed in Chapter 2 (Section 2.1), Lee and coworkers determined that (-)-
lasonolide A (Figure 3.2.1) is indeed the biologically active enantiomer. Armed with 
this information, it was necessary to construct the C15-C25 segment of (-)-lasonolide 
A while optimizing the reaction sequence.  
 Aldehyde 3-15 was treated with the chlorotitanium enolate of acyl 
thiazolidinethione 3-5 to afford Evans syn aldol product 3-12 in excellent yield and 
diastereoselectivity (Scheme 3.2.9). At this point, exchange of the N-acyl thioimide 
for the corresponding methyl ester was optimized. Methyl ester 3-4 is volatile and 
co-elutes with the N-acyl thioimide by-product of the reaction, therefore isolation in 
high yield is problematic. Originally, copious amounts of methanol were used for the 
esterification, which was difficult to remove in vacuo due to the volatility of methyl 
ester 3-4. By using dichloromethane as the solvent and only twenty equivalents each 
of methanol and imidazole, and additional catalytic dimethylaminopyridine (DMAP) 
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to aid the esterification, removal of methanol in vacuo was no longer an issue. The 
additive effect of these simple alterations resulted in a yield increase of at least 30%. 
 Attention was then directed towards the installation of the quaternary center. 
Benzyl ether 3-41 was obtained in excellent selectivity using a chelation-controlled 
Frater-Seebach alkylation with benzyloxymethyl chloride (BOMCl = BnOCH2Cl). 
Commercially available BOMCl and material generated in the laboratory are 
contaminated with large quantities of benzyl alcohol. The yield of this reaction is 
dependent upon successful separation of BOMCl from benzyl alcohol via careful 
distillation. This precaution in conjunction with exceptionally pure methyl ester 
increases the yield to nearly 80%. Methyl ester 3-41 was reduced to the diol and 
selective oxidation49 of the primary alcohol to the corresponding the aldehyde was 
followed by conversion to α,β-unsaturated ester 3-42 via a Horner-Wadsworth-
Emmons protocol.  
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Scheme 3.2.9. Formation of α,β-Unsaturated Ester 3-42 via Evans Syn: Aldol Adduct 3-12  
 
 53 
 At this juncture, it was necessary to remove the benzyl group from 
intermediate 3-42. As will be discussed in Section 3.5, late-stage removal of the 
benzyl group proved quite difficult. Hydrogenation conditions employed to remove 
the benzyl moieties led to olefin reduction, while dissolving metal conditions, 2,3-
dichloro-5,6-dicyano-1,4-benzoquinone (DDQ), and Lewis acids resulted in 
decomposition. Therefore, it was deemed necessary to remove the benzyl groups 
early in the synthetic route.  
 Debenzylation of 3-42 required some experimentation. Using a wealth of Lewis 
acids including Me3SiBr, Me3SiI, Me2BBr, BCl3, BBr3, FeCl3, and CrO3/AcOH among 
others resulted in decomposition and/or low mass recovery of the starting material, 
while treatment with boron trifluoride etherate did not affect the benzyl ether. 
Furthermore, hydrogenation conditions employing Raney Nickel, Pd/C, and Pd(OH)2 
with a variety of solvents provided the alkane via reduction of the terminal olefin.  
 The use of DDQ led to an interesting result (Scheme 3.2.10). After dissolving 
benzyl ether 3-42 in dichloroethane (DCE) and aqueous buffer, the addition of DDQ 
afforded a mixture of desired diol 3-43 and the corresponding benzylidene acetal 3-
44 even if the secondary alcohol was protected as the silyl ether (TES or TBS). 
Varying reaction conditions, e.g. solvent ratio, temperature, equivalents, did not 
favor diol 3-43. In fact, the addition of buffer consistently led to poor mass recovery. 
However, it was found that the benzylidene acetal could be removed via acid 
hydrolysis in high yield. Based on these results, intermediate 3-41 was subjected to 
DDQ in dry DCE to yield benzylidene acetal 3-44 in good yield. Subsequent acid-
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catalyzed hydrolysis provided desired diol 3-43 in excellent yield based on recovery 
of acetal 3-44.  
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Scheme 3.2.10. Benzyl Ether 3-42 DDQ Experiment 
 
As shown in Scheme 3.2.11, this sequence was successfully applied and 
followed by protection of the resultant diol. Oxidative cleavage of the terminal alkene 
delivered aldehyde 3-45, which was subjected to the asymmetric alkynylzinc tandem 
1,4-conjugate addition. For comparison purposes, the original route is also 
illustrated. Alcohol 3-42 was protected as the silyl ether, followed by oxidative 
cleavage and asymmetric alkynylzinc addition tandem 1,4-conjugate addition to yield 
2,6-cis-tetrahydropyran 3-47. 
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Scheme 3.2.11. Revised Synthesis of 2,6-cis Tetrahydropyran 3-46 
 
The yield of the zinc triflate-mediated asymmetric alkynylzinc addition is 
dependent on a variety of factors. First, the zinc triflate purchased from Aldrich 
chemical company gave inconsistent results, while material obtained from Strem 
was reliable. It was necessary to dry this reagent under vacuum (0.2 mm Hg) at 110 
oC overnight; N-methylephedrine must also be dried under vacuum, but not heated. 
In addition, it was determined that performing the reaction under dilute conditions led 
to poor conversion and using the previously described drying precautions increased 
the reliability and yield of this reaction.  
While the mechanism of the reaction remains unclear, it is hypothesized that 
coordination of the metal with the alkyne generates species 3-51, which increases 
the acidity of the terminal alkyne (Scheme 3.2.12).50 This coordination allows for a 
weak amine base, such as triethylamine, to deprotonate the terminal alkyne and 
form the sp-hybridized anion, producing zinc acetylide 3-53. In the presence of 
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optically pure N-methylephedrine, chiral propargylic alcohols species 3-50 are 
isolated in high enantiomeric excess (92-98%).  
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Scheme 3.2.12. Mechanistic Hypothesis of the Alkynyzinc Addition Proposed by Carreira   
 
The rationale for the observed selectivity involving the formation of 2,6-cis 
tetrahydropyran 3-46 is shown in Scheme 3.2.13. Upon asymmetric alkynylzinc 
addition, a number of puckered conformations may be adopted en route to 1,4-
conjugate addition. Two chair conformations can be visualized, where a diaxial 
interaction exists in conformer 3-54 involving the bulky t-butyldimethylsilyl ether and 
the α,β-unsaturated ester. In conformer 3-56, this nonbonding interaction is 
minimized, leading to the observed 2,6-cis tetrahydropyran 3-46. A combination of 
COSY and NOESY NMR analysis confirmed the stereochemistry of the isolated 
product. 
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Scheme 3.2.13. Rational for Selectivity Observed in the Formation of 2,6-cis Tetrahydropyran 3-46 
 
A trans-hydrometalation51 and subsequent protodemetalation52 was used to 
achieve a two-step net trans reduction of alkyne 3-46 to olefin 3-57 (Scheme 3.2.14). 
The ester was reduced to the corresponding aldehyde 3-58, which completed the 
C15-C25 segment of (-)-lasonolide A. 
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Scheme 3.2.14. Installation of the C17-C18 trans olefin  
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3.3 B Ring: Synthesis of the C1-C14 Segment 
 
On the basis of the success of the tandem alkynylzinc-hetero 1,4-conjugate 
addition utilized to construct the A-ring, the strategy was to be similarly applied to the 
synthesis of the C1-C14 B-ring segment 3-59 of (-)-lasonolide A (Scheme 3.3.1). 
Pivotal intermediate 3-60 could be formed via reduction of the ring-closing 
metathesis (RCM) product obtained from 3-61.  
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Scheme 3.3.1. Retrosynthetic Analysis of C1-C14 Segment of (-)-lasonolide A 
 
3.3.1 Exploiting the Non-Evans Syn Aldol 
 
The construction of ester 3-62 began with formation of non-Evans syn aldol 
adduct 3-65, which was obtained via chelated transition state 3-64.53  Protection as 
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the silyl ether was followed by cross-metathesis to provide α,β-unsaturated ester 3-
66. A reduction-oxidation sequence was used to acquire aldehyde 3-67 and allow 
the ester to remain intact. 
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Scheme 3.3.2. Synthesis of Aldehyde 3-67 via Non-Evans syn Aldol 
 
Requisite aldehyde 3-67 was subjected to an asymmetric zinc-mediated alkyne 
addition to yield 2,6-cis-tetrahydropyran 3-69 presumably through transition state 
3.68 (Scheme 3.3.3). Pyran 3-69 was elaborated to metathesis precursor 3-71 via a 
three-step sequence. Deprotection of the acetylene was readily achieved under 
standard conditions and the terminal olefin was obtained through hydrogenation of 
the alkyne in the presence of Lindlar’s catalyst. Numerous conditions were used to 
instigate transesterification with methallyl alcohol, but potassium t-butoxide 
conferred the cleanest reaction.  
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Scheme 3.3.3. Synthesis of Diene 3-71 via Zinc-mediated Alkyne Addition 
 
3.3.2 Installation of the C12-C13 Trisubstituted Olefin  
 
3.3.2.1. Ring Closing Metathesis Approach 
 
Efforts to obtain the nine-membered ring closing metathesis product 3-72 led 
only to dimerization of the terminal olefin (Scheme 3.3.4). Further attempts to form 
the trisubstituted olefin via cross-metathesis also led to dimerization of 3-71 at the 
terminal olefin.  
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Scheme 3.3.4. Metathesis Reactions Involving Diene 3-71  
 
3.3.2.2. Nozaki Hiyama Kishi Reaction 
 
Since lactone 3-72 was never isolated, a new strategy was devised for the 
addition of an organochromium compound to aldehyde 3-67 which could directly 
install the trisubstituted olefin. These reaction conditions were originally described by 
Nozaki and Hiyama as a method for vinylic C-C bond formation, while Kishi later 
found that nickel salts exhibit a catalytic effect on the formation the C-Cr bond.54  
Trisubstituted vinyl iodide 3-76 was prepared via Grignard addition to propargyl 
alcohol and subsequent protection of the resulting allylic alcohol. The 
alkenylchromium reagent was prepared from protected vinyl iodide 3-76 by reduction 
with chromium(II) chloride under nickel catalysis (Scheme 3.3.5). This reaction 
proved problematic. Since the reaction is known to be particularly solvent-
dependent, numerous attempts were made to increase the yield by varying reaction 
conditions as highlighted in Table 3.3.1. In addition, use of ligand 3-79, constructed 
following Kishi’s procedure,55 resulted in the wrong diastereomer (confirmed by 
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Mosher ester analysis and NMR after conversion to the pyran under Michael 
conditions). This was not surprising, since previous examples of vinyl additions 
involving this ligand and α-methyl-substituted aldehydes have not been reported.  
 Probing whether substrate control could result in higher steric bias towards 
the desired diastereomer, the reaction was allowed to proceed without ligand 3-79. 
As shown in Table 3.3.1, the yields increased, but no stereoselectivitiy was 
observed.  
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Scheme 3.3.5. Organochromium Addition Involving Aldehyde 3-67 
 
3.3.3 Revised Approach to the C1-C14 Segment 
 
After additional attempts to install the trisubstituted olefin via stereoselective 
addition to aldehyde 3-62, or addition to the corresponding Weinreb amide 
surrogate, it was apparent the route should be abandoned. An alternate route to 
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tetrahydropyran B was investigated that relied on an Evans syn aldol involving 
vinylic aldehyde 3-82 (Scheme 3.3.6). A boron-mediated 1,3-syn reduction would 
then be used to install the oxygenated stereocenter at C9. 
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Scheme 3.3.6. Revised Retrosynthetic Analysis en route to C1-C14 Segment 3-59 
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3.3.4 Evans Syn Aldol Involving a Vinylic Aldehyde  
 
Aldehyde 3-86 was prepared in three steps from benzyl propargyl ether (Scheme 
3.3.7). Upon carbomethoxylation, the corresponding α,β-acetylenic ester 3-84 was 
treated with a Gilman reagent to form the trisubstituted α,β-unsaturated ester 3-85.56 
Reduction of the ester moiety was followed by oxidation to yield trisubstituted α,β-
unsaturated aldehyde 3-86.  
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Scheme 3.3.7. Preparation of Aldehyde 3-86 
 
Aldehyde 3-86 was added to the chlorotitanium enolate of N-acyl thioimide 3-5 to 
form Evans syn aldol adduct 3-88 in 90% yield and 98:2 diastereoselectivity 
(Scheme 3.3.7). At this point aldol adduct 3-88 required a two-carbon homologation 
in order to complete the carbon framework of lactone 3-80 (Scheme 3.3.5).  
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Scheme 3.3.7. Evans syn Aldol Adduct 3-88 via N-thioimide 3-5 
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3.3.5 Extending the Versatility of the Thiazolidinethione Auxiliary  
 
The N-acyl thioimide auxiliary, unlike traditional oxazolidinone variants, is easily 
removed from aldol adducts via nucleophillic addition to provide a variety of 
functional groups as shown in Scheme 3.3.8.57 For example, Weinreb amide 
derivative 3-90 and ester 3-91 are formed in moderate yield, while DIBAL-H 
reduction affords aldehyde 3-93 in high yield. After it was discovered methyl 
phosphonate could directly displace the auxiliary to form β-ketophosphonate 3-92, 
alternate carbon nucleophiles were explored to prepare homologated products, 
particularly β-ketonitrile 3-95 and β-ketoester 3-94, for the construction of lactone 3-
80.  
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Scheme 3.3.8. Displacement of the N-thioimide Auxiliary 
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 After some experimentation, N-acyl thioimide aldol adduct 3-88 was treated with 
lithiated acetonitrile to give the β-ketonitrile 3-89 (Scheme 3.3.9). Reduction of β-
ketonitrile 3-89 set the stereochemistry at C9. Nitrile 3-90 was then reduced, 
followed by in situ formation of the hemiacetal. However, all attempts at selective 
oxidization to lactone 3-91 in the presence of the secondary alcohol failed with this 
substrate. A more direct route was explored; where the lithium enolate of ethyl 
acetate was utilized as a nucleophile in the displacement of N-acyl thioimide aldol 
adduct 3-88. Reduction of β-ketoester 3-93 set the stereochemistry at C9, and 
subsequent exposure to PPTS in refluxing benzene afforded lactone 3-91. 
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Scheme 3.3.9. Displacement of the N-Thioimide Auxiliary  
 
 Alcohol 3-91 was protected to give 3-94, which was treated with 
allylmagnesium bromide to give the corresponding hemiketal (Scheme 3.3.10).  
Further reduction with triethylsilane and boron trifluoride etherate furnished cis-
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substituted pyran 3-95 in 84% yield and >20:1 diastereoselectivity.58 A variety of 
protocols were employed to remove the benzyl group including Lewis acids and 
DDQ, but only dissolving metal conditions cleanly provided allylic alcohol 3-96, albeit 
in widely varying yields.  
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Scheme 3.3.10. 2,6-cis-tetrahydropyran 3-95 via Nucleophillic Addition to Lactone   
 
After the synthesis of 2,6-cis-tetrahydropyran 3-95  (Scheme 3.3.10), Jennings 
and coworkers published their work on the C1-C14 segment of (-)-lasonolide A 
(section 2.1.7). Because the nucleophillic addition to lactone 3-94 was similar to the 
protocol employed by Jennings and coworkers, and the benzyl deprotection was 
unreliable, an alternate synthesis from Jennings was pursued (Scheme 3.3.11).  
 Based upon previous success, aldehyde 3-97 was added to the 
chlorotitanium enolate of N-acyl thioimide 3-5 to form Evans syn aldol adduct 3-98 in 
good yield and excellent selectivity. The thioimide auxiliary was displaced with 
lithiated acetonitrile, and further 1,3-syn reduction of β-ketonitrile 3-99 set the 
stereochemistry at C9. Nitrile 3-100 was reduced, followed by in situ formation of the 
hemiacetal. A Horner-Wadsworth-Emmons olefination and in situ 1,4-conjugate 
addition furnished 2,6-cis-tetrahydropyran 3-102 as one diastereomer as detected by 
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1H and 13C NMR.59 Protection of the secondary alcohol as the silyl ether supplied 3-
103. 
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Scheme 3.3.11. 2,6-cis-tetrahydropyran 3-101 via Horner-Wadsworth-Emmons Protocol 
 
3.3.6 Installation of the C2-C5 Diene 
  
 Two strategies were explored to install the C2-C5 diene based on 
homologation of 3-96 or 3-102. The first involved a cross-metathesis and the other 
involved a Horner-Wadsorth-Emmons protocol. 
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3.3.6.1. Cross-Metathesis Approach  
 
 A cross-metathesis utilizing Grubbs’ second generation catalyst and diene 3-
104 was utilized to achieve extension of 3.96.60 In addition, varying amounts of 
dimer 3-106 were also isolated, and successfully recycled61 to provide additional 3-
105. A mild allylic oxidation with manganese dioxide gave aldehyde 3-107.  
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Scheme 3.3.12. Homologation to Diene via Cross-Metathesis 
 
3.3.6.2. Horner-Wadsworth-Emmons Approach 
 
 To extend ester 3-102, a Horner-Wadsorth-Emmons protocol utilizing 
phosphonocrotonate 3-108 was employed.62 The allylic alcohol was deprotected 
using tetrabutylammonium fluoride (TBAF) at 0 oC, and the ester was reduced to the 
corresponding aldehyde by careful addition of diisobutylaluminum hydride. The 
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aldehyde was immediately subjected to the lithium anion of phosphonate 3-10863 to 
provide the C1-C14 segment 3-110 after oxidation with manganese dioxide. 
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Scheme 3.3.13. Homologation to Diene via Horner-Wadsworth-Emmons Protocol 
 
3.4 Side Chain: Synthesis of the C26-C35 Segment 
 
3.4.1 Glycolate Alkylation Approach 
 
 The C28 stereogenic center present in the side chain was installed via 
asymmetric alkylation of the sodium enolate of glycolate 3-111 (R = Bn) or glycolate 
3-112 (R = TBS) with allyl iodide to stereoselectively provide 3-113 or 3-115, 
respectively (Scheme 3.4.1).64 The side chain synthesis was initiated with benzyl 
glycolate 3-111, but after troublesome late-stage benzyl deprotection (section 3.5), it 
was deemed necessary to reconstruct the side chain beginning with silyl glycolate 3-
112.  
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Scheme 3.4.1. Glycolate Alkylation to Install the C28 Stereocenter 
 
 Glycolate alkylation product 3-113 was subjected to a two-step oxidative 
cleavage sequence and subsequent reduction to yield primary alcohol 3-114, while 
product 3-115 was subjected to ozonolysis and in situ reduction to yield the 
corresponding alcohol. Alcohols 3-114 and 3-116 were protected as the t-
butyldimethylsilyl ether and hydrolyzed to yield acids 3-117 and 3-118, respectively.  
 Following a protocol similar to Lee, alcohol 3-121 was assembled in six steps 
from 2-butenediol 3-119. Bis-silyl protection, ozonolysis, and Grignard addition 
provided racemic alcohol 3-120. Swern oxidation of alcohol 3-120 to the ketone 
followed by a methylene Wittig reaction furnished the 1,1-disubstituted olefin. 
Desilylation with hydrofluoric acid in acetonitrile supplied alcohol 3-121 necessary for 
the side chain esterification. 
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Scheme 3.4.2. Construction of alcohol 3-121 
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A DCC-mediated coupling of alcohol 3-121 with acids 3-117 and 3-118 afforded 
esters 3-122 and 3-123, respectively (Scheme 3.4.3). The primary alcohols were 
liberated, converted to the corresponding iodide, and subsequently to their 
phosphonium salts 3-124 and 3-125.  
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Scheme 3.4.3. Assembly of the Phosphonium Salt of the Side Chain 
 
3.5 Coupling Strategies  
 
A variety of substrates were utilized in an effort to construct the carbon backbone 
of (-)-lasonolide A. The initial approach involved the coupling of benzyl-protected 
phosphonium salt 3-124 and benzyl-protected aldehyde 3-126 using a standard 
Wittig olefination protocol to provide coupled product 3-127 (Scheme 3.5.1).  
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Scheme 3.5.1. Wittig Olefination: Coupling the A-Ring and the Side-Chain  
 
 Oxidation of sulfide 3-127 to sulfone 3-129 (Scheme 3.5.2) allowed for Julia 
olefination65 with PMB-protected aldehyde 3-107 providing intermediate 3-131 
(Scheme 3.5.3). 
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Scheme 3.5.2. Oxidation of the Sulfide to the Sulfone 
 
Substrate 3-131 was treated with HF-pyridine to deprotect the secondary TBS 
ether and trifluoroacetic acid to liberate the PMB-protected acid, and subjected to 
Yamaguchi macrolactonization conditions.66 Disappointingly, the resulting NMR 
spectra showed impurities despite purification via HPLC. Regardless, the material 
generated was subjected to hydrogenation conditions (H2/Pd-C, THF), dissolving 
metal reduction (Na/NH3, LDBB), 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ), 
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and Lewis acids (BCl3, SnCl4, BF3.OEt2). Unfortunately, all attempts at late-state 
benzyl-deprotection of 3-133 did not result in the isolation of (-)-lasonolide A. After 
this disappointing result, it was necessary to construct the segments using different 
protecting groups, such as silyl ethers, that did not require such a rigorous late-stage 
deprotection.  
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Scheme 3.5.3. Julia Olefination: Appending the B-Ring 
 
 Thus, after reconstructing the silyl-protected fragments, the anion of TBS-
protected phosphonium salt 3-125 was reacted with TBS-protected aldehyde 3-58 to 
provide coupled intermediate 3-128 (Scheme 3.5.1). Oxidation of sulfide 3-128 
provided sulfone 3-130 (Scheme 3.5.2). Julia olefination with aldehyde 3-107 
afforded polyene 3-132 (Scheme 3.5.3). Unfortunately, liberation of the PMB-
protected acid from this substrate with trifluoroacetic acid suffered from poor results 
and did not lead to the successful isolation of the desired macrolactone 3-134 
(Scheme 3.5.4). Numerous attempts involving a variety of deprotection conditions 
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exhausted supplies of 3-132, and prompted further reconsideration of the final 
deprotection strategy of the macrolactone precursor.  
 
O
OMe
Me O
OTBS
O
OMOM
PMBO
Me
OR
H
Me
Me
RO
H H
H
H
O
O
OMe
Me O
ORO O
OMOMO
OR
Me
Me
Me
H
HH
H
H
3-131
3-132
R = Bn
R = TBS
3-133
3-134
R = Bn
R = TBS
 
Scheme 3.5.4. Late-Stage Deprotection-Macrolactonization Strategy with PMB-Protected Acid 
 
 Since deprotection of the PMB-protected acid proved problematic, it was 
reasoned that a TIPS-protected acid would offer a wider range of deprotection 
conditions to test. Therefore, intermediate 3-129 was prepared once more and 
coupled with aldehyde 3-110 to afford silyl protected intermediate 3-135 (Scheme 
3.5.5). However, another challenge was encountered during the ensuing 
deprotection-macrolactonization sequence.  
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Scheme 3.5.5. Julia Olefination: Appending the Silyl-Protected B-Ring 
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Previous attempts at deprotection and macrolactonization at a scale necessary 
for detection by 1H NMR quickly consumed material, therefore a different tactic had 
to be utilized to minimize fast consumption of precious intermediate 3-135. 
Experiments were performed on µg – mg scale, and analyzed by mass spectrometry 
(Scheme 3.5.6).  
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Scheme 3.5.6. Late-Stage Deprotection-Macrolactonization Strategy with TBS-Protected Acid 
 
Deprotection strategies involving fluoride sources led to decomposition, while 
experiments involving acid sources led to varied results. In each case, the liberation 
of the acid moiety occurred based on the mass spectra results. Using 1% HCl in 
EtOH resulted in full deprotection, while reactions involving PPTS, CSA, and TsOH 
resulted in products with various silyl groups remaining intact. Each of the products 
isolated were subjected to Yamaguchi macrolactonization conditions.  
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 Based on promising mass spectral results of the products isolated from the 
Yamaguchi macrolactonization, increasing quantities of 3-135 were subjected to 1% 
HCl in EtOH and subsequent macrolactonization. After purification via HPLC, the 1H 
NMR spectra of the isolated product was similar to the natural product, but 
unfortunately there were discrepancies from 2.5 – 4.0 ppm. Based on 1H NMR and 
mass spectra, the isolated product could be 3-137, resulting from macrolactonization 
with the less-hindered primary alcohol.  
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Scheme 3.5.6. Macrolactonization Efforts 
 
  In an effort to inhibit cyclization leading to 3-137, attempts were made to 
selectively protect the primary alcohol of intermediate 3-136 (Scheme 3.5.7, A - C). 
The material was subjected to various silylation conditions (TESCl, TMSCl, TMSOTf) 
and subsequent Yamaguchi macrolactonization. However, the desired products 
were never isolated. 
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Scheme 3.5.7. Efforts Directed Toward Selective Protection of the Primary Alcohol 
  
Another strategy (Scheme 3.5.7, D) involved formation of the mixed anhydride 
prior to silyl protection. After formation of the mixed anhydride, the reaction medium 
was filtered, concentrated in vacuo, and subjected to TMSCl/pyridine. The 
intermediate was dissolved in benzene and added via syringe pump to a solution of 
DMAP in benzene. Regrettably, the desired product was not isolated.  
Based upon these unsatisfactory results, a new approach was considered to 
intercept macrolactone 3-138 and avoid a deprotection-macrolactonization 
sequence. The pivotal step would entail the ring-closing-metathesis (RCM) 
macrocyclization of polyene 3-139 to install the C4-C5 trans alkene (Scheme 
3.5.8).67  
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Scheme 3.5.8. RCM-Macrocyclization Retrosynthetic Approach 
  
Necessary aldehyde 3-140 was constructed from intermediate 3-103 in a four-
step sequence involving reduction of the ester to the aldehyde with DIBAL-H, 
followed by a methylene Wittig to install the terminal olefin. Deprotection of the allylic 
alcohol with TBAF and oxidation with manganese dioxide provided aldehyde 3-140 
for the Julia olefination.  
 In order to construct polyene 3-139 from tetrahydropyran 3-57, the ester was 
reduced to the primary alcohol and protected as the pivaloate. Oxidation to the 
sulfone was achieved under standard conditions with ammonium heptamolybdate. A 
bis-TBS silyl deprotection was performed followed by selective protection of the 
primary alcohol with TBSCl and protection of the secondary alcohol with TMSOTf to 
provide intermediate 3-141, which was reacted with aldehyde 3-140 utilizing 
NaHMDS.  
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The selective deprotection of the secondary TMS ether in the presence of the 
primary TBS ether utilizing acidic conditions (0.5M HCl, THF) or treatment with a 
fluoride source (H2SiF6, MeCN) proved problematic. In each instance, the diol 
resulted from concomitant liberation of the primary alcohol. After protecting the 
primary alcohol with TBSCl, the secondary alcohol was subjected to DCC-mediated 
esterification conditions to supply ring-closing-metathesis (RCM) macrocyclization 
precursor 3-139. Preliminary experiments involving polyene 3-139 were performed in 
an effort to find suitable ring-closing-metathesis (RCM) macrocyclization reaction 
conditions. In particular, both Grubb’s first and second generation ruthenium catalyst 
were employed in dichloromethane at ambient temperature and under reflux, but 
desired macrolide 3-138 was not isolated.  
 
 
 
  
 
 
EXPERIMENTAL 
 
A.  Materials and Methods 
 
Infrared (IR) spectra were obtained using a JASCO FT/IR 460-plus. Proton and 
carbon nuclear magnetic resonance (1H, 13C NMR, COSY, NOESY) spectra were 
obtained on the following instruments: Bruker model DRX 300 (1H at 300 MHz; 13C 
at 75 MHz), Bruker model DRX 400 (1H at 400 MHz; 13C at 100 MHz), and Bruker 
model DRX 500 (1H at 500 MHz; 13C at 125 MHz). Chemical shifts are reported in 
ppm with internal references for 1H NMR: CHCl3
 
(7.26), C6D6
 
(7.15), CD3OD (3.31) 
and deuterated solvent shifts for 13C NMR CHCl3
 
(77.0), C6D6
 
(128.06), CD3OD 
(49.00). Multiplicities are reported as (s) singlet, (d) doublet, (t) triplet, (q) quartet and 
(m) multiplet. Unresolved, overlapping resonances are reported as “band”. Coupling 
constants (J) are given in Hertz. Optical rotations were determined using a JASCO 
P-1010 polarimeter. Mass spectra were obtained using a Micromass Quattro II (triple 
quad) with nano-electrospray ionization. Thin layer chromatography (TLC) was 
conducted on silica gel 60 F254 TLC plates purchased from EMD Chemicals, Inc. 
Flash chromatography was performed using silica gel (60 Å, 40 to 63 µm) purchased 
from Sorbent Technologies, Inc. Diethyl ether (Et2O), tetrahydrofuran (THF), 
dichloromethane (CH2Cl2), and toluene (PhMe) were dried by passing through a 
column of neutral alumina under nitrogen immediately prior to use. Alkylamines and 
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benzene were distilled from calcium hydride immediately prior to use. Dimethyl 
sulfoxide (DMSO) was distilled under reduced pressure from calcium hydride and 
stored over 4Å molecular sieves. Anhydrous N,N-dimethylformamide (DMF) and N-
methylpyrrolidinone (NMP) were purchased from Aldrich chemical company in 1L 
Sure/SealTM bottles. Titanium (IV) chloride was stored in a Schlenk flask under 
argon. Pivaloyl chloride was distilled and stored over 4Å molecular sieves. Titanium 
(IV) isopropoxide was distilled under reduced pressure and stored in a dark 
desiccator. Dess-Martin periodinane was prepared according to literature 
procedures and stored at -20 ºC. Zinc triflate (ZnOTf)2 was purchased from Strem 
chemical company and dried in the reaction vessel for 12 h under vacuum (0.2 
mmHg). The reaction vessel was placed in a 110 oC oil bath during the drying 
process. N-methylephedrine (NME) was dried for 12 h under vacuum (0.2 mmHg). 
All other reagents and solvents were used as received from the manufacturer. All air 
and water sensitive reactions were performed in flasks flame dried under vacuum, 
cooled under a positive flow of argon, and conducted under an argon atmosphere. 
 
B: Experimental 
B-1. A-ring: C15-C25 Segment of (-)-lasonolide A: 
OH
OH
Br
3-13 3-14
 
THF (130 mL), DI water (130 mL), allyl bromide (624 mmol, 54 mL), and 40% 
aqueous glyoxal (260 mmol, 30 mL) were added to a three-neck round-bottomed 
flask fitted with a mechanical stirrer and reflux condenser. Granular tin metal (624 
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mmol, 74g) was added in three portions. The suspension was stirred under 
ultrasonic irradiation (few ice cubes added to sonicator) for 2 h. The THF was 
removed in vacuo and 25% aq. KOH was added (60 mL). Solid NaCl and diethyl 
ether (350 mL) were added and the mixture was allowed to stir vigorously for 1 h. 
The thick suspension was filtered through celite using a large Buchner funnel under 
vacuum (aspirator). The filter pad was rinsed with excess Et2O, and the combined 
ether washes were concentrated in vacuo. The residue was purified by gradient 
flash column chromatography, by eluting with 15%-25%-45% EtOAc/hexanes, to 
afford 31.75g (86%) of diol 3-14 as translucent, viscous oil. 
 
OH
OH
3-14
O
3-15
 
Diol 3-14 (77.01 mmol, 10.94 g) was dissolved in CH2Cl2
 
(40 mL) and pH = 4 buffer 
(40 mL). The flask was fitted with a mechanical stirrer and cooled in an ice bath. 
Sodium periodate (92.41 mmol, 20 g) was added and the suspension was stirred for 
2 h. Aqueous 1:1 Na2S2O3:NaHCO3 was added and the mixture was stirred for 10 
min. The layers were separated and the aqueous solution was extracted with CH2Cl2
 
(2x 10 mL). The combined organic extracts were washed with brine (2x) and dried 
over Na2SO4 with a septum and positive flow of argon. The flask was cooled to -78 
°C awaiting transfer to the reaction vessel describ ed in the following procedure.  
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A stirring solution of (S)-4-benzyl-3-propionyl-1,3-thiazolidine-2-thione 3-5 (13.62 g, 
51.34 mmol) in CH2Cl2
 
(350 mL) was cooled in an ice bath. TiCl4
 
(5.91 mL, 53.9 
mmol) was added at once, turning the solution a yellow-orange hue. After stirring the 
mixture for 20 min, (-)-sparteine (11.8 mL, 51.34 mmol) was added at once 
converting the solution to a purple-brown hue. After stirring the mixture for 20 min, 
N-methyl-2-pyrrolidinone (NMP) (5.0 mL, 51.34 mmol) was added dropwise. After 
stirring the mixture for 20 min the solution was cooled to -78 °C and pre-cooled 3-
butenal 3-15 was added as a solution in CH2Cl2. The homogeneous reaction mixture 
was stirred at -78 °C for 4 h, and then warmed in a n ice bath. Half-saturated NH4Cl 
solution was added and the resulting mixture was stirred vigorously while warming to 
room temperature. The layers were separated and the aqueous solution was 
extracted with CH2Cl2
 
(2x). The combined organic extracts were washed with brine, 
dried over Na2SO4, filtered, and evaporated in vacuo. The residue was purified by 
gradient flash column chromatography, eluting with 5%-15%-25% EtOAc/hexanes, 
to afford 16.68 g (97%) of aldol 3-12 as a bright-yellow colored, viscous oil. 1H NMR 
(500 MHz, CDCl3) δ ppm 7.32 (dd, J = 9.11, 5.72 Hz, 2H), 7.30-7.23 (m, 4H), 5.77 
(dd, J = 17.10, 10.14 Hz, 1H), 5.32 (ddd, J = 10.80, 7.06, 3.91 Hz, 1H), 5.12 (dd, J = 
14.11, 5.67 Hz, 2H), 4.48 (dd, J = 6.82, 3.48 Hz, 1H), 4.01-3.95 (m, 1H), 3.37 (dd, J 
= 11.45, 7.04 Hz, 1H), 3.19 (dd, J = 13.18, 3.83 Hz, 1H), 3.02 (dd, J = 13.17, 10.54 
Hz, 1H), 2.88 (d, J = 11.53 Hz, 1H), 2.27 (t, J = 7.48 Hz, 1H), 2.25-2.17 (m, 1H), 
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1.21 (m, 12H); 13C NMR (126 MHz, CDCl3) δ ppm 201.131, 177.893, 173.045, 
136.248, 134.095, 129.346, 128.836, 127.189, 118.144, 95.242, 77.177, 77.126, 
76.968, 76.923, 76.669, 71.459, 68.680, 42.617, 38.771, 36.651, 31.977, 29.616, 
14.056, 10.626; IR (film) 3442.94, 2926.01, 1689.64, 1494.83, 1454.33, 1361.74,  
1342.46, 1261.45, 1192.01, 1165, 1136.07, 1029.99, 918.12, 744.52, 702.09 cm-1; 
MS calculated for C17H21NO2S2 [M + Na]+: 358.1, found 358.3; [α]24D = +151.6 o (c 
1.55, CH2Cl2).  
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O
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Aldol product 3-12 (16.68 g, 49.79 mmol) was diluted in CH2Cl2 (200 ml), treated 
with MeOH (31 mL, 770 mmol), imidazole (52.5 g, 770 mmol), and 4-
dimethylaminopyridine (DMAP) (0.6 g, 4.9 mmol) before stirring for 18 h. The crude 
reaction mixture was evaporated in vacuo and the residue was mixed with hexanes, 
whereupon the (S)-4-(phenylmethyl)-2-thiazolidinethione precipitated as a white 
solid (after seeding). The solid was filtered off and washed with additional hexanes. 
The combined hexanes solution was washed several times with ice cold 2.5M 
aqueous sodium hydroxide to remove any remaining (S)-4-(phenylmethyl)-2-
thiazolidinethione. The combined organic extracts were washed with brine, dried 
over Na2SO4, filtered, and evaporated in vacuo. The residue was purified by flash 
column chromatography, eluting with 25% EtOAc/hexanes, to afford 6.56 g (84%) of 
methyl ester 3-4 as pale-yellow colored, viscous oil. 1H NMR (500 MHz, CDCl3) δ 
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ppm 5.84-5.74 (m, 1H), 5.16-5.07 (m, 2H), 3.98-3.91 (m, 1H), 3.68 (s, 3H), 2.59-2.51 
(m, 1H), 2.28-2.15 (m, 2H), 1.19 (t, J = 8.85 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 
ppm 176.280, 134.355, 118.057, 77.253, 77.000, 76.745, 70.918, 51.816, 43.643, 
38.489, 10.822; IR (film) 2953.02, 2953.02, 2922.16, 2922.16, 2852.72, 1697.36, 
1672.28, 1454.33, 1261.45, 1165, 1136.07, 1029.99, 918.12, 746.45, 702.09 cm-1; 
MS calculated for C8H14O3 [M + H]+: 159.09, found 159.0; [α]24D = +5.4 o (c 0.9, 
CH2Cl2).  
 
O OH
MeO
Me
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O
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In a 3-neck round-bottomed flask, a solution of diisopropylamine (18.3 mL, 130.8 
mmol) in THF (40 mL) was cooled to -78 °C. A 2.5M s olution of n-butyllithium (43.6 
mL, 109 mmol) was added via addition funnel. Upon complete addition, the solution 
was stirred for 20 min. A solution of methyl ester 3-4 (8.57 g, 54.5 mmol) in THF 
(100 mL) was pre-cooled to -78 °C and added via can nula. The reaction vessel was 
placed in a pre-cooled (-20 °C)  cryocool instrument for 20 min, then re-cooled to -78 
°C. Freshly distilled (0.2 mmHg, 80 °C oil bath, gl ass-wool insulated short-path, 
distillate collected over anhydrous CaCl2 spheres at ~60 °C) benzyloxymethyl 
chloride (BOMCl) (30 mL, 218 mmol) was added via addition funnel. The reaction 
vessel was place in a precooled (-30 °C)  cryocool instrument and the mixture was 
stirred under an argon-filled balloon for 48 h. Half-saturated NH4Cl solution was 
added and the resulting mixture was stirred vigorously while warming to room 
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temperature. The layers were separated and the aqueous solution was extracted 
with CH2Cl2
 
(2x). The combined organic extracts were washed with brine, dried over 
Na2SO4, filtered, and evaporated in vacuo. The residue was purified by gradient 
flash column chromatography, eluting with 5%-15%-25%-40% EtOAc/hexanes, to 
afford 12.08 g (79%) of 3-41 as an opaque, viscous oil. 1H NMR (500 MHz, CDCl3) δ 
ppm 7.35 (tt, J = 12.78, 5.36 Hz, 3H), 7.31-7.27 (m, 3H), 5.93-5.83 (m, 1H), 5.11 
(ddd, J = 16.72, 8.29, 2.31 Hz, 2H), 4.52-4.49 (m, 2H), 3.92 (dd, J = 10.06, 2.77 Hz, 
1H), 3.62 (dd, J = 9.05, 4.32 Hz, 1H), 3.72-3.69 (m, 3H), 3.68 (d, J = 5.38 Hz, 1H), 
2.28-2.21 (m, 1H), 2.14-2.06 (m, 1H), 1.26 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 
ppm 175.705, 175.689, 137.775, 137.761, 135.430, 128.480, 128.461, 128.331, 
128.314, 127.669, 127.653, 127.513, 127.496, 126.884, 117.143, 117.119, 77.254, 
76.999, 76.746, 73.718, 73.692, 73.523, 73.502, 73.427, 73.403, 51.985, 51.971, 
51.956, 51.280, 51.262, 36.800, 16.691, 16.676; IR (film) 3512.37, 2949.16, 2918.3, 
2866.22, 1728.22, 1716.65, 1641.42, 1454.33, 1361.74, 1234.44, 1138, 1097.5, 
1072.42, 1028.06, 991.41, 914.26, 736.81, 698.23 cm-1; MS calculated for C16H22O4 
[M + Na]+: 301.15, found 301.1; [α]24D = +3.0 o (c 1.51, CH2Cl2).  
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A solution of ester 3-41 (12.08 g, 43.6 mmol) in CH2Cl2 (400 mL) was cooled to -78 
°C. A solution of i-Bu2AlH (1 M in hexanes, 175 mL, 175 mmol) was added dropwise 
via addition funnel and the mixture was stirred for 3 h after addition was complete. A 
saturated solution of sodium potassium tartrate (200 mL) was added and the mixture 
was warmed to room temperature. Water (100 mL) and CH2Cl2
 
(100 mL) were added 
and the mixture was stirred vigorously for 1 h. The layers were separated and the 
aqueous solution was extracted with CH2Cl2
 
(2x100 mL). The combined organic 
extracts were washed with brine, dried over Na2SO4, filtered, and evaporated in 
vacuo. The residue was purified by gradient flash column chromatography, eluting 
with 25%-40% EtOAc/hexanes, to afford 9.61 g (88%) of the diol as opaque, viscous 
oil. 1H NMR (500 MHz, CDCl3) δ ppm 7.40-7.32 (m, 3H), 7.33-7.27 (m, 3H), 5.88 
(dddd, J = 16.73, 10.64, 8.10, 5.93 Hz, 1H), 5.18-5.12 (m, 2H), 4.70 (s, 1H), 4.51 (q, 
J = 12.08 Hz, 2H), 3.89 (td, J = 10.61, 2.72 Hz, 1H), 3.74 (dd, J = 11.08, 6.14 Hz, 
1H), 3.65 (dd, J = 11.08, 4.18 Hz, 1H), 3.51-3.46 (m, 2H), 2.80 (d, J = 4.11 Hz, 1H), 
2.52 (t, J = 8.50 Hz, 1H), 2.29 (ddd, J = 13.89, 3.96, 1.85 Hz, 1H), 2.17-2.08 (m, 1H), 
0.81 (s, 3H); 13C NMR (126 MHz, CDCl3) δ ppm 137.893, 135.977, 128.519, 
128.438, 127.759, 127.595, 127.550, 126.942, 117.742, 77.253, 77.000, 76.745, 
75.725, 73.557, 73.536, 68.164, 42.611, 36.085, 15.454; IR (film) 3377.36, 3361.93, 
3064.89, 3030.17, 2962.66, 2929.87, 2914.44, 2875.86, 1639.49, 1454.33, 1417.68, 
1361.74, 1207.44, 1095.57, 1076.28, 1039.63, 1028.06, 991.41, 912.33, 736.81, 
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698.23 cm-1; MS calculated for C15H22O3 [M + Na]+: 273.33, found 273.3; [α]24D = 
+2.36 o (c 2.18, CH2Cl2).  
 
OH
HO
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OBn
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O
Me
OBn
 
The diol (1.47 g, 5.87 mmol) was dissolved in CH2Cl2
 
(20 mL) and DI water (2 mL). 
PhI(OAc)2 and TEMPO were added and the solution was stirred at room 
temperature for 30 min. Aqueous 1:1 Na2S2O3:NaHCO3 was added and the mixture 
was stirred for 10 min. The layers were separated and the aqueous solution was 
extracted with CH2Cl2
 
(2x 10 mL). The organic extracts were concentrated in vacuo 
and the residue was purified by gradient flash column chromatography, eluting with 
hexanes-5%-15% EtOAc/hexanes, to afford 1.21 g (83%) of the aldehyde as an 
opaque, viscous oil. 1H NMR (400 MHz, CDCl3) δ ppm 9.72 (s, 1H), 7.38-7.26 (m, 
7H), 5.86 (dddd, J = 20.89, 9.53, 7.77, 6.16 Hz, 1H), 5.18-5.09 (m, 2H), 4.50 (d, J = 
5.87 Hz, 2H), 4.04 (dd, J = 10.19, 2.76 Hz, 1H), 3.69-3.61 (m, 1H), 3.59 (d, J = 9.40 
Hz, 1H), 2.68 (d, J = 0.59 Hz, 1H), 2.28 (dtdd, J = 7.47, 4.19, 2.78, 1.40 Hz, 1H), 
2.19-2.07 (m, 2H), 1.07 (d, J = 7.91 Hz, 4H); 13C NMR (126 MHz, CDCl3) δ ppm 
205.511, 137.380, 134.960, 128.469, 127.901, 127.625, 118.086, 77.317, 76.999, 
76.682, 73.660, 72.928, 72.283, 54.019, 36.455, 13.242; IR (film) 3438.46, 2859.92, 
1725.01, 1641.13, 1496.49, 1306.54, 1096.33, 997.232, 738.603, 699.069 cm-1; MS 
calculated for C15H22O3 [M + Na]+: 271.14, found 271.2; [α]24D = +9.06 o (c 0.675, 
CH2Cl2).  
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A solution of sodium hydride (60% suspension in mineral oil, 0.23 g, 9.6 mmol) in 
THF (20 mL) was treated with ethyl (diethylphosphono)acetate (1.81 mL, 9.6 mmol) 
and the mixture was stirred for 20 min at room temperature. The aldehyde (0.93 g, 
3.2 mmol) in THF (5 mL + 5 mL rinse) was added to the reaction vessel via cannula. 
The solution was stirred for 2 h at room temperature. Half-saturated NH4Cl solution 
was added and the resulting mixture was stirred vigorously. The layers were 
separated and the aqueous solution was extracted with EtOAc
 
(2x). The combined 
organic extracts were washed with brine, dried over Na2SO4, filtered, and 
evaporated in vacuo. The residue was purified by gradient flash column 
chromatography, eluting with hexanes-5%-15% EtOAc/hexanes, to afford 0.956 g 
(94%) of 3-42 as an opaque, viscous oil. 1H NMR (500 MHz, CDCl3) δ ppm 7.36-
7.21 (m, 6H), 5.06 (dd, J = 11.96, 5.93 Hz, 2H), 7.08 (d, J = 16.25 Hz, 1H), 5.88-5.75 
(m, 2H), 4.49 (dd, J = 17.82, 5.74 Hz, 2H), 4.14 (q, J = 7.12 Hz, 2H), 3.70-3.61 (m, 
1H), 3.53 (d, J = 8.95 Hz, 1H), 3.37 (t, J = 11.36 Hz, 1H), 2.74 (d, J = 3.73 Hz, 1H), 
2.21 (ddd, J = 6.05, 5.09, 2.54 Hz, 1H), 2.02-1.92 (m, 1H), 1.30-1.19 (m, 4H), 1.05 
(m, 4H); 13C NMR (126 MHz, CDCl3) δ ppm 166.415, 150.543, 137.540, 135.666, 
128.390, 127.759, 127.566, 121.389, 117.386, 77.254, 77.000, 76.745, 76.149, 
75.590, 73.590, 60.298, 45.117, 36.772, 18.790, 14.199; IR (film) 3437.15, 2978.09, 
2929.87, 2856.58, 1716.65, 1651.07, 1454.33, 1367.53, 1309.67, 1269.16, 1184.29, 
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1095.57, 993.34, 910.4, 866.04, 736.81, 698.23 cm-1; MS calculated for C19H26O4 [M 
+ H]+: 319.18, found 319.3; [α]24D = +17.45 o (c 2.95, CH2Cl2).  
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A solution of benzyl ether 3-42 (0.956 g, 3.0 mmol) in freshly distilled dichloroethane 
(30 mL) was treated with DDQ (3.41g, 15.0 mmol) and the mixture was stirred 
vigorously at 40 °C for 18 h. Aqueous 1:1 Na 2S2O3:NaHCO3 was added and the 
mixture was stirred for 20 min. The biphasic red-colored mixture was filtered through 
a pad of celite, rinsing with excess CH2Cl2. The layers were separated and the 
aqueous solution was extracted with CH2Cl2
 
(2x100 mL). The combined organic 
extracts were washed with brine, dried over Na2SO4, filtered, and evaporated in 
vacuo. The residue was purified by gradient flash column chromatography, eluting 
with 10%-25%-40% EtOAc/hexanes, to afford 0.873 g (92%) of benzylidine acetal 3-
44 as an opaque, viscous oil. 1H NMR (500 MHz, CDCl3) δ ppm 7.54-7.45 (m, 2H), 
7.36 (dd, J = 15.23, 7.33 Hz, 2H), 7.18 (d, J = 16.27 Hz, 1H), 5.97 (d, J = 16.29 Hz, 
1H), 5.87 (dt, J = 16.52, 8.25 Hz, 3H), 5.56 (s, 1H), 5.14-5.05 (m, 3H), 4.20 (dd, J = 
13.42, 6.72 Hz, 3H), 3.90 (d, J = 11.18 Hz, 1H), 3.77-3.65 (m, 5H), 3.59 (d, J = 9.59 
Hz, 1H), 3.20 (s, 1H), 2.30-2.13 (m, 3H), 2.09-1.97 (m, 1H), 1.28 (dd, J = 15.38, 8.54 
Hz, 7H), 1.04-0.94 (m, 6H), 0.89 (s, 11H), 0.06 (d, J = 2.61 Hz, 13H); 13C NMR (126 
MHz, CDCl3) δ ppm 166.372, 150.609, 150.188, 149.844, 138.052, 138.030, 
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135.772, 134.932, 134.881, 128.804, 128.157, 126.082, 126.061, 121.548, 121.383, 
121.143, 117.190, 116.696, 102.001, 101.964, 84.947, 84.899, 77.254, 77.000, 
76.745, 76.592, 76.304, 70.267, 60.300, 60.248, 51.464, 45.335, 39.204, 39.171, 
36.951, 34.715, 29.632, 25.723, 25.638, 18.189, 18.086, 17.910, 17.839, 14.222, 
14.197, 0.959, -5.700, -5.745; IR (film) 2929.87, 2906.73, 2883.58, 2856.58, 
1712.79, 1699.29, 1643.35, 1462.04, 1392.61, 1365.6, 1311.59, 1269.16, 1184.29, 
1101.35, 1072.42, 1033.85, 995.27, 914.26, 837.11, 779.24, 736.81, 698.23, 671.23 
cm-1; MS calculated for C19H24O4 [M + Na]+: 339.17, found 339.2; [α]24D = +9.38 o (c 
0.7, CH2Cl2). 
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Benzylidine acetal 3-44 (0.873 g, 2.76 mmol) was dissolved in 4:1 THF:10% 
aqueous H2SO4 (50 mL total) and the mixture was stirred for 48 h at room 
temperature. Saturated NaHCO3 and EtOAc were added, the layers were separated 
and the aqueous solution was extracted with EtOAc
 
(2x). The combined organic 
extracts were washed with brine, dried over Na2SO4, filtered, and evaporated in 
vacuo. The residue was purified by gradient flash column chromatography, eluting 
with 25%-40%-60% EtOAc/hexanes, to afford 0.616 g (98 %) of diol 3-43 as a white 
powder. Efforts to recrystalize the solid were unsuccessful. 1H NMR (500 MHz, 
CDCl3) δ ppm 7.16 (dd, J = 16.27, 10.28 Hz, 1H), 5.86-5.75 (m, 1H), 5.90 (td, J = 
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16.27, 4.58 Hz, 1H), 5.18-5.11 (m, 2H), 4.23-4.14 (m, 1H), 3.69 (ddd, J = 20.68, 
10.42, 7.60 Hz, 2H), 3.62 (t, J = 8.34 Hz, 1H), 3.74 (d, J = 11.63 Hz, 2H), 2.98 (d, J = 
0.92 Hz, 1H), 2.74 (s, 1H), 2.30 (ddd, J = 14.01, 3.45, 1.54 Hz, 1H), 2.05-1.96 (m, 
1H), 1.28 (dd, J = 9.11, 5.15 Hz, 2H), 1.24 (t, J = 3.43 Hz, 1H), 1.05 (t, J = 5.20 Hz, 
3H); 13C NMR (126 MHz, CDCl3) δ ppm 166.953, 166.570, 150.389, 150.063, 
134.972, 134.922, 121.846, 121.435, 118.694, 118.644, 101.025, 77.254, 77.000, 
76.745, 76.061, 76.038, 69.667, 69.627, 60.464, 60.392, 51.586, 45.451, 45.436, 
37.073, 31.211, 29.643, 27.068, 18.352, 18.291, 14.204, 14.139; IR (film) 3415.31, 
3076.87, 2923.56, 2852.2, 1704.76, 1645.95, 1435.74, 1369.21, 1314.25, 1198.54, 
1098.26, 1034.62, 992.196, 914.093, 865.882, 722.211, 588.182, 530.328 cm-1; MS 
calculated for C12H20O4 [M + H]+: 229.14, found 229.1; [α]24D = +10.35 o (c 1.9, 
CH2Cl2). 
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A solution of diol 3-43 (0.6 g, 1.74 mmol) in CH2Cl2
 
(25 mL) was cooled to 0 °C. To 
the stirring solution was added 2,6-lutidine (0.3 mL, 2.4 mmol) and t-
butyldimethylsilyl trifluoromethanesulfonate (0.6 mL, 2.4 mmol). After 1 h saturated 
NaHCO3
 
solution was added and the mixture was extracted with CH2Cl2
 
(2x). The 
combined organic extracts were washed with brine, dried over Na2SO4, filtered, and 
evaporated in vacuo. The residue was purified by gradient flash column 
chromatography, eluting with 5%-10% EtOAc/hexanes, to afford 0.771 g (97 %) of 
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the bis-silyl ether as a viscous oil. 1H NMR (500 MHz, CDCl3) δ ppm 7.14 (t, J = 9.39 
Hz, 1H), 5.88-5.79 (m, 1H), 5.82-5.77 (m, 2H), 5.00 (dd, J = 20.29, 4.97 Hz, 2H), 
4.22-4.16 (m, 2H), 3.85-3.80 (m, 1H), 3.54 (d, J = 9.63 Hz, 1H), 3.39 (d, J = 9.61 Hz, 
1H), 2.37-2.29 (m, 1H), 2.19-2.11 (m, 1H), 1.32-1.25 (m, 4H), 1.01 (s, 3H), 0.87 (dd, 
J = 13.28, 4.56 Hz, 19H), 0.07-0.03 (m, 6H), 0.02 (t, J = 3.31 Hz, 6H); 13C NMR (126 
MHz, CDCl3) δ ppm 166.759, 152.893, 136.469, 120.935, 116.331, 77.254, 76.999, 
76.746, 74.658, 67.649, 60.045, 47.951, 38.408, 26.035, 25.882, 25.853, 18.239, 
17.583, 14.259, -3.528, -4.445, -5.424, -5.532; IR (film) 3426.89, 2955.38, 2857.02, 
2360.44, 1721.16, 1645.95, 14782.38, 1363.43, 1307.5, 1256.4, 1182.15, 1089.58, 
1004.73, 910.236, 836.955, 775.224, 668.214, 546.72, 522.615 cm-1; MS calculated 
for C24H48O4Si2 [M + Na]+: 479.3, found 479.4; [α]24D = +1.85 o (c 0.907, CH2Cl2). 
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The bis-silyl ether (0.21 g, 0.42 mmol) was dissolved in 4:1 THF:H2O (5 mL total 
volume). N-methylmorpholine oxide (NMO) (52 mg, 0.44 mmol) and osmium 
tetroxide (0.26 mL of 20 mg/mL solution in H2O, 0.021 mmol) were added and the 
solution was stirred for 5 h. To this solution was added sodium periodate (0.27 g, 
1.26 mmol) and the reaction mixture was stirred for an additional 2 h. Aqueous 1:1 
Na2S2O3:NaHCO3 was added and the mixture was stirred for 20 min. The mixture 
was partitioned through the addition of EtOAc. The layers were separated and the 
aqueous solution was extracted with EtOAc
 
(2x). The combined organic extracts 
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were washed with brine, dried over Na2SO4, filtered, and evaporated in vacuo. The 
residue was purified by gradient flash column chromatography, eluting with 5%-15%-
60% EtOAc/hexanes, to afford 0.174 g (90%) of aldehyde 3-45 as an opaque oil. 1H 
NMR (500 MHz, CDCl3) δ ppm 9.77 (s, 1H), 7.08 (d, J = 16.22 Hz, 1H), 5.85 (dd, J = 
16.25, 9.19 Hz, 1H), 4.39 (t, J = 5.05 Hz, 1H), 4.19 (q, J = 7.10 Hz, 2H), 3.58 (d, J = 
9.78 Hz, 1H), 3.39 (d, J = 9.80 Hz, 1H), 2.64 (dd, J = 17.00, 4.83 Hz, 1H), 2.50 (ddd, 
J = 17.01, 5.29, 2.51 Hz, 1H), 1.26 (td, J = 14.88, 6.17 Hz, 5H), 1.01-0.92 (m, 4H), 
0.89 (dd sext., J = 19.69, 13.47, 5.05 Hz, 21H), 0.09 (s, 3H), 0.03 (t, J = 7.43 Hz, 
9H); 13C NMR (126 MHz, CDCl3) δ ppm 201.312, 166.412, 151.172, 121.989, 
101.051, 77.401, 77.382, 77.356, 77.253, 77.091, 77.000, 76.817, 76.745, 69.897, 
67.146, 60.275, 48.442, 47.500, 25.985, 25.866, 25.836, 25.773, 18.237, 18.118, 
17.325, 14.224, -4.194, -4.726, -5.447, -5.564; IR (film) 3852.11, 3434.6, 2957.3, 
2857.99, 2089.49, 1646.91, 1472.38, 1362.46, 1308.46, 1257.36, 1184.08, 1092.48, 
835.99, 776.208, 553.47, 525.507, 513.936 cm-1; MS calculated for C23H46O5Si2 [M 
+ H]+: 459.39, found 459.4; [α]24D = +1.77 o (c 1.75, CH2Cl2). 
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A solution of 3-butyne-1-ol (0.76 mL, 10.0 mmol) in THF (100 mL) was charged with 
PPh3, (2.89 g, 11.0 mmol), diethylazodicarboxylate (DEAD) (1.81 mL, 11.0 mmol), 
and 2-mercaptobenzothiazole (1.84 g, 11.0 mmol). The resulting mixture was stirred 
for 12 h at room temperature. Saturated NaHCO3
 
solution was added and the 
mixture was extracted with EtOAc
 
(2x). The combined organic extracts were washed 
with brine, dried over Na2SO4, filtered, and evaporated in vacuo. The residue was 
purified by gradient flash column chromatography, eluting with 5%-10% 
EtOAc/hexanes, to afford 1.6 g (72 %) of thioether 3-32 as a clear, viscous oil. 1H 
NMR (500 MHz, CDCl3) δ ppm 7.87 (d, J = 8.12 Hz, 1H), 7.75 (d, J = 7.94 Hz, 1H), 
7.41 (t, J = 7.43 Hz, 1H), 7.29 (t, J = 7.60 Hz, 1H), 3.52 (t, J = 7.15 Hz, 2H), 2.79 (dt, 
J = 7.14, 2.51 Hz, 2H), 2.08 (t, J = 3.31 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ ppm 
ppm 95.949, 83.321, 65.462, 56.238, 54.502, 51.751, 51.191, 12.047, 7.514, 7.260, 
7.005, 0.363, -37.756, -50.253; IR (film) 3905.15, 3294.79, 3060.48, 2929.34, 
2118.42, 1685.48, 1560.13, 1458.89, 1427.07, 1322.93, 1309.43, 1282.43, 1238.08, 
1159.01, 1126.22, 1077.05, 1019.19, 996.053, 935.306, 905.415, 851.418, 755.959, 
726.068, 704.855, 642.179 cm-1; MS calculated for C11H9NS2 [M + H]+: 220.02, 
found 220.0. 
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N-methylephedrine (NME) was dried for 12 h under vacuum (0.2 mmHg). Zinc triflate 
(ZnOTf)2 (0.34g, 0.93 mmol) was pre-weighed (based on theoretical yield of 
aldehyde 3-45) and dried in the reaction vessel for 12 h under vacuum (0.2 mmHg). 
The reaction vessel was placed in a 110 oC oil bath during the drying process. It is 
beneficial to use a conical-shaped flask for this reaction due to issues with the 
suspension. The reaction vessel was cooled under argon and (-)-NME (0.18 g, 1.01 
mmol) (weighed in glove box) was added under positive argon flow. Toluene (2 mL) 
and Et3N (0.14 mL, 1.01 mmol) were added and the suspension was stirred for 2 h 
at room temperature. Acetylene 3-32 (0.5 mL of 2M solution in toluene, 1.01 mmol) 
was added and the suspension was stirred for 1 h. Aldehyde (0.174 g, 0.378 mmol) 
3-45 in toluene (1 mL + 1 mL rinse) was added via cannula. If excess solvent was 
need to transfer the aldehyde, then the solvent level was marked on the side of the 
flask, and a positive flow of argon with an outlet needle was used to reduce the 
solvent level. The reaction medium was heated to reflux for 8 h, and then cooled to 
ambient temperature. Saturated NH4Cl and EtOAc were added, the layers were 
separated and the aqueous solution was extracted with EtOAc
 
(2x). The combined 
organic extracts were washed with brine, dried over Na2SO4, filtered, and 
evaporated in vacuo. The residue was purified by gradient flash column 
chromatography, eluting with 5%-10%-25%-40% EtOAc/hexanes, to afford 0.189 g 
(74 %) of pyran 3-46 as a clear oil. 1H NMR (500 MHz, CDCl3) δ ppm 7.86 (d, J = 
7.96 Hz, 1H), 7.75 (d, J = 7.91 Hz, 1H), 7.41 (t, J = 7.33 Hz, 1H), 7.29 (t, J = 7.86 
Hz, 1H), 4.62 (d, J = 6.74 Hz, 1H), 4.17 (td, J = 11.63, 6.19 Hz, 2H), 3.73 (s, 1H), 
3.72-3.65 (m, 1H), 3.49 (dd, J = 12.55, 7.05 Hz, 2H), 3.46-3.40 (m, 1H), 3.39-3.32 
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(m, 1H), 2.78 (d, J = 4.25 Hz, 2H), 2.72-2.58 (m, 1H), 2.50-2.40 (m, 1H), 1.99 (s, 
1H), 1.75-1.67 (m, 1H), 1.32-1.23 (m, 5H), 0.97 (t, J = 7.89 Hz, 2H), 0.94-0.82 (m, 
22H), 0.05 (m, 13H); 13C NMR (126 MHz, CDCl3) δ ppm 172.439, 172.117, 166.377, 
153.486, 135.546, 135.536, 126.284, 126.255, 124.497, 124.475, 121.810, 121.204, 
108.406, 101.322, 82.557, 82.407, 81.891, 81.661, 77.521, 77.424, 77.411, 77.385, 
77.327, 77.267, 77.149, 77.132, 77.013, 76.928, 76.908, 76.888, 76.861, 76.832, 
76.672, 76.643, 76.584, 75.143, 72.091, 71.989, 71.876, 71.656, 71.635, 67.387, 
65.627, 65.601, 63.213, 61.602, 60.717, 60.689, 60.575, 42.478, 41.855, 37.198, 
36.860, 35.992, 35.155, 35.139, 32.548, 32.499, 32.320, 29.963, 26.218, 26.150, 
26.124, 26.018, 20.464, 20.419, 20.353, 18.557, 18.543, 18.376, 16.272, 16.254, 
14.540, 14.484, 7.276, 5.266, -3.551, -4.051, -4.730, -4.837, -5.179, -5.207, -5.292, -
5.359; IR (film) 2954.41, 2928.38, 2856.06, 2359.48, 1737.55, 1651.73, 1558.2, 
1539.88, 1507.1, 1462.74, 1428.03, 1361.5, 1298.82, 1254.47, 1185.04, 1081.87, 
1052.94, 1004.73, 957.484, 888.059, 835.99, 812.849, 774.279, 755.959, 669.178 
cm-1; MS calculated for C34H55NO5S2Si2 [M + Na]+: 700.31, found 700.3; [α]24D = -
7.52 o (c 0.75, CH2Cl2). 
 
O
OTBSTBSO
S
Me
HH
OEtO
N
S
3-57
O
OTBSTBSO
Me
HH
OEtO S
22
3-46
N
S
 
A solution of alkyne 3-46 (66.1 mg, 0.98 mmol) in CH2Cl2 (0.3M; 0.5 mL) and freshly 
distilled triethoxy silane (9 µL, 0.12 mmol) was cooled to 0 oC. [Cp*Ru(NCMe)3]PF6 
(2.5 mg, 0.005 mmol) was added under positive argon flow. The suspension was 
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immediately warmed to ambient temperature and the mixture was stirred for 1 h. The 
reaction mixture was diluted in Et2O and filtered through fluorisil (eluting with excess 
Et2O). The Et2O was removed in vacuo and the residue was dissolved in THF (1 
mL). A suspension of AgF in MeOH (0.0126g in 0.1 ml) was added at once and the 
mixture was stirred (shielded from light) for 3 h. The dark reaction mixture was 
filtered through fluorisil and concentrated in vacuo. The residue was purified via The 
residue was purified by gradient flash column chromatography, eluting with 10%-
25%-40% EtOAc/hexanes to afford 0.542 g (87 %) of olefin 3-57 as a clear oil. 1H 
NMR (500 MHz, CDCl3) δ ppm 7.86 (d, J = 7.90 Hz, 1H), 7.75 (d, J = 7.90 Hz, 1H), 
7.41 (d, J = 7.27 Hz, 1H), 7.28 (dd, J = 13.96, 5.63 Hz, 2H), 5.66 (s, 1H), 5.60 (d, J = 
5.24 Hz, 1H), 4.30-4.21 (m, 2H), 4.15 (dd, J = 6.70, 3.78 Hz, 2H), 3.88-3.78 (m, 1H), 
3.70 (s, 1H), 3.46 (d, J = 9.79 Hz, 1H), 3.43-3.34 (m, 3H), 2.72-2.59 (m, 1H), 2.60-
2.50 (m, 2H), 2.35 (d, J = 10.36 Hz, 1H), 1.70 (s, 1H), 1.46 (s, 1H), 1.24 (dd, J = 
13.86, 6.79 Hz, 5H), 1.05-0.80 (m, 26H), 0.04 (dd, J = 16.71, 10.03 Hz, 14H); 13C 
NMR (126 MHz, CDCl3) δ ppm 172.531, 166.938, 153.306, 135.183, 133.418, 
127.718, 125.976, 124.113, 121.470, 120.900, 77.254, 77.151, 77.000, 76.913, 
76.746, 74.600, 72.293, 71.939, 67.284, 60.194, 41.633, 36.914, 35.882, 32.910, 
32.140, 25.955, 25.873, 18.274, 18.129, 14.278, 6.984, 5.033, -4.335, -4.990, -
5.476, -5.611; IR (film) 3444.24, 3059.51, 2954.41, 2929.34, 2884.02, 2857.02, 
2738.42, 2709.5, 2360.44, 2341.16, 2125.17, 1735.62, 1644.98, 1559.17, 1462.74, 
1428.03, 1389.46, 1644.98, 1559.17, 1462.74, 1428.03, 1389.46, 1361.5, 1337.39, 
1299.79, 1256.4, 1186.97, 1079.94, 1051.98, 1004.73, 995.089, 961.341, 938.199, 
923.736, 835.026, 812.849, 775.244, 938.199, 923.736, 835.026, 812.849, 775.244, 
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755.959 cm-1; MS calculated for C34H57NO5S2Si2 [M + Na]+: 702.32, found 702.4; 
[α]24D = -11.7 o (c 0.55, CH2Cl2). 
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Ester 3-57 (20.5 mg, 0.03 mmol) was dissolved in CH2Cl2 (1 mL) and cooled to -78 
oC. DIBAL-H (1.0M in hexanes, 0.13 mL, 0.13 mmol) was added at once. The 
reaction was closely monitored by TLC and was complete in within 20 min. A 
saturated solution of sodium potassium tartrate (10 mL) was added and the mixture 
was warmed to room temperature. Water (5 mL) and CH2Cl2
 
(5 mL) were added and 
the mixture was stirred vigorously for 1 h. The layers were separated and the 
aqueous solution was extracted with CH2Cl2
 
(2x20 mL). The combined organic 
extracts were washed with brine, dried over Na2SO4, filtered, and evaporated in 
vacuo. Chromatography, eluting with 15% EtOAc/hexanes, to afford 15.1 mg (84 %) 
of 3-58 as a clear, viscous oil. 1H NMR (400 MHz, CDCl3) δ ppm 9.73 (d, J = 1.52 
Hz, 1H), 7.84 (d, J = 8.08 Hz, 1H), 7.72 (d, J = 7.60 Hz, 1H), 7.38 (s, 1H), 7.26 (s, 
1H), 5.71-5.60 (m, 1H), 5.59-5.50 (m, 1H), 4.27 (s, 2H), 3.67 (s, 1H), 3.43 (s, 1H), 
3.35 (dd, J = 16.16, 8.70 Hz, 3H), 2.52 (d, J = 7.07 Hz, 3H), 2.46-2.36 (m, 1H), 1.75-
1.65 (m, 1H), 1.47-1.39 (m, 1H), 1.23 (s, 2H), 0.90-0.82 (m, 18H), 0.02 (m, 12H); 13C 
NMR (126 MHz, CDCl3) δ ppm 202.912, 166.913, 153.277, 135.167, 133.106, 
128.310, 127.952, 125.988, 124.130, 121.464, 120.914, 77.701, 77.654, 77.620, 
77.577, 77.542, 77.500, 77.317, 77.190, 77.129, 76.999, 76.682, 76.554, 72.003, 
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67.281, 65.854, 45.132, 41.571, 35.878, 32.821, 32.149, 29.695, 26.001, 25.935, 
25.854, 22.012, 21.594, 18.260, 18.118, 16.031, 15.281, 15.261, 14.292, 6.578, -
4.335, -5.016, -5.508, -5.626, -11.434; IR (film) 3435.56, 2953.45, 2928.38, 2856.06, 
2712.39, 1728.87, 1651.73, 1360.53, 1308.46, 1255.43, 1407.78, 1388.5, 1360.53, 
1308.46, 1255.43, 1077.05, 1019.19, 994.125, 961.341, 938.199, 904.451, 835.026, 
813.81, 775.244, 755.959, 726.068, 702.926, 667.25, 563.112 cm-1; MS calculated 
for C32H53NO4S2Si2 [M + Na]+: 658.30, found 658.3; [α]24D = -4.22 o (c 1.6, CH2Cl2). 
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A solution of alcohol 3-65 (0.167 g, 0.5 mmol) in CH2Cl2
 
(5 mL) was cooled to 0 °C. 
To the stirring solution was added 2,6-lutidine (0.17 mL, 0.65 mmol).and t-
butyldimethylsilyl trifluoromethanesulfonate (76 µL, 0.65 mmol). After 1 h saturated 
NaHCO3
 
solution was added and the mixture was extracted with CH2Cl2
 
(2x). The 
combined organic extracts were washed with brine, dried over Na2SO4, filtered, and 
evaporated in vacuo. The residue was purified by gradient flash column 
chromatography, eluting with 5%-10%-25% EtOAc/hexanes, to afford 0.209 g (93 %) 
of the silyl ether as a viscous, yellow oil. 1H NMR (400 MHz, CDCl3) δ ppm 7.30-7.23 
(m, 4H), 7.32 (dd, J = 9.11, 5.72 Hz, 2H), 5.77 (dd, J = 17.10, 10.14 Hz, 1H), 5.32 
(ddd, J = 10.80, 7.06, 3.91 Hz, 1H), 5.12 (dd, J = 14.11, 5.67 Hz, 2H), 4.48 (dd, J = 
6.82, 3.48 Hz, 1H), 4.01-3.95 (m, 1H), 3.37 (dd, J = 11.45, 7.04 Hz, 1H), 3.19 (dd, J 
= 13.18, 3.83 Hz, 1H), 3.02 (dd, J = 13.17, 10.54 Hz, 1H), 2.88 (d, J = 11.53 Hz, 1H), 
2.27 (t, J = 7.48 Hz, 1H), 2.25-2.17 (m, 1H), 1.21 (m, 12H), 0.99-0.85 (m, 9H), 0.06 
(m 6H); 13C NMR (126 MHz, CDCl3) δ ppm 201.131, 177.893, 173.045, 136.248, 
134.095, 129.346, 128.836, 127.189, 118.144, 95.242, 77.177, 77.126, 76.968, 
76.923, 76.669, 71.459, 68.680, 42.617, 38.771, 36.651, 31.977, 29.616, 14.056, 
10.626, -5.0, -5.1; IR (film) 3442.94, 2926.01, 1689.64, 1494.83, 1454.33, 1361.74,  
1342.46, 1261.45, 1192.01, 1165, 1136.07, 1029.99, 918.12, 744.52, 702.09 cm-1; 
MS calculated for C23H35NO2S2Si [M + Na]+: 472.19, found 472.2; [α]24D = +139.2 o 
(c 0.98, CH2Cl2).  
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A solution of the aldol adduct (0.21 g, 0.46 mmol) in CH2Cl2
 
(5 mL) and freshly 
distilled methyl acrylate (0.13 mL, 1.4 mmol) were degassed with argon for 30 min. 
Grubbs 2nd generation catalyst (39 mg, 0.046 mmol) was weighed in the glovebox 
and placed into a dry vial. Under positive flow of argon, the vial was inverted and the 
contents were added to the reaction vessel. The reaction mixture was allowed to stir 
under an atmosphere of argon for 8 h and then open to air for 12 h. The reaction 
medium was concentrated in vacuo. The residue was mixed with silica gel and 
hexanes, concentrated in vacuo and loaded onto the column as a powder. The 
residue was purified by gradient flash column chromatography, eluting with 5%-10%-
15% EtOAc/hexanes, to afford 0.205 g (88%, E:Z >95:5) of 3-66 as a viscous, yellow 
oil. 1H NMR (400 MHz, CDCl3) δ ppm 7.40-7.23 (m, 12H), 6.95 (d, J = 15.62 Hz, 1H), 
5.83 (d, J = 15.62 Hz, 1H), 5.30-5.18 (m, 1H), 4.58-4.47 (m, 1H), 4.13 (q, J = 7.17 
Hz, 3H), 3.72 (d, J = 5.59 Hz, 4H), 3.39-3.30 (m, 1H), 3.28-3.19 (m, 1H), 3.09-2.96 
(m, 1H), 2.88 (d, J = 11.65 Hz, 1H), 2.53-2.43 (m, 2H), 1.31-1.20 (m, 8H), 0.93-0.83 
(m, 9H), 0.06 (m 6H); MS calculated for C26H39NO4S2Si [M + Na]+: 544.21, found 
544.2. 
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A solution of 3-66 (0.781 g, 1.5 mmol) in THF
 
(2 mL) and MeOH (5 mL) was cooled 
to 0 °C. NaBH 4 (85 mg, 2.25 mmol) was added under positive argon flow. After 1 h 
saturated NaHCO3
 
solution was slowly added and the mixture was extracted with 
EtOAc (2x). The combined organic extracts were washed with brine, dried over 
Na2SO4, filtered, and evaporated in vacuo. The residue was purified by gradient 
flash column chromatography, eluting with 5%-10%-25% EtOAc/hexanes, to afford 
0.403 g (84 %) of the primary alcohol as a viscous, opaque oil. 1H NMR (400 MHz, 
CDCl3) δ ppm 6.99-6.85 (m, 1H), 7.40-7.16 (m, 5H), 5.86 (d, J = 15.64 Hz, 1H), 4.45 
(t, J = 7.22 Hz, 1H), 3.92 (d, J = 3.13 Hz, 1H), 3.72 (s, 3H), 3.68-3.45 (m, 3H), 3.32 
(dd, J = 11.18, 6.82 Hz, 1H), 3.00 (dd, J = 7.20, 3.30 Hz, 2H), 2.40 (t, J = 7.03 Hz, 
2H), 2.34 (s, 1H), 1.96-1.83 (m, 1H), 0.90-0.81 (m, 14H), 0.06 (m, 7H); MS 
calculated for C9H16O4 [M + Na]+: 211.10, found 211.1. 
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To a solution of the alcohol (0.196 g, 0.613 mmol) and 6 mL CH2Cl2 at room 
temperature was added Dess-Martin periodinane (0.390 g, 0.920 mmol). The 
solution was allowed to stir for 1 h. After the addition of a 1:1 aqueous solution of 
Na2S2O3:NaHCO3 the organic layer was separated and the aqueous layer extracted 
twice with CH2Cl2. The combined organic extracts were dried over Na2SO4 and 
concentrated in vacuo. The residue was purified by gradient flash column 
chromatography, eluting with 15%-25% EtOAc/hexanes, to afford 0.173 g (89 %) of 
aldehyde 3-67 as a viscous, opaque oil. 1H NMR (400 MHz, CDCl3) δ ppm 9.72 (s, 
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1H), 6.94-6.80 (m, 1H), 5.85 (d, J = 15.62 Hz, 1H), 4.33-4.07 (m, 4H), 2.42 (tdd, J = 
16.44, 7.47, 5.20 Hz, 3H), 1.33-1.17 (m, 5H), 1.09 (t, J = 7.63 Hz, 4H), 0.99-0.80 (m, 
12H), 0.05 (dd, J = 11.71, 8.29 Hz, 7H). 
 
H HO
Me
OTBS
O
EtO
TMS
BH
Me
OTBS O
OEt
O
3-67 3-69
 
N-Methylephedrine (NME) was dried for 12 h under vacuum (0.2 mmHg). Zinc triflate 
Zn(OTf)2 (0.113g, 0.31 mmol) was pre-weighed (based on theoretical yield of 
aldehyde 3-44) and dried in the reaction vessel for 12 h under vacuum (0.2 mmHg). 
The reaction vessel was placed in a 110 oC oil bath during the drying process. It is 
beneficial to use a conical-shaped flask for this reaction due to issues with the 
suspension. The reaction vessel was cooled under argon and (-)-NME (0.061 g, 0.34 
mmol) was added under positive argon flow. Toluene (2 mL) and Et3N (47 µL, 0.34 
mmol) were added and the suspension was stirred for 2 h at room temperature. 
Trimethylsilyl acetylene (0.1 mL, 0.71 mmol) was obtained from an ampoule (opened 
immediately prior to use) and added and the suspension was stirred for 1 h. 
Aldehyde 3-67 (45 mg, 0.142 mmol) in toluene (0.2 mL + 0.2 mL rinse) was added 
via cannula. If excess solvent was need to transfer the aldehyde, then the solvent 
level was marked on the side of the flask, and a positive flow of argon with an outlet 
needle was used to reduce the solvent level. The reaction medium was heated to 
reflux for 8 h, and then cooled to ambient temperature. Saturated NH4Cl and EtOAc 
were added, the layers were separated and the aqueous solution was extracted with 
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EtOAc
 
(2x). The combined organic extracts were washed with brine, dried over 
Na2SO4, filtered, and evaporated in vacuo. The residue was purified by gradient 
flash column chromatography, eluting with 5%-10%-25%-40% EtOAc/hexanes, to 
afford 37 mg (63 %) of pyran 3-69 as a clear oil. 1H NMR (400 MHz, CDCl3) δ ppm 
4.51 (d, J = 5.12 Hz, 1H), 4.13 (dd, J = 7.16, 4.97 Hz, 4H), 2.49 (d, J = 7.62 Hz, 1H), 
2.42 (d, J = 5.53 Hz, 1H), 1.91-1.82 (m, 1H), 1.74-1.60 (m, 2H), 1.31-1.18 (m, 13H), 
0.94 (dd, J = 6.66, 4.78 Hz, 4H), 0.90-0.78 (m, 18H), 0.21-0.08 (m, 17H), 0.03 (dd, J 
= 11.71, 8.29 Hz, 9H). 
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To a solution of pyran 3-69 (0.08 g, 0.19 mmol) in EtOH (200 proof, 2.7 mL) was 
added K2CO3 (0.11 g, 0.7 mmol). The mixture was allowed to stir at room 
temperature for 12 h. Saturated NH4Cl and EtOAc were added, the layers were 
separated and the aqueous solution was extracted with EtOAc
 
(2x). The combined 
organic extracts were washed with brine, dried over Na2SO4, filtered, and 
evaporated in vacuo. The residue was purified by gradient flash column 
chromatography, eluting with 5%-15% EtOAc/hexanes, to afford 43 mg (78 %) of the 
terminal alkyne as a clear oil. 1H NMR (400 MHz, CDCl3) δ ppm 4.74 (t, J = 2.44 Hz, 
2H), 4.58-4.52 (m, 1H), 4.42-4.31 (m, 1H), 4.26-4.12 (m, 2H), 3.85 (d, J = 2.89 Hz, 
2H), 2.67-2.51 (m, 3H), 2.45-2.30 (m, 6H), 1.06 (d, J = 7.22 Hz, 6H), 0.89-0.83 (m, 
9H), 0.03 (m, 6H). 
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A solution of the terminal alkyne (0.0165 g, 0.055 mmol), EtOAc (3 mL), and 
quinoline (~1 µL, 0.0135 mmol) was evacuated under vacuum and backfilled with 
hydrogen 3x with the aid of a 3-way stop-cock and hydrogen-filled balloon. Lindlar’s 
catalyst (5% Pd on CaCO3 modified with lead salts, 11 mg, 0.005 mmol Pd) was 
added and the reaction medium was stirred under a balloon filled with hydrogen for 
12 h. The reaction vessel was opened to air for 1 h. The suspension was filtered 
through celite and concentrated in vacuo. The residue was purified by gradient flash 
column chromatography, eluting with 5%-15% EtOAc/hexanes, to afford 13 mg (82 
%) of terminal olefin # as a clear oil. 1H NMR (400 MHz, CDCl3) δ ppm 5.71 (m, 1H), 
5.17 (td, J = 17.33, 1.94 Hz, 2H), 5.10-5.03 (m, 1H), 4.44 (dd, J = 4.51, 2.18 Hz, 1H), 
3.86-3.81 (m, 1H), 3.65 (d, J = 4.25 Hz, 3H), 2.56 (dd, J = 14.83, 7.29 Hz, 1H), 2.37 
(dd, J = 14.83, 6.05 Hz, 1H), 1.64-1.50 (m, 3H), 1.44-1.37 (m, 1H), 1.30-1.19 (m, 
8H), 0.85 (m, 9H), 0.03 (m, 6H). 
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A solution of terminal olefin 3-70 (44 mg, 0.153 mmol) in THF
 
(2 mL) and freshly 
distilled methallyl alcohol (50 µL, 0.306 mmol) was cooled to 0 °C. KO t-Bu (0.3 mL of 
1M solution in THF, 0.275 mmol) was added. After 4 h saturated NaHCO3
 
solution 
was slowly added and the mixture was extracted with EtOAc (2x). The combined 
organic extracts were washed with brine, dried over Na2SO4, filtered, and 
evaporated in vacuo. The residue was purified by gradient flash column 
chromatography, eluting with 5%-10% EtOAc/hexanes, to afford 38 mg (71 %) of 3-
71 as a viscous, opaque oil. 1H NMR (400 MHz, CDCl3) δ ppm 5.82-5.67 (m, 1H), 
5.25-5.22 (m, 1H), 5.19-5.16 (m, 1H), 5.12-5.10 (m, 1H), 5.08-5.06 (m, 1H), 4.99 (s, 
1H), 4.93-4.90 (m, 1H), 4.52 (d, J = 4.45 Hz, 2H), 4.50-4.46 (m, 1H), 4.32-4.22 (m, 
1H), 3.89-3.86 (m, 1H), 2.67-2.58 (m, 1H), 2.49-2.40 (m, 1H), 1.75 (d, J = 0.42 Hz, 
3H), 0.08-0.04 (m, 7H), 0.92-0.88 (m, 9H), 0.86 (d, J = 7.18 Hz, 3H). 
 
 
 
 
 
 
OH I
Me
OH
 
Copper iodide (0.191 g, 3.0 mmol) was added to a round-bottomed flask and was 
gently stirred under positive argon flow for 15 min. Et2O (90 mL) was added, 
followed by propargyl alcohol (1.74 mL, 30.0 mmol). The suspension was cooled to -
20 °C using a recrystallization dish wrapped in gla ss-wool and tin foil (use of a 
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Dewer complicated stirring). Methylmagnesium bromide (25 mL of 3M solution in 
Et2O, 75.0 mmol) was dissolved in Et2O and added via syring pump 4 mL/h. The 
reaction medium changed from a suspension to a yellow solution. The reaction 
mixture was allowed to slowly warm to room temperature while stirring overnight. A 
suspension of I2 (23g, 9.0 mmol) in Et2O (90 mL) was allowed to stir overnight at 
room temperature shielded from light. After ~12 h, the original I2/Et2O suspension 
had become a homogeneous solution. The reaction medium was cooled to 0 °C and 
a solution of I2 in Et2O was added slowly via cannula. The reaction was complete in 
8 h. Saturated NH4Cl, and Et2O were added, the layers were separated and the 
aqueous solution was extracted with EtOAc (2x). The combined organic extracts 
were washed with saturated Na2S2O3 and brine, dried over Na2SO4, filtered, and 
evaporated in vacuo. The residue was purified by gradient flash column 
chromatography, eluting with 5%-15%-25% EtOAc/hexanes, to afford 5.15 g (88 %) 
of the vinyl iodide as a clear oil. 1H NMR (400 MHz, CDCl3) δ ppm 4.56 (s, 1H), 3.73 
(td, J = 3.63, 1.81 Hz, 2H), 3.21 (s, 1H), 3.09 (d, J = 1.47 Hz, 2H). 
 
I
Me
OH I
Me
OMOM
3-76
 
A solution of vinyl iodide (5.5 g, 28.0 mmol) in CH2Cl2 (150 mL) was cooled to 0 °C. 
N,N-diisopropylethylamine (DIEA) (20 mL, 113.0 mmol), MOMCl (8.5 mL, 113.0 
mmol), and 4-dimethylaminopyridine (DMAP) (0.34 g, 2.8 mmol) were added. The 
reaction mixture was stirred for 12 h at room temperature. Half-saturated NH4Cl 
solution was added and the resulting mixture was stirred vigorously. The layers were 
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separated and the aqueous solution was extracted with CH2Cl2
 
(2x). The combined 
organic extracts were washed with brine, dried over Na2SO4, filtered, and 
evaporated in vacuo. The residue was purified by gradient flash column 
chromatography, eluting with 5%-15%-25% EtOAc/hexanes, to afford 5.76 g (87%) 
of protected vinyl iodide 3-76 as a viscous oil. 1H NMR (400 MHz, CDCl3) δ ppm 
6.03 (dd, J = 1.54, 0.78 Hz, 1H), 4.63-4.60 (m, 2H), 4.14 (d, J = 8.38 Hz, 2H), 3.39-
3.36 (m, 3H), 1.91 (dd, J = 6.83, 1.54 Hz, 3H). 
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CrCl2 (0.368 g, 3.0 mmol) and NiCl2 (77 mg, 0.06 mmol) purchased from Strem 
chemical company were opened and weighed into a flame-dried vial in the glovebox. 
Upon removal from the glovebox with a septum present, the vial was purged with 
argon and served as the reaction vessel. THF (4 mL) was added resulting in a thick 
suspension, DMF (3 mL) was added yielding a bright blue solution, and t-BuPy (1 
mL) was added resulting in a bright green solution, whereupon the mixture was 
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stirred for 15 min.1 Aldehyde 3-67 (0.159 g, 0.5 mmol) was added in THF (1.5 mL), 
followed by vinyl iodide 3-76 (0.63 mL of 2M solution in THF, 1.25 mmol). The 
reaction mixture was stirred for 12 h at room temperature. 1.0M aqueous 
ethylenediamine was added, creating a purple aqueous layer, and the resulting 
mixture was stirred vigorously for 20 min. The layers were separated and the 
aqueous solution was extracted with EtOAc
 
(2x). The combined organic extracts 
were washed with 10% aqueous HCl, NaHSO4, and brine. The organic layer was 
dried over Na2SO4, filtered, and evaporated in vacuo. The residue was purified by 
gradient flash column chromatography, eluting with 5%-15%-25% EtOAc/hexanes, 
to afford 0.156 g (73%, 1.5:1 dr) of racemic alcohols 3-77 and 3-78 as translucent, 
viscous oil. 1H NMR (400 MHz, CDCl3) δ ppm 6.95-6.81 (m, 1H), 5.85 (d, J = 15.64 
Hz, 1H), 5.55 (d, J = 8.42 Hz, 1H), 4.67-4.58 (m, 2H), 4.49 (dd, J = 8.46, 4.47 Hz, 
1H), 4.20 (td, J = 16.18, 7.01 Hz, 3H), 3.42-3.36 (m, 4H), 3.97 (d, J = 11.64 Hz, 1H), 
3.90 (d, J = 3.29 Hz, 1H), 2.49-2.40 (m, 2H), 1.81 (d, J = 1.21 Hz, 3H), 1.63-1.52 (m, 
1H), 1.29 (t, J = 7.14 Hz, 3H), 0.98 (d, J = 6.90 Hz, 3H), 0.92-0.86 (m, 10H), 0.06 (d, 
J = 7.65 Hz, 6H). 
 
                                            
1
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Dry benzene (5 mL) was added to ligand 3-79 (0.444 g, 1.5 mmol) and the solution 
was concentrated in vacuo. This was repeated two additional times, after which the 
residue was dissolved in THF (1 mL). Triethylamine (0.21 mL, 1.5 mmol) was added 
and the mixture was stirred for 5 min. Chromium (II) chloride (0.184 g, 1.5 mmol) 
and nickel (II) chloride (0.13 g, 1.0 mmol) purchased from Strem chemical company 
were added and the suspension was stirred for 1 h. Aldehyde 3-67 (0.159 g, 0.5 
mmol) was added in THF (1 mL), followed by vinyl iodide 3-76 (0.5 mL of 2M 
solution in THF, 1.0 mmol). The reaction mixture was stirred for 12 h at room 
temperature. 1.0M aqueous ethylenediamine was added and the resulting mixture 
was stirred vigorously (purple aqueous layer). The layers were separated and the 
aqueous solution was extracted with EtOAc
 
(2x). The combined organic extracts 
were washed with 10% aqueous HCl, NaHSO4, and brine. The organic layer was 
dried over Na2SO4, filtered, and evaporated in vacuo. The residue was purified by 
gradient flash column chromatography, eluting with 5%-15%-25% EtOAc/hexanes, 
to afford 96 mg (45%, 2.5:1 dr) of alcohol 3-77 as translucent, viscous oil. 1H NMR 
(400 MHz, CDCl3) δ ppm 6.96-6.82 (m, 1H), 5.92-5.78 (m, 1H), 5.42-5.33 (m, 1H), 
4.66-4.53 (m, 2H), 4.16 (d, J = 7.02 Hz, 3H), 3.35 (s, 3H), 2.53-2.32 (m, 3H), 1.78 (s, 
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4H), 1.54 (s, 4H), 1.25 (dd, J = 13.05, 5.59 Hz, 5H), 0.86 (d, J = 9.57 Hz, 9H), 0.70 
(d, J = 6.95 Hz, 2H), 0.06 (t, J = 11.52 Hz, 6H). 
 
OTBS
MeO2COTBS
 
TBS-protected propargylic ether (25.55 g, 150 mmol) was dissolved in THF (500 mL) 
and cooled to -78 °C. n-Butyllithium (2.5M in hexanes, 80 mL, 200 mmol) was added 
dropwise via addition funnel. The mixture was stirred for 1 h upon complete addition 
while gradually warming to -60 °C. Methylchloroform ate (15.5 mL, 200 mmol) was 
added via addition funnel and the reaction mixture was gradually warmed to 0 °C 
over 2 h. Saturated NaHCO3
 
solution was added and the mixture was extracted with 
Et2O
 
(2x). The combined organic extracts were washed with brine, dried over 
Na2SO4, filtered, and evaporated in vacuo. The residue was purified by gradient 
flash column chromatography, eluting with 5%-10% EtOAc/hexanes, to afford 31.12 
g (91 %) of the alkyne # as a viscous, translucent oil. 1H NMR (500 MHz, CDCl3) δ 
ppm 4.36 (d, J = 19.80 Hz, 2H), 3.73-3.63 (m, 3H), 0.81 (d, J = 8.22 Hz, 9H), 0.05 
(d, J = 5.84 Hz, 6H); 13C NMR (126 MHz, CDCl3) δ ppm 153.421, 85.841, 77.255, 
77.000, 76.744, 76.186, 52.394, 51.114, 25.477, 17.976, -5.492; IR (film) 3423.65, 
2954.95, 2929.87, 2887.44, 2858.51, 2241.28, 1716.65, 1463.97, 1435.04, 1409.96, 
1361.74, 1255.66, 1107.14, 1056.99, 1028.06, 1006.84, 939.33, 839.03, 815.89, 
781.17, 752.24 cm-1; MS calculated for C11H20O3Si [M + Na]+: 251.12, found 251.1. 
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1H NMR (500 MHz, CDCl3) ppm 7.36 (m, 5H), 4.60 (s, 2H), 4.26 (s, 2H), 3.80-3.73 
(m, 3H); 13C NMR (126 MHz, CDCl3) δ ppm 153.017, 136.407, 128.051, 128.002, 
127.907, 127.655, 127.621, 127.159, 83.244, 77.543, 71.526, 56.233, 52.258; IR 
(film) 3868.33, 3727.73, 3660.23, 3413.39, 3088.44, 3064.33, 3031.55, 2953.45, 
2862.81, 2359.48, 2340.19, 2237.99, 2071.17, 1959.32, 1874.37, 1719.23, 1659.45, 
1606.41, 1548.56, 1496.49, 1453.1, 1435.74, 1353.78, 1256.4, 1154.19, 1096.33, 
1058.73, 1027.87, 941.092, 858.168, 817.67, 750.174, 699.069, 668.214 cm-1; MS 
calculated for C12H12O3 [M + Na]+: 227.08, found 227.0. 
 
Me
COOMe
OTBS
MeO2C
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Copper iodide (15.24 g, 80.0 mmol) suspended in Et2O (500 mL) and cooled to 0 
°C. 2 Methyl lithium (1.6M in Et2O, 100 mL, 160.0 mmol) was added and the yellow-
colored mixture was stirred for 45 min at 0 °C. The  reaction vessel was placed in a 
Dewer and the mixture was cooled to -78 °C. Pre-coo led (-78 °C) alkyne (33.3 mL of 
a 2M solution in Et2O, 66.6 mmol) was transferred to the reaction mixture via 
cannula and the solution was allowed to stir for 3-4 h at -78 °C. Acetic acid (10 mL) 
was added and the reaction mixture was warmed to 0 °C. Half-saturated NaHCO 3 
solution was added and the resulting mixture was stirred vigorously. The layers were 
separated and the aqueous solution was extracted with Et2O (2x). The combined 
organic extracts were washed with brine, dried over Na2SO4, filtered, and 
                                            
2
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evaporated in vacuo. The residue was purified by gradient flash column 
chromatography, eluting with 5%-15%-25% EtOAc/hexanes, to afford 14.32 g (88%) 
of the vinyl ester as a viscous oil. 1H NMR (500 MHz, CDCl3) δ ppm 5.96 (s, 1H), 
4.07 (s, 2H), 3.65 (d, J = 1.90 Hz, 3H), 2.01 (s, 3H), 0.91-0.83 (m, 12H), 0.04 (d, J = 
1.56 Hz, 8H); 13C NMR (126 MHz, CDCl3) δ ppm 112.694, 66.854, 50.671, 25.695, 
15.243, -5.627,; IR (film) 2953.02, 2929.87, 2897.08, 2885.51, 2856.58, 1720.5, 
1662.64, 1471.69, 1463.97, 1435.04, 1388.75, 1377.17, 1361.74, 1321.24, 1251.8, 
1224.8, 1155.36, 1112.93, 1066.64, 1039.63, 1006.84, 839.03, 815.89, 777.31, 
738.74, 669.3 cm-1; MS calculated for C12H24O5Si [M + H]+: 245.13, found 245.1. 
 
Me
COOMe
OBn
MeO2C
BnO
3-84 3-85
 
1H NMR (500 MHz, CDCl3) δ ppm 7.27 (m, 5H), 5.69 (s, 1H), 4.58 (s, 2H), 4.44 (d, J 
= 6.21 Hz, 2H), 3.58 (s, 3H), 1.92 (s, 3H); 13C NMR (126 MHz, CDCl3) δ ppm 
166.300, 157.274, 137.993, 130.011, 128.394, 128.319, 128.292, 128.232, 127.673, 
127.528, 127.512, 126.313, 116.702, 77.254, 77.000, 76.745, 73.822, 72.549, 
69.135, 50.962, 21.598; IR (film) 2951.52, 2862.81, 2359.48, 2340.19, 2237.99, 
2071.17, 1959.32, 1874.37, 1719.23, 1657.52, 1606.41, 1548.56, 1496.49, 1443.46, 
1368.25, 1260.25, 1153.22, 1099.23, 738.603, 698.105 cm-1;MS calculated for 
C13H16O3 [M + H]+:221.09, found 221.1. 
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The vinyl ester (16.71 g, 68.37 mmol) was dissolved in CH2Cl2 (500 mL) and cooled 
to -78 oC. DIBAL-H (1.0M in hexanes, 171 mL, 171 mmol) was added at once. The 
reaction was monitored by TLC and was complete in within 3 h. A saturated solution 
of sodium potassium tartrate (200 mL) was added and the mixture was warmed to 
room temperature. Water (100 mL) and CH2Cl2
 
(100 mL) were added and the 
mixture was stirred vigorously for 1 h. The layers were separated and the aqueous 
solution was extracted with CH2Cl2
 
(2x100 mL). The combined organic extracts were 
washed with brine, dried over Na2SO4, filtered, and evaporated in vacuo. 
Chromatography, eluting with 15% EtOAc/hexanes, to afford 12.43 g (84 %) of the 
alcohol as a clear, viscous oil. 1H NMR (500 MHz, CDCl3) δ ppm 5.61 (t, J = 5.93 Hz, 
1H), 4.13 (d, J = 6.30 Hz, 3H), 3.98 (s, 2H), 2.38-2.11 (m, 1H), 1.59 (s, 3H), 0.87 (s, 
12H), 0.04 (d, J = 6.37 Hz, 8H); 13C NMR (126 MHz, CDCl3) δ ppm 122.783, 77.233, 
76.978, 76.723, 67.654, 58.742, 25.792, 25.750, 18.247, 13.325, -5.481, -5.503; IR 
(film) 3338.78, 2954.95, 2927.94, 2885.51, 2856.58, 1471.69, 1462.04, 1442.75, 
1406.11, 1388.75, 1361.74, 1251.8, 1188.15, 1111, 1076.28, 1004.91, 960.55, 
837.11, 813.96, 775.38, 667.37 cm-1; MS calculated for C12H24O2Si [M + H]+: 217.15, 
found 217.2. 
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1H NMR (300 MHz, CDCl3) δ ppm 7.22 (m, 5H), 5.61-5.51 (m, 1H), 4.39 (s, 2H), 4.02 
(dd, J = 7.07, 0.94 Hz, 2H), 3.93 (s, 2H), 1.73 (dd, J = 2.40, 1.03 Hz, 3H), 1.54 (t, J = 
7.43 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ ppm 139.231, 138.292, 128.367, 
127.796, 127.612, 121.479, 77.253, 77.000, 76.745, 72.376, 68.077, 66.185, 
13.886; IR (film) 3397.96, 3087.48, 3063.37, 2917.77, 2859.92, 2360.44, 1813.72, 
1722.12, 1678.73, 1604.48, 1548.56, 1495.53, 1454.06, 1363.43, 1328.71, 1269.9, 
1205.29, 1069.33, 1026.91, 943.02, 844.669, 738.603, 698.105 cm-1; MS calculated 
for C12H15O2 [M + H]+:193.08, found 193.1. 
 
Me
O
Me
OHTBSO TBSO
3-97
 
A solution of the alcohol (5.41 g, 25 mmol) in CH2Cl2 (100 mL) and cooled to 0 oC. 4-
Methyl-morpholine-N-oxide (NMO) (5.6 g, 50 mmol) and tetrapropylammonium 
perruthenate (TPAP)3 (0.44 g, 1.25 mmol) were added at once. The reaction mixture 
was stirred for 1 h depending on scale. The black solution was partially concentrated 
in vacuo, silica gel was added, and then the mixture was fully concentrated to yield a 
gray powder. The powder was purified by chromatography, eluting with 15% 
EtOAc/hexanes, to afford 4.77 g (89 %) of aldehyde 3-97 as a clear, viscous oil. 1H 
NMR (500 MHz, CDCl3) δ ppm 10.00 (t, J = 9.52 Hz, 1H), 6.13 (dd, J = 8.17, 1.28 
Hz, 1H), 4.11 (d, J = 0.93 Hz, 2H), 4.09-4.00 (m, 1H), 2.11-1.88 (m, 6H), 1.21-1.15 
(m, 2H), 0.87-0.81 (m, 9H), 0.01 (m, 6H); 13C NMR (126 MHz, CDCl3) δ ppm 
191.028, 161.415, 124.054, 77.318, 77.000, 76.681, 66.564, 60.255, 25.709, 
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25.659, 25.579, 20.915, 18.211, 14.087, 13.935, -5.542, -5.598; IR (film) 2954.95, 
2929.87, 2885.51, 2856.58, 1732.08, 1681.93, 1651.07, 1471.69, 1444.68, 1408.04, 
1361.74,1315.45, 1253.73, 1222.87, 1165, 1120.64, 1006.84, 939.33, 839.03, 
815.89, 779.24, 669.3 cm-1; MS calculated for C12H22O2Si [M + H]+: 215.12, found 
215.1. 
 
Me
OH
Me
OBnO BnO
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1H NMR (400 MHz, CDCl3) δ ppm 9.32 (s, 1H), 7.46-7.22 (m, 5H), 4.53-4.38 (m, 3H), 
4.20 (d, J = 5.56 Hz, 2H), 1.59 (dd, J = 6.83, 1.54 Hz, 4H); IR (film) 3354.57, 
3030.59, 2854.13, 1691.27, 1496.49, 1454.06, 1364.39, 1328.71, 1266.04, 1203.36, 
1113.69, 1073.19, 1026.91, 835.99, 739.567, 699.069 cm-1. 
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A stirring solution of (S)-4-benzyl-3-propionyl-1,3-thiazolidine-2-thione 3-5 (2.12 g, 
8.0 mmol) in CH2Cl2
 
(80 mL) was cooled in an ice bath. TiCl4
 
(0.92 mL, 8.4 mmol) 
was added at once, turning the solution a yellow-orange hue. After stirring the 
mixture for 20 min, (-)-sparteine (1.85 mL, 8.0 mmol) was added at once converting 
the solution to a purple-brown hue. After stirring the mixture for 20 min, N-methyl-2-
pyrrolidinone (NMP) (0.77 mL, 8.0 mmol) was added, dropwise. After stirring the 
mixture for 20 min the solution was cooled to -78 °C and pre-cooled aldehyde 3-97 
(1.78 g, 8.0 mmol) in CH2Cl2
 
(10 mL) was added. The homogeneous reaction 
mixture was stirred at -78 °C for 3 h, and then war med in an ice bath. Half-saturated 
NH4Cl solution was added and the resulting mixture was stirred vigorously while 
warming to room temperature. The layers were separated and the aqueous solution 
was extracted with CH2Cl2
 
(2x). The combined organic extracts were washed with 
brine, dried over Na2SO4, filtered, and evaporated in vacuo. The residue was purified 
by gradient flash column chromatography, eluting with 5%-15%-25% 
EtOAc/hexanes, to afford 3.607 g (94%) of aldol 3-98 as a bright-yellow colored, 
viscous oil. 1H NMR (500 MHz, CDCl3) δ ppm 7.36-7.30 (m, 2H), 7.30-7.24 (m, 5H), 
5.51 (dd, J = 8.87, 1.40 Hz, 1H), 5.12 (ddd, J = 10.64, 6.85, 3.83 Hz, 1H), 4.69-4.63 
(m, 1H), 4.50 (dd, J = 12.92, 6.27 Hz, 1H), 3.99 (s, 2H), 3.41 (dd, J = 11.34, 7.02 Hz, 
1H), 3.24 (dd, J = 13.21, 3.72 Hz, 1H), 3.04 (dd, J = 13.18, 10.72 Hz, 1H), 2.87 (d, J 
= 11.33 Hz, 1H), 2.09 (d, J = 3.19 Hz, 1H), 1.65 (s, 3H), 1.58 (s, 3H), 1.33 (t, J = 
5.56 Hz, 3H), 0.87-0.81 (m, 9H), 0.01 (m, 6H); 13C NMR (126 MHz, CDCl3) δ ppm 
201.171, 177.343, 139.169, 136.510, 129.414, 128.893, 127.186, 123.203, 77.254, 
77.154, 77.000, 76.861, 76.835, 76.746, 70.055, 69.227, 67.555, 45.038, 36.630, 
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32.402, 25.891, 25.867, 18.329, 14.046, 12.201, -5.358, -5.394; IR (film) 2953.02, 
2927.94, 2854.65, 1697.36, 1454.33, 1361.74, 1342.46, 1263.37, 1190.08, 1165, 
1114.86, 1029.99, 837.11, 777.31, 702.09 cm-1; MS calculated for C24H37NO3S2Si 
[M + Na]+: 502.198, found 502.2; [α]24D = +113.3 o (c 0.82, CH2Cl2). 
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1H NMR (500 MHz, CDCl3) δ ppm 7.39-7.21 (m, 10H), 5.47 (d, J = 8.64 Hz, 1H), 
5.18 (s, 1H), 4.63 (dd, J = 8.57, 5.77 Hz, 1H), 4.57-4.50 (m, 1H), 4.49 (d, J = 3.47 
Hz, 2H), 4.08 (d, J = 11.60 Hz, 1H), 3.98 (d, J = 11.66 Hz, 1H), 3.28 (dd, J = 11.35, 
7.02 Hz, 1H), 3.21 (dd, J = 13.16, 3.73 Hz, 1H), 3.01 (dd, J = 13.17, 10.61 Hz, 1H), 
2.84 (d, J = 11.48 Hz, 1H), 1.81 (s, 3H), 1.30 (d, J = 6.74 Hz, 3H); 13C NMR (126 
MHz, CDCl3) δ ppm 201.195, 177.030, 137.947, 136.673, 136.366, 129.319, 
129.080, 128.932, 128.793, 128.543, 128.426, 128.324, 128.237, 127.623, 127.092, 
77.256, 77.000, 76.746, 72.408, 69.543, 68.976, 68.918, 44.777, 36.539, 32.320, 
21.915, 12.175; IR (film) 3416.28, 3027.69, 2927.41, 2360.44, 1693.19, 1603.52, 
1495.53, 1454.06, 1343.18, 1291.11, 1263.15, 1192.76, 1164,79, 1137.8, 1028.84, 
901.558, 740.531, 700.033 cm-1; MS calculated for C25H29NO3S2 [M + H]+:456.16, 
found 456.3; [α]24D = +110.7 o (c 1.82, CH2Cl2). 
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In a 3-neck round-bottomed flask, a solution of diisopropylamine (3.1 mL, 22 mmol) 
in THF (15 mL) was cooled to -78 °C. A 2.5M solutio n was of n-butyllithium (8.34 
mL, 20.84 mmol) was added via addition funnel. Upon complete addition, the 
solution was stirred for 30 min. Freshly distilled MeCN (1.1 mL, 20.84 mmol) was 
added and the mixture was stirred for 15 min. A solution of aldol adduct 3-98 (2.5 g, 
5.2 mmol) in THF (20 mL) was pre-cooled to -78 °C a nd added to the solution via 
cannula. The reaction mixture was stirred at -78 °C  for 1 h. Half-saturated NH4Cl 
solution was added and the resulting mixture was stirred vigorously while warming to 
room temperature. The layers were separated and the aqueous solution was 
extracted with EtOAc
 
(2x). The combined organic extracts were washed with brine, 
dried over Na2SO4, filtered, and evaporated in vacuo. The residue was purified by 
gradient flash column chromatography, eluting with 5%-15%-25%-40% 
EtOAc/hexanes, to afford 1.28 g (85%) of β−ketonitrile 3-99 as an opaque, viscous 
oil. 1H NMR (500 MHz, CDCl3) δ ppm 5.43 (d, J = 9.18 Hz, 1H), 4.66 (dd, J = 9.20, 
5.08 Hz, 1H), 4.02 (d, J = 15.40 Hz, 2H), 3.75-3.55 (m, 2H), 2.99-2.88 (m, 1H), 1.98 
(s, 1H), 1.64 (s, 3H), 1.11 (dd, J = 13.24, 7.02 Hz, 3H), 0.94-0.84 (m, 10H), 0.06 (m, 
7H); 13C NMR (126 MHz, CDCl3) δ ppm 200.220, 140.418, 121.645, 113.874, 
77.317, 77.000, 76.682, 69.002, 67.152, 50.877, 32.789, 25.833, 18.309, 13.835, 
11.340, -5.411, -5.439; IR (film) 3423.65, 2954.95, 2929.87, 2856.58, 1724.36, 
1463.97, 1388.75, 1361.74, 1303.88, 1253.73, 1114.86, 1076.28, 1006.84, 937.4, 
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837.11, 777.31, 667.37 cm-1; MS calculated for C16H29NO3Si [M + Na]+: 334.19, 
found 334.2; [α]24D = +23.8 o (c 0.79, CH2Cl2). 
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In a 3-neck round-bottomed flask, a solution of diisopropylamine (8.21 mL, 58.6 
mmol) in THF (40 mL) was cooled to -78 °C. A 2.5M s olution was of n-butyllithium 
(21.33 mL, 58.6 mmol) was added via addition funnel. Upon complete addition, the 
solution was stirred for 30 min. Freshly distilled EtOAc (5.2 mL, 53.4 mmol) was 
added dropwise and the mixture was stirred for 15 min. A solution of aldol adduct 3-
88 (3.04 g, 6.65 mmol) in THF (20 mL) was pre-cooled to -78 °C and added via 
cannula. The reaction vessel was stirred at -78 °C for ~90 min. Half-saturated NH4Cl 
solution was added and the resulting mixture was stirred vigorously while warming to 
room temperature. The layers were separated and the aqueous solution was 
extracted with EtOAc
 
(2x). The combined organic extracts were washed with brine, 
dried over Na2SO4, filtered, and evaporated in vacuo. The residue was purified by 
gradient flash column chromatography, eluting with 5%-15%-25%-40% 
EtOAc/hexanes, to afford 0.923 g (91%) of β -ketoester 3-92 as an opaque, viscous 
oil. 1H NMR (500 MHz, CDCl3) δ ppm 7.38-7.26 (m, 5H), 5.44 (d, J = 8.58 Hz, 1H), 
4.67 (dd, J = 8.54, 4.60 Hz, 1H), 4.51-4.45 (m, 2H), 4.18 (dq, J = 7.15, 3.19 Hz, 2H), 
4.12-4.06 (m, 1H), 3.96 (dd, J = 11.62, 4.22 Hz, 1H), 3.49 (s, 2H), 2.82 (dq, J = 7.07, 
4.64 Hz, 1H), 1.82 (s, 3H), 1.27 (dt, J = 7.13, 3.84 Hz, 3H), 1.15 (t, J = 6.59 Hz, 3H); 
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13C NMR (126 MHz, CDCl3) δ ppm 205.847, 167.041, 137.658, 136.200, 128.717, 
128.691, 128.330, 128.121, 128.078, 128.045, 127.994, 127.483, 127.451, 127.391, 
127.365, 127.004, 77.214, 76.958, 76.703, 72.090, 68.580, 68.518, 67.855, 60.969, 
51.435, 48.852, 21.741, 13.907, 13.794, 10.938; IR (film) 3437.49, 3087.48, 
3063.37, 3030.59, 2979.48, 2934.16, 2875.34, 2247.63, 1956.43, 1878.33, 1740.44, 
1710.55, 1645.95, 1496.49, 1454.06, 1407.78, 1368.25, 1311.36, 1263.15, 1156.12, 
1093.44, 1071.26, 1017.27, 844.669, 807.063, 740.531, 700.033, 652.786, 618.074, 
560.22, 521.65, 504.294 cm-1; MS calculated for C19H26O5 [M + H]+: 335.18, found 
335.2; [α]24D = +13.73o (c 3.49, CH2Cl2). 
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A solution of β -ketoester 3-92 (0.4429 g, 1.32 mmol) in THF (10 mL) and MeOH (3 
mL) was cooled to -78 °C. Et 2BOMe (2 mL of 1M solution, 2.0 mmol) was added via 
syringe and the solution was stirred for 15 min before adding NaBH4 (0.1 g, 2.64 
mmol) under positive argon flow. The reaction vessel was stirred at -78 °C for ~3 h. 
A solution of pH = 7 buffer and 30% aqueous H2O2 (1:1; 2.5 mL) was added slowly 
and the mixture was stirred for 30 min while warming to ambient temperature. Half-
saturated NH4Cl solution was added and the resulting mixture was stirred vigorously. 
The layers were separated and the aqueous solution was extracted with EtOAc
 
(2x). 
The combined organic extracts were washed with sodium sulfite to remove 
peroxides (checked with starch paper), brine, dried over Na2SO4, filtered, and 
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evaporated in vacuo. The residue was purified by gradient flash column 
chromatography, eluting with 25%-40% EtOAc/hexanes, to afford 0.351 g (79%) of 
diol 3-93 as an opaque, viscous oil. 1H NMR (500 MHz, CDCl3) δ ppm 7.39-7.24 (m, 
5H), 5.51 (d, J = 8.47 Hz, 1H), 4.56 (dd, J = 8.22, 3.86 Hz, 1H), 4.50 (q, J = 11.83 
Hz, 3H), 4.22 (d, J = 9.23 Hz, 1H), 4.16 (q, J = 7.11 Hz, 2H), 4.02 (dd, J = 27.72, 
11.21 Hz, 2H), 3.50 (s, 1H), 2.71-2.60 (m, 1H), 2.56 (dd, J = 16.07, 9.65 Hz, 1H), 
2.31 (dd, J = 16.15, 3.00 Hz, 1H), 1.83 (d, J = 8.75 Hz, 4H), 1.31-1.21 (m, 6H), 1.00 
(d, J = 6.94 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ ppm 172.883, 137.807, 135.414, 
130.869, 128.463, 128.439, 127.855, 127.802, 77.253, 77.000, 76.745, 72.566, 
71.659, 70.868, 69.114, 60.681, 42.699, 39.421, 29.681, 22.446, 14.172, 6.429; IR 
(film) 3436.53, 2921.63, 1731.76, 1454.06, 1374.03, 1261.22, 1180.22, 1095.37, 
1026.91, 739.576, 699.069 cm-1; MS calculated for C19H28O5 [M + H]+: 337.19, found 
337.2; [α]24D = +1.59 o (c 5.6, CH2Cl2). 
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To a solution of diol 3-93 (0.2889 g, 0.859 mmol) in dry benzene (10 mL) was added 
pyridinium p-toluenesulfonate (PPTS) (0.022 g, 0.0859 mmol). The solution was 
heated to reflux for 1 h (color changes from opaque to light yellow). After cooling to 
ambient temperature, half-saturated NaHCO3 solution was added and the resulting 
mixture was stirred vigorously. The layers were separated and the aqueous solution 
was extracted with EtOAc (2x). The combined organic extracts were washed with 
brine, dried over Na2SO4, filtered, and evaporated in vacuo. The residue was purified 
by gradient flash column chromatography, eluting with 40%-60% EtOAc/hexanes, to 
afford 0.204 g (82%) of lactone 3-91 as a viscous oil. 1H NMR (500 MHz, CDCl3) δ 
ppm 7.39-7.32 (m, 2H), 5.48 (s, 1H), 4.52 (d, J = 11.73 Hz, 1H), 4.44 (d, J = 11.72 
Hz, 1H), 4.10 (d, J = 11.91 Hz, 1H), 3.97 (d, J = 11.92 Hz, 1H), 2.80 (dd, J = 18.37, 
5.62 Hz, 1H), 2.48 (dd, J = 18.33, 3.49 Hz, 1H), 1.90-1.84 (m, 2H), 1.57 (s, 1H), 0.95 
(d, J = 7.19 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ ppm 137.980, 128.482, 127.968, 
127.858, 124.283, 77.253, 77.116, 77.000, 76.870, 76.849, 76.745, 76.607, 76.569, 
76.519, 76.500, 74.554, 72.327, 68.800, 68.389, 39.112, 35.784, 21.918, 10.703; IR 
(film) 3428.81, 2923.56, 2854.13, 1716.34, 1454.06, 1363.43, 1245.79, 1061.62, 
983.518, 737.639, 699.069, 609.396 cm-1; MS calculated for C17H22O4 [M + Na]+: 
313.15, found 313.1; [α]24D = +26.6 o (c 0.29, CH2Cl2). 
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Lactone 3-91 (35 mg, 0.12 mmol) was dissolved in CH2Cl2 (2 mL) and cooled to 0 
°C. N,N-diisopropylethylamine (DIEA) (84 µL, 0.48 mmol), MOMCl (46 µL, 0.6 
mmol), and 4-dimethylaminopyridine (DMAP) (~2 mg, 0.012 mmol) were added. The 
reaction mixture was stirred for 12 h at room temperature. Half-saturated NH4Cl 
solution was added and the resulting mixture was stirred vigorously. The layers were 
separated and the aqueous solution was extracted with CH2Cl2
 
(2x). The combined 
organic extracts were washed with brine, dried over Na2SO4, filtered, and 
evaporated in vacuo. The residue was purified by gradient flash column 
chromatography, eluting with 5%-15%-25% EtOAc/hexanes, to afford 37 mg (92%) 
of protected lactone 3-94 as a viscous oil. 1H NMR (500 MHz, CDCl3) δ ppm 7.39-
7.31 (m, 4H), 7.32-7.27 (m, 1H), 5.50 (d, J = 8.83 Hz, 1H), 5.44 (dd, J = 8.99, 2.86 
Hz, 1H), 4.63-4.59 (m, 2H), 4.48 (q, J = 11.88 Hz, 2H), 4.07 (d, J = 11.98 Hz, 1H), 
3.98 (d, J = 11.99 Hz, 1H), 3.84 (dd, J = 9.09, 4.40 Hz, 1H), 3.33 (s, 3H), 2.80 (dd, J 
= 18.28, 5.64 Hz, 1H), 2.60 (dd, J = 18.22, 3.40 Hz, 1H), 2.04 (dt, J = 7.73, 7.47, 
3.77 Hz, 1H), 1.87 (s, 3H), 0.97 (t, J = 7.87 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 
ppm 137.974, 137.861, 128.385, 128.348, 128.309, 127.862, 127.754, 127.724, 
127.672, 127.653, 127.606, 124.197, 124.114, 95.001, 77.211, 76.956, 76.703, 
74.632, 72.198, 72.077, 68.624, 68.357, 68.076, 38.852, 35.712, 33.821, 29.606, 
21.788, 21.750, 10.834, 10.635, 0.934; IR (film) 2924.52, 1738.51, 1496.49, 
1454.06, 1363.43, 1260.25, 1234.22, 1149.37, 1036.55, 917.95, 801.278, 740.531, 
699.069, 559.255 cm-1; MS calculated for C19H26O5 [M + H]+: 335.24, found 335.2; 
[α]24D = +10.58 o (c 0.91, CH2Cl2). 
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A solution of lactone 3-94 (0.1024 g, 0.306 mmol) in THF (2 mL) was cooled to -78 
°C. 4 Allyl magnesium bromide (0.92 mL of 1.0M solution in Et2O, 0.92 mmol) and the 
reaction mixture was stirred for 5 min while monitoring via TLC. Half-saturated NH4Cl 
solution was added and the resulting mixture was stirred vigorously while warming to 
ambient temperature. The layers were separated and the aqueous solution was 
extracted with CH2Cl2
 
(2x). The combined organic extracts were washed with brine, 
dried over Na2SO4, filtered, and evaporated in vacuo. Dry benzene was added to the 
residue and the solution was evaporated in vacuo. This was repeated three times 
before attaching the flask to the vacuum-pump manifold (0.2 mmHg) for 30 min. The 
residue was admixed with a solution of Et3SiH (0.27 mL, 1.7 mmol) in CH2Cl2 (0.3 
mL) and MeCN (0.7 mL). The resulting solution was cooled to -78 °C and treated 
with SnCl4 (1.0M in CH2Cl2, 0.19 mL, 0.19 mmol) and gradually warmed to -20 °C 
over 90 min. Water was added and the resulting mixture was stirred vigorously while 
warming to ambient temperature. The layers were separated and the aqueous 
solution was extracted with CH2Cl2
 
(2x). The combined organic extracts were 
washed with brine, dried over Na2SO4, filtered, and evaporated in vacuo. The 
residue was purified by gradient flash column chromatography, eluting with 5%-15%-
25% EtOAc/hexanes, to afford 93 mg (84%) of pyran 3-95 as a viscous oil. 1H NMR 
                                            
4
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(500 MHz, CDCl3) δ ppm 7.40-7.22 (m, 5H), 5.86-5.76 (m, 1H), 5.50-5.45 (m, 1H), 
5.11-4.99 (m, 3H), 4.60-4.42 (m, 6H), 4.06 (d, J = 13.78 Hz, 4H), 3.71 (s, 3H), 3.29 
(s, 7H), 2.34-2.26 (m, 2H), 2.20-2.13 (m, 2H), 1.83 (s, 6H), 1.55 (s, 13H), 0.95 (d, J = 
7.12 Hz, 8H); 13C NMR (126 MHz, CDCl3) δ ppm 167.735, 138.450, 134.885, 
134.402, 132.451, 130.860, 128.853, 128.827, 128.790, 128.337, 127.701, 127.530, 
127.473, 116.579, 101.061, 77.505, 77.253, 77.103, 77.000, 76.745, 76.604, 
76.559, 76.537, 76.522, 76.499, 76.477, 76.458, 76.430, 76.395, 76.366, 76.347, 
76.333, 76.317, 76.299, 76.256, 76.214, 76.192, 75.800, 75.716, 71.766, 71.732, 
70.900, 70.815, 68.698, 68.152, 40.572, 40.515, 38.735, 33.580, 31.926, 30.363, 
29.701, 29.663, 29.365, 28.926, 25.807, 25.764, 23.749, 22.984, 22.692, 21.287, 
18.009, 14.117, 14.048, 11.171, 10.960, 1.018, -4.844, -4.944; IR (film) 3073.98, 
3026.73, 2973.7, 2928.38, 2873.42, 1728.87, 1639.2, 1496.49, 1454.06, 1435.74, 
1367.28, 1269.9, 1202.4, 1070.3, 1047.16, 997.017, 913.129, 737.639, 697.141 cm-
1; MS calculated for C22H32O4 [M + H]+: 361.32, found 361.3; [α]24D = +18.9 o (c 0.3, 
CH2Cl2). 
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To a solution of napthalene (0.613 g, 4.78 mmol) in THF (8 mL) was added sodium 
metal (washed in hexanes, 0.1 g, 4.35 mmol). The flask was subjected to sonication 
for 2 h. A solution of benzyl ether 3-95 (72 mg, 0.2 mmol) in THF (2 mL) was cooled 
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to 0 °C. The preformed sodium naphthalene solution was added in 1 mL portions 
until the green color was sustained in the reaction mixture. The reaction was 
complete in 30 min. Water was added and the resulting mixture was stirred 
vigorously while warming to ambient temperature. The layers were separated and 
the aqueous solution was extracted with EtOAc
 
(2x). The combined organic extracts 
were washed with brine, dried over Na2SO4, filtered, and evaporated in vacuo. The 
residue was purified by gradient flash column chromatography, eluting with 5%-15%-
25% EtOAc/hexanes, to afford 49 mg (91%) of allylic alcohol 3-96 as a viscous oil. It 
should be noted that the yields of this reaction varied from 13% to 91%. 1H NMR 
(500 MHz, CDCl3) δ ppm 5.87-5.76 (m, 1H), 5.39-5.32 (m, 1H), 5.12-5.03 (m, 1H), 
4.76-4.69 (m, 1H), 4.34-4.26 (m, 1H), 4.26-4.18 (m, 1H), 3.98-3.87 (m, 1H), 3.86-
3.81 (m, 1H), 3.52-3.45 (m, 1H), 2.33-2.14 (m, 3H), 2.07-1.97 (m, 2H), 1.83 (s, 2H), 
1.39-1.03 (m, 3H); 13C NMR (126 MHz, CDCl3) δ ppm 139.586, 134.678, 130.008, 
129.724, 127.011, 117.105, 96.113, 71.979, 71.231, 70.641, 62.515, 40.632, 
39.901, 37.097, 33.624, 31.929, 31.904, 30.035, 29.766, 29.701, 29.660, 29.523, 
29.364, 29.326, 29.238, 29.208, 29.115, 27.221, 27.165, 25.786, 25.518, 22.723, 
22.694, 22.390, 18.032, 14.120, 11.207, 1.019. IR (film) 2927.41, 2856.06, 1726.94, 
1462.74, 1259.29, 1078.98, 800.314 cm-1; MS calculated for C15H26O4 [M + Na]+: 
302.18, found 302.2; [α]24D = +29.1 o (c 0.19, CH2Cl2). 
 
 130 
O
OMOM
Me
OH
Me
H HO
OPMB
H
O
OMOM
Me
Me
OH
H H
H
3-96 3-105
 
A solution of pyran 3-96 (30 mg, 0.11 mmol) in CH2Cl2
 
(0.5 mL) and freshly prepared 
diene (0.33 mL of 1M solution in CH2Cl2, 0.33 mmol) were degassed with argon for 
30 min. Grubbs 2nd generation catalyst (9 mg, 0.011 mmol) was weighed in the 
glovebox and placed into a dry vial. Under positive flow of argon, the vial was 
inverted and the contents were added to the reaction vessel. The reaction mixture 
was allowed to stir under an atmosphere of argon for 8 h and then open to air for 12 
h. The reaction medium was concentrated in vacuo. The residue was mixed with 
silica gel and hexanes, concentrated in vacuo and loaded onto the column as a 
powder. The residue was purified by gradient flash column chromatography, eluting 
with 5%-10%-15% EtOAc/hexanes, to afford 42 mg (81% based on recycled 3-96 
dimer) of the homologated pyran 3-105 as a viscous oil. 1H NMR (500 MHz, CDCl3) 
δ ppm 7.30-7.24 (m, 2H), 7.24-7.18 (m, 1H), 6.39 (m, 1H), 6.30-6.20 (m, 2H), 5.88 
(m, 1H), 5.54 (d, J = 16.92 Hz, 1H), 5.08 (s, 2H), 4.78-4.73 (m, 1H), 4.04 (s, 2H), 
3.97-3.89 (m, 1H), 3.88-3.83 (m, 1H), 3.73 (d, J = 10.62 Hz, 3H), 2.44-2.36 (m, 1H), 
2.36-2.27 (m, 1H), 1.70 (s, 3H), 1.59 (s, 10H), 1.28 (d, J = 15.44 Hz, 9H), 1.10 (d, J 
= 7.47 Hz, 22H), 0.97-0.87 (m, 15H), 0.06 (d, J = 6.96 Hz, 6H); 13C NMR (126 MHz, 
CDCl3) δ ppm 166.827, 159.788, 145.167, 140.140, 134.883, 130.270, 128.303, 
125.863, 122.171, 114.095, 71.589, 71.463, 70.733, 68.360, 66.219, 55.416, 
39.637, 39.603, 33.900, 29.697, 25.810, 25.753, 17.998, 17.818, 14.116, 12.009, 
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11.266; IR (film) 3359.39, 2925.48, 2854.13, 1733.69, 1653.66, 1633.41, 1463.71, 
1428.99, 1376.93, 1256.4, 1077.05, 1004.73, 835.99, 776.208, 741.496 cm-1; MS 
calculated for C27H40O7 [M + Na]+: 508.28, found 508.3; [α]24D = +9.4o (c 1.2, 
CH2Cl2). 
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To a solution of allylic alcohol 3-105 (20 mg, 0.042 mmol) in CH2Cl2
 
(0.5 mL) was 
added 85% MnO2 (82 mg, 0.84 mmol). The reaction mixture was stirred at ambient 
temperature 12 h then filtered through celite rinsing with excess CH2Cl2. The filtrate 
was concentrated in vacuo. The residue was mixed with silica gel and hexanes, 
concentrated in vacuo and loaded onto the column as a powder. The residue was 
purified by gradient flash column chromatography, eluting with 5%-10%-15% 
EtOAc/hexanes, to afford 19 mg (93%) of aldehyde 3-107 as a viscous oil. 1H NMR 
(500 MHz, CDCl3) δ ppm 9.43 (s, 1H), 7.30-7.24 (m, 2H), 7.24-7.18 (m, 1H), 6.39 (m, 
1H), 6.30-6.20 (m, 2H), 5.88 (m, 1H), 5.54 (d, J = 16.92 Hz, 1H), 5.08 (s, 2H), 4.78-
4.73 (m, 1H), 4.04 (s, 2H), 3.97-3.89 (m, 1H), 3.88-3.83 (m, 1H), 3.73 (d, J = 10.62 
Hz, 3H), 2.44-2.36 (m, 1H), 2.36-2.27 (m, 1H), 1.70 (s, 3H), 1.59 (s, 10H), 1.28 (d, J 
= 15.44 Hz, 9H), 1.10 (d, J = 7.47 Hz, 22H), 0.97-0.87 (m, 15H), 0.06 (d, J = 6.96 
Hz, 6H); 13C NMR (126 MHz, CDCl3) δ ppm 195.221, 166.827, 159.788, 145.167, 
140.140, 134.883, 130.270, 128.303, 125.863, 137.866, 130.515, 122.171, 114.095, 
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71.589, 71.463, 70.733, 68.360, 66.219, 55.416, 39.637, 39.603, 33.900, 29.697, 
25.810, 25.753, 22.640, 17.998, 17.818, 14.116, 12.009, 11.266; IR (film) 3073.98, 
3026.73, 2973.7, 2928.38, 2873.42, 1728.87, 1639.2, 1496.49, 1454.06, 1435.74, 
1367.28, 1269.9, 1202.4, 1070.3, 1047.16, 997.017, 913.129, 737.639 cm-1; MS 
calculated for C26H34O7 [M + Na]+: 490.23, found 490.2; [α]24D = +19.2 o (c 0.21, 
CH2Cl2). 
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β−ketonitrile 3-99 (1.28 g, 4.44 mmol) was dissolved in THF (30 mL) and MeOH (9 
mL) before cooling to -78 °C. Et 2BOMe (26.7 mL of 1M solution, 6.66 mmol) was 
added via syringe and the solution was stirred for 15 min before adding NaBH4 
(0.553 g, 8.88 mmol) under positive argon flow. The reaction vessel was stirred at -
78 °C for 3 h. A solution of pH = 7 buffer and 30% aqueous H2O2 (1:1; 5 mL) was 
added slowly and the mixture was stirred for 30 min while warming to ambient 
temperature. Half-saturated NH4Cl solution was added and the resulting mixture was 
stirred vigorously. The layers were separated and the aqueous solution was 
extracted with EtOAc
 
(2x). The combined organic extracts were washed with sodium 
sulfite to remove peroxides (checked with starch paper), brine, dried over Na2SO4, 
filtered, and evaporated in vacuo. The residue was purified by gradient flash column 
chromatography, eluting with 25%-40% EtOAc/hexanes, to afford 1.182 g (92%) of 
diol 3-100 as an opaque, viscous oil. 1H NMR (500 MHz, CDCl3) δ ppm 5.56 (d, J = 
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8.45 Hz, 1H), 4.65 (d, J = 8.32 Hz, 1H), 4.21 (d, J = 6.57 Hz, 1H), 3.97 (s, 2H), 3.41 
(d, J = 10.73 Hz, 1H), 2.59 (dd, J = 16.78, 6.95 Hz, 1H), 2.45 (dd, J = 16.68, 6.83 
Hz, 1H), 1.59 (d, J = 15.26 Hz, 5H), 1.74 (s, 1H), 1.83-1.76 (m, 1H), 1.72-1.65 (m, 
1H), 0.98 (t, J = 7.86 Hz, 3H), 0.87 (s, 12H), 0.03 (s, 7H); 13C NMR (126 MHz, 
CDCl3) δ ppm 200.287, 128.955, 128.886, 128.217, 77.254, 76.999, 76.745, 68.894, 
67.149, 50.920, 32.726, 25.781, 25.755, 18.245, 13.756, 11.255, 0.913, -5.464, -
5.497; IR (film) cm-1; MS calculated for C16H31NO3Si [M + Na]+: 336.21, found 336.2; 
[α]24D = -12.9 o (c 1.91, CH2Cl2). 
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Nitrile 3-100 (0.5617 g, 1.94 mmol) was dissolved in CH2Cl2 (40 mL) and cooled to -
78 oC. DIBAL-H (1.0M in hexanes, 6.8 mL, 6.8 mmol) was added at once. The 
reaction mixture was stirred at -78 oC for 2 h, and then placed in an ice bath for 1 h. 
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Aqueous citric acid (1M, 20 mL) was added very slowly and the mixture was warmed 
to room temperature. A saturated solution of sodium potassium tartrate (20 mL) was 
added. Water (20 mL) and CH2Cl2
 
(20 mL) were added and the mixture was stirred 
vigorously for 1 h. The layers were separated and the aqueous solution was 
extracted with CH2Cl2
 
(2x100 mL). The combined organic extracts were washed with 
brine, dried over Na2SO4, filtered, and evaporated in vacuo. Chromatography, 
eluting with 50% EtOAc/hexanes, to afford 0.316 g (83 %) of hemiacetal 3-101 as a 
clear, viscous oil. 1H NMR (500 MHz, CDCl3) δ ppm 5.45 (t, J = 9.02 Hz, 2H), 5.16-
4.98 (m, 2H), 4.57-4.50 (m, 1H), 4.06 (ddd, J = 21.48, 12.41, 7.16 Hz, 3H), 3.92 (s, 
4H), 2.59-2.48 (m, 1H), 2.43 (d, J = 6.11 Hz, 1H), 1.73-1.46 (m, 12H), 1.15 (t, J = 
6.99 Hz, 2H), 0.93-0.73 (m, 29H), 0.021 (m, 14H); 13C NMR (126 MHz, CDCl3) δ 
ppm 137.212, 124.229, 121.894, 117.805, 92.230, 77.319, 76.999, 76.680, 71.093, 
70.696, 70.257, 67.480, 67.311, 62.433, 60.231, 41.542, 38.580, 30.832, 25.631, 
23.272, 20.710, 18.072, 18.052, 13.868, 13.666, 13.633, 13.518, 11.010, 10.815, 
5.924, -5.605; IR (film) cm-1; MS calculated for C16H32O4Si [M + Na]+: 339.21, found 
339.2; [α]24D = +8.53 o (c 3.8, CH2Cl2). 
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A mixture of sodium hydride (60% suspension in mineral oil, 0.112 g, 2.82 mmol) in 
THF (5 mL) was cooled to 0 oC and treated with ethyl (diethylphosphono)acetate 
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(0.54 mL, 2.82 mmol) and the mixture was stirred for 20 min. A precooled (0 oC) 
solution of hemi-acetal 3-101 (0.2779 g, 0.88 mmol) in THF (5 mL) was added to the 
reaction vessel via cannula. The solution was stirred for 12 h while warming to room 
temperature. Half-saturated NH4Cl solution was added and the resulting mixture was 
stirred vigorously. The layers were separated and the aqueous solution was 
extracted with EtOAc
 
(2x). The combined organic extracts were washed with brine, 
dried over Na2SO4, filtered, and evaporated in vacuo. The residue was purified by 
gradient flash column chromatography, eluting with hexanes-5%-15% 
EtOAc/hexanes, to afford 0.31 g (91%) of pyran 3-102 as an opaque, viscous oil. 1H 
NMR (500 MHz, CDCl3) δ ppm 5.57 (d, J = 8.58 Hz, 1H), 4.67 (dd, J = 8.51, 2.37 Hz, 
1H), 4.21 (dd, J = 9.21, 4.45 Hz, 1H), 4.01 (d, J = 5.28 Hz, 2H), 3.75 (s, 1H), 2.62 
(dd, J = 16.73, 7.15 Hz, 1H), 2.48 (dd, J = 16.72, 6.61 Hz, 1H), 2.34 (d, J = 2.68 Hz, 
1H), 1.71 (ddd, J = 9.35, 6.77, 4.16 Hz, 1H), 1.64 (s, 3H), 1.24 (qd, J = 8.34, 7.19 
Hz, 2H), 1.06-0.96 (m, 3H), 0.94-0.78 (m, 11H), 0.08 (d, J = 18.22 Hz, 7H); 13C NMR 
(126 MHz, CDCl3) δ ppm 138.250, 123.749, 117.871, 77.318, 77.000, 76.681, 
71.992, 71.357, 67.308, 41.418, 29.619, 25.829, 23.413, 18.311, 13.781, 5.603, -
5.401; IR (film) 3418.21, 2954.41, 2928.38, 2857.02, 2710.46, 2252.45, 1721.16, 
1644.02, 1471.42, 1462.74, 1422.24, 1389.46, 1361.5, 1255.43, 1189.9, 1110.8, 
1072.23, 1005.7, 971.947, 939.163, 837.919, 814.775, 777.172, 668.214, 552.506, 
537.078, 522.615, 507.187 cm-1; MS calculated for C20H38O5Si [M + Na]+: 409.25, 
found 409.4; [α]24D = 0.64 o (c 3.46, CH2Cl2). 
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A solution of pyran 3-102 (0.1692 g, 0.653 mmol) in CH2Cl2
 
(6 mL) was cooled to 0 
°C. To the stirring solution was added 2,6-lutidine  (0.15 mL, 1.3 mmol).and t-
butyldimethylsilyl trifluoromethanesulfonate (0.3 mL, 1.3 mmol). After 1 h saturated 
NaHCO3
 
solution was added and the mixture was extracted with CH2Cl2
 
(2x). The 
combined organic extracts were washed with brine, dried over Na2SO4, filtered, and 
evaporated in vacuo. The residue was purified by gradient flash column 
chromatography, eluting with 5%-10% EtOAc/hexanes, to afford 0.32 g (98 %) of 
bis-silyl ether 3-103 as a viscous oil. 1H NMR (500 MHz, CDCl3) δ ppm 5.45 (dd, J = 
8.99, 1.38 Hz, 1H), 4.66 (dd, J = 9.04, 2.85 Hz, 1H), 3.97 (s, 2H), 3.89-3.82 (m, 1H), 
2.77 (dd, J = 16.81, 6.09 Hz, 1H), 2.59 (dd, J = 16.78, 4.00 Hz, 1H), 1.85-1.73 (m, 
2H), 1.62 (s, 3H), 1.55 (s, 3H), 0.98-0.83 (m, 18H), 0.13 (d, J = 7.84 Hz, 4H), 0.04 
(m, 12H); 13C NMR (126 MHz, CDCl3) δ ppm 134.844, 125.400, 118.641, 77.253, 
77.140, 77.122, 77.000, 76.863, 76.746, 76.591, 70.438, 68.577, 67.445, 45.267, 
25.879, 25.849, 25.795, 25.772, 24.110, 20.991, 18.279, 18.042, 17.978, 14.005, 
13.983, 10.792, -3.812, -4.466, -4.490, -4.557, -4.580, -4.793, -5.355, -5.375; IR 
(film) 3944.68, 3757.62, 3437.49, 3053.73, 2985.27, 2956.34, 2930.31, 2857.02, 
2685.39, 2521.47, 2410.58, 2348.8887, 2305.48, 1731.76, 1643.05, 1550.49, 
1471.4442, 1462.74, 1422.24, 1377.89, 1265.07, 1161.9, 1076.08, 1052.94, 
1006.66, 984.482, 939.163, 895.773, 837.919, 741.44496, 705.819, 554.434 cm-1; 
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MS calculated for C26H52O5Si2 [M + Na]+: 523.34, found 523.4; [α]24D = +34.2 o (c 
1.28, CH2Cl2). 
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A solution of the bis-silyl ether 3-103 (0.2 g, 0.4 mmol) in CH2Cl2
 
(4 mL) was cooled 
to -10 °C. To the stirring solution was added t-butylammonium fluoride (TBAF) (0.44 
mL of 1M solution in THF, 0.44 mmol). The reaction was closely monitored by TLC. 
In ~40 min the primary silyl group was removed. Saturated NaHCO3
 
solution was 
added and the mixture was extracted with EtOAc
 
(2x). The combined organic 
extracts were washed with brine, dried over Na2SO4, filtered, and evaporated in 
vacuo. The residue was purified by gradient flash column chromatography, eluting 
with 5%-10%-40% EtOAc/hexanes, to afford 0.11 g (71 %) of the allylic alcohol as a 
viscous oil. 1H NMR (500 MHz, CDCl3) δ ppm 5.66 (dd, J = 8.35, 1.23 Hz, 1H), 4.59 
(dd, J = 8.28, 5.05 Hz, 1H), 4.14-4.08 (m, 3H), 4.06 (s, 2H), 3.68 (dt, J = 9.52, 4.48 
Hz, 1H), 2.56 (dd, J = 15.02, 8.16 Hz, 1H), 2.42 (dd, J = 15.02, 5.20 Hz, 1H), 1.90 
(ddd, J = 12.64, 4.35, 2.81 Hz, 1H), 1.83-1.74 (m, 1H), 1.70 (s, 3H), 1.27-1.21 (m, 
4H), 0.85 (m, 13H); 13C NMR (126 MHz, CDCl3) δ ppm 171.445, 141.924, 120.034, 
77.254, 77.000, 76.746, 72.558, 70.179, 68.214, 66.717, 60.460, 41.358, 41.248, 
40.188, 25.787, 18.011, 14.193, 13.043, -4.177, -4.731; IR (film) 2955.38, 2929.34, 
2857.02, 2222.56, 1736.58, 1462.74, 1371.14, 1322.93, 1301.72, 1255.43, 1213.01, 
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1161.9, 1081.87, 1044.26, 985.447, 937.235, 919.879, 906.379, 836.955, 775.244, 
736.674, 702.926, 666.285, 579.504, 538.042, 520.686 cm-1; MS calculated for 
C20H38O5Si [M + Na]+: 409.25, found 409.3; [α]24D = +29.5 o (c 4.65, CH2Cl2). 
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A solution of the ester (96 mg, 0.25 mmol) in CH2Cl2 (3 mL) was cooled to -78 oC. 
DIBAL-H (1.0M in hexanes, 0.75 mL, 0.75 mmol) was added at once. The reaction 
was monitored by TLC and was complete in within 20 min. A saturated solution of 
sodium potassium tartrate (10 mL) was added and the mixture was warmed to room 
temperature. Water (5 mL) and CH2Cl2
 
(5 mL) were added and the mixture was 
stirred vigorously for 1 h. The layers were separated and the aqueous solution was 
extracted with CH2Cl2. The combined organic extracts were washed with brine, dried 
over Na2SO4, filtered, and evaporated in vacuo. Chromatography, eluting with 15% 
EtOAc/hexanes, to afford 79 mg (82 %) of the aldehyde as a clear, viscous oil. 1H 
NMR (500 MHz, CDCl3) δ ppm 9.72 (s, 1H), 5.47 (dd, J = 7.84, 1.34 Hz, 1H), 4.78 
(dd, J = 7.79, 2.29 Hz, 1H), 4.43-4.32 (m, 1H), 4.01 (s, 3H), 3.86 (d, J = 2.76 Hz, 
1H), 2.61-2.51 (m, 1H), 2.46 (dd, J = 4.79, 2.00 Hz, 1H), 1.74-1.52 (m, 11H), 1.33-
1.16 (m, 11H), 0.95-0.78 (m, 9H), 0.06 (m, 6H); 13C NMR (126 MHz, CDCl3) δ ppm 
201.611, 136.903, 124.600, 77.253, 77.000, 76.848, 76.745, 71.598, 70.495, 
68.256, 68.029, 49.628, 39.408, 34.073, 29.690, 25.756, 18.009, 14.109, 11.215, -
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4.890, -4.933; IR (film) 3073.98, 3026.73, 2973.7, 2928.38, 2973.42, 1728.87, 
1639.2, 1496.49, 1454.06, 1435.74, 1367.28, 1269.9, 1202.4, 1070.3, 1047.16, 
997.017, 913.129, 737.639, 697.141 cm-1; MS calculated for C18H34O4Si [M + Na]+: 
365.22, found 365.2; [α]24D = +18.5 o (c 0.7, CH2Cl2). 
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A solution of phosphonate 3-108 (0.97 mL of 1M solution in THF, 0.97 mmol) and 
THF (1 mL) were cooled to -78 oC. Lithium bis(trimethylsilyl)amide (LiHMDS) (0.97 
mL of 1M solution in THF, 0.97 mmol) was added and the yellow solution was stirred 
for 1 h. The aldehyde (0.2779 g, 0.88 mmol) in THF (1.4 mL) was added to the 
reaction vessel via cannula. The solution was stirred for 2 h while warming to 0 oC. 
Half-saturated NH4Cl solution was added and the resulting mixture was stirred 
vigorously. The layers were separated and the aqueous solution was extracted with 
EtOAc
 
(2x). The combined organic extracts were washed with brine, dried over 
Na2SO4, filtered, and evaporated in vacuo. The residue was purified by gradient 
flash column chromatography, eluting with hexanes-5%-15% EtOAc/hexanes, to 
afford 0.121 g (89%) of polyene 3-109 as an opaque, viscous oil. 1H NMR (500 MHz, 
CDCl3) δ ppm 7.26-7.20 (m, 1H), 6.30-6.20 (m, 2H), 6.20-6.13 (m, 1H), 5.86-5.78 (m, 
1H), 5.56-5.49 (m, 1H), 4.78-4.73 (m, 1H), 4.04 (s, 2H), 3.97-3.89 (m, 1H), 3.88-3.83 
(m, 1H), 2.44-2.36 (m, 1H), 2.36-2.27 (m, 1H), 1.70 (s, 3H), 1.59 (s, 10H), 1.28 (d, J 
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= 15.44 Hz, 9H), 1.10 (d, J = 7.47 Hz, 22H), 0.97-0.87 (m, 15H), 0.06 (d, J = 6.96 
Hz, 6H); 13C NMR (126 MHz, CDCl3) δ ppm 166.883, 145.193, 140.140, 136.700, 
130.271, 124.972, 121.500, 77.407, 77.253, 77.000, 76.874, 76.745, 76.597, 
76.558, 76.541, 76.519, 71.589, 71.463, 70.733, 68.360, 39.637, 39.603, 33.900, 
29.697, 25.810, 25.753, 17.998, 17.818, 14.116, 12.009, 11.266, -4.868, -4.915; IR 
(film) 3417.24, 2926.45, 2856.06, 2348.87, 2127.1, 1642.09, 1462.74, 1377.89, 
1264.11, 1170.58, 1079.94, 883.238, 835.99, 740.531, 663.393, 597.825, 530.328 
cm-1; MS calculated for C31H58O5Si2 [M + Na]+: 589.38, found 589.4; [α]24D = +11.3 o 
(c 0.865, CH2Cl2). 
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To a solution of polyene 3-109 (30 mg, 0.052 mmol) in CH2Cl2
 
(1 mL) was added 
85% MnO2 (110 mg, 1.04 mmol). The reaction mixture was stirred at ambient 
temperature 12 h and then filtered through celite. The celite was washed with excess 
CH2Cl2. The combined filtrates were concentrated in vacuo. The residue was mixed 
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with silica gel and hexanes, concentrated in vacuo and loaded onto the column as a 
powder. The residue was purified by gradient flash column chromatography, eluting 
with 5%-10%-15% EtOAc/hexanes, to afford 26 mg (90%) of the homologated pyran 
3-110 as a viscous oil. 1H NMR (500 MHz, CDCl3) δ ppm 9.42 (s, 1H), 7.27-7.18 (m, 
1H), 6.45 (d, J = 6.88 Hz, 1H), 6.24 (dd, J = 14.98, 11.04 Hz, 1H), 6.18-6.10 (m, 1H), 
5.84-5.79 (m, 1H), 4.96 (d, J = 6.57 Hz, 1H), 3.94 (td, J = 10.28, 5.23 Hz, 1H), 3.87 
(s, 1H), 2.40 (td, J = 13.85, 6.79 Hz, 1H), 2.36-2.28 (m, 1H), 1.75 (s, 3H), 1.08 (d, J 
= 7.48 Hz, 21H), 0.95-0.88 (m, 14H), 0.06 (d, J = 7.58 Hz, 6H); 13C NMR (126 MHz, 
CDCl3) δ ppm 194.751, 166.782, 153.436, 144.949, 139.574, 137.866, 130.515, 
121.778, 77.253, 77.000, 76.745, 72.496, 71.584, 70.397, 39.464, 39.258, 33.749, 
31.575, 25.772, 25.731, 22.640, 17.980, 17.807, 14.102, 12.010, 11.386, 9.659, -
4.851, -4.951; IR (film) 3434.6, 2927.41, 2866.67, 2359.48, 2341.16, 2089.49, 
1692.23, 1644.02, 1463.71, 1257.36, 1142.62, 1062.59, 1000.87, 835.026, 668.214, 
551.542 cm-1; MS calculated for C31H56O5Si2 [M + Na]+: 587.37, found 587.4; [α]24D = 
+25.1 o (c 0.39, CH2Cl2). 
 
B-3. Side-Chain: C26-C35 Segment of (-)-lasonolide A: 
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A flask containing a solution of freshly prepared sodium bis(trimethylsilyl)amide 
(NaHMDS) (12.0 mL, 8.97 mmol; 0.75 M in toluene/THF) and 30 mL THF was 
cooled to -78 ºC under an argon atmosphere. A solution of glycolate 3-112 (1.80 g, 
5.98 mmol) in 30 mL THF was added dropwise over 20 min and the solution was 
stirred at -78 ºC for 45 min. Freshly distilled allyl iodide (1.6 mL, 17.3 mmol) was 
added and the resulting mixture was stirred for 30 min. The reaction mixture was 
quenched using saturated NH4Cl. The organic layer was separated and the aqueous 
layer was extracted twice with EtOAc. The combined organic fractions were dried 
over MgSO4 and concentrated under reduced pressure. Purification by flash 
chromatography gave 1.76 g (86%) of the desired alkylation product 3-115 as a 
single diastereomer (judged by NMR analysis). 1H NMR (500 MHz, CDCl3) δ ppm 
5.92-5.74 (m, 1H), 5.35 (dd, J = 7.21, 3.97 Hz, 1H), 5.06 (dd, J = 20.41, 4.95 Hz, 
2H), 4.45 (td, J = 8.49, 3.57 Hz, 1H), 4.28 (t, J = 8.87 Hz, 1H), 4.17 (dd, J = 9.16, 
3.38 Hz, 1H), 2.59-2.46 (m, 1H), 2.35 (td, J = 14.78, 7.49 Hz, 1H), 2.25 (dtd, J = 
13.88, 6.94, 4.02 Hz, 1H), 0.90-0.77 (m, 15H), 0.06 (t, J = 9.60 Hz, 6H); 13C NMR 
(126 MHz, CDCl3) δ ppm 173.413, 153.561, 133.337, 118.035, 77.318, 77.000, 
76.681, 70.944, 58.111, 39.900, 28.164, 25.670, 25.582, 18.245, -4.936, -4.995, -
5.203, -5.256; IR (film) 3078.8, 2959.23, 29.30.31, 2885.95, 2857.95, 2391.3, 
1784.94, 1716.34, 1642.09, 1487.81, 1472.38, 1389.46, 1362.46, 1247.72, 1116.58, 
970.983, 812.849, 663.393, 476.331, 431.977  cm-1; MS calculated for C17H31NO4Si 
[M + Na]+: 364.20, found 364.2; [α]24D = +5.4 o (c 2.3, CH2Cl2). 
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To a two-neck round-bottom flask fitted with a bubbler and a drying tube were added 
CH2Cl2 (50 mL) and the olefin 3-115 (1.435 g, 4.2 mmol). The solution was treated 
with ozone for 1 h at −78 oC then allowed to warm to room temperature. Then 
NaBH4 (1.59g, 42 mmol) was added and the mixture was stirred for 1 h at room 
temperature. The reaction mixture was washed with water (2.30 mL), dried over 
Na2SO4, filtered, and concentrated in vacuo to provide 1.02 g (70%) of primary 
alcohol 3-116, which was used directly in the next reaction.  
 
N O
O
TBSO
O
Me
MeHO
N O
O
TBSO
O
Me
MeTBSO
3-116
 
A solution of alcohol 3-116 (1.02 g, 3.0 mmol) in CH2Cl2
 
(25 mL) was cooled to 0 °C. 
To the stirring solution was added 2,6-lutidine (0.4 mL, 3.6 mmol) and t-
butyldimethylsilyl trifluoromethanesulfonate (0.82 mL, 3.6 mmol). After 1 h saturated 
NaHCO3
 
solution was added and the mixture was extracted with CH2Cl2
 
(2x). The 
combined organic extracts were washed with brine, dried over Na2SO4, filtered, and 
evaporated in vacuo. The residue was purified by gradient flash column 
chromatography, eluting with 5%-10% EtOAc/hexanes, to afford 1.11 g (81 %) of the 
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bis-silyl ether as a viscous oil. 1H NMR (500 MHz, CDCl3) δ ppm 5.35 (dd, J = 7.21, 
3.97 Hz, 1H), 4.45 (td, J = 8.49, 3.57 Hz, 1H), 4.28 (t, J = 8.87 Hz, 1H), 4.17 (dd, J = 
9.16, 3.38 Hz, 1H), 3.21-3.34 (m, 1H), 2.59-2.46 (m, 1H), 2.35 (td, J = 14.78, 7.49 
Hz, 1H), 2.25 (dtd, J = 13.88, 6.94, 4.02 Hz, 1H), 0.90-0.77 (m, 15H), 0.06 (t, J = 
9.60 Hz, 6H); 13C NMR (126 MHz, CDCl3) δ ppm 173.413, 153.561, 77.318, 77.000, 
76.681, 70.944, 58.111, 55.822, 39.583, 28.164, 25.670, 25.582, 18.245, -4.936, -
4.995, -5.203, -5.256; IR (film) 2955, 2876, 1780, 1715, 1454, 1389, 1350, 1211, 
1136, 1103, 1015, 972, 733, 700 cm-1; MS calculated for C22H45NO5Si2 [M + 
Na]+:491.28 , found + 491.3; [α]24D = -43.4 o (c 0.99, CH2Cl2). 
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A solution of the bis-silyl ether (0.44 g, 1.0 mmol) in THF (10 mL) at 0 oC was treated 
with LiOH-H2O (3.0 mL, 6.0 mmol) and hydrogen peroxide (30% in H2O, 2 mL). The 
resultant suspension was stirred at ambient temperature for 2 h and treated with 
water (10 mL). The resulting solution was diluted with Et2O (5 mL) and washed with 
saturated Na2S2O3 (15 mL) solution. The organic phase was washed with 25% 
aqueous NaOH several times. The aqueous phase was then treated with 10% 
H2SO4 and extracted with Et2O (10 mL x2). The combined organic extracts were 
washed with brine, dried over Na2SO4, filtered, and evaporated in vacuo, affording 
0.302g (93 %) of acid 3-118. 1H NMR (400 MHz, CDCl3) δ ppm 9.87 (s, 1H), 5.22 
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(m,1H), 3.81-3.68 (m, 2H), 1.33 (m, 2H), 0.92-0.83 (m, 18H), 0.8-0.04 (m, 12H); 13C 
NMR (126 MHz, CDCl3) δ ppm 176.50, 72.97, 58.66, 36.17, 27.74, 25.91, 25.73, 
22.47, 18.29, 18.26, -4.882, -5.327, -5.365, -5.462; IR (film) 3445, 2955, 2876, 1456, 
1414, 1364, 1238, 1096, 1007, 741 cm-1; MS calculated for C16H36O4Si2 [M + Na]+: 
380.22, found 380.2; [α]24D = -4.49 o (c 2.4, CH2Cl2). 
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A solution of the alcohol 3-121 (0.6 g, 1.9 mmol) and acid 3-118 (0.696 g, 2.0 mmol) 
in CH2Cl2 (15 mL) was cooled to 0 oC. dicyclohexyl carbodiimide (DCC) (0.5 g, 2.0 
mmol), and 4-dimethylaminopyridine (DMAP) (0.6 g, 2.0 mmol) were added and the 
flask was removed from the ice bath. After 4 days, the resulting solution was diluted 
with ether (20 mL) and washed with saturated NH4Cl (25 mL) solution. The aqueous 
phase was extracted with ether (20 mL). The combined organic extracts were 
washed with brine, dried over Na2SO4, filtered, and evaporated in vacuo. The 
residue was purified by gradient flash column chromatography, eluting with 10%-
25%-40% EtOAc/hexanes, to afford 0.334 g (61 %) of ester 3-122. 1H NMR (500 
MHz, CDCl3) δ ppm 5.02 (s, 1H), 4.93 (s, 1H), 4.56 (s, 2H), 4.43-4.38 (m, 1H), 3.81-
3.68 (m, 2H), 2.06 (m, 2H), 1.97-1.82 (m, 2H), 1.60-1.50 (m, 1H), 1.33 (m, 2H), 0.92-
0.83 (m, 18H), 0.8-0.04 (m, 12H); 13C NMR (126 MHz, CDCl3) δ ppm 173.742, 
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144.127, 112.158, 68.872, 67.056, 65.850, 58.641, 38.218, 36.644, 31.076, 27.774, 
25.913, 25.735, 22.479, 18.295, 18.263, -4.882, -5.327, -5.365, -5.462; IR (film) 
2955.38, 2929.34, 2857.02, 1756.83, 1471.42, 1361.5, 1255.43, 1138.76, 1097.3, 
1005.7, 836.955, 778.136, 523.579, 512.972, 503.33 cm-1; MS calculated for 
C24H50O4Si2 [M + Na]+: 481.32, found 481.3; [α]24D = +9.6 o (c 0.54, CH2Cl2). 
 
 
Me O
O
OTBS
Me
OHMe O
O
OTBS
Me
OTBS
3-122
 
A solution of the bis-silyl ether 3-123 (0.2 g, 0.4 mmol) in CH2Cl2
 
(4 mL) was cooled 
to -10 °C. To the stirring solution was added t-butylammonium fluoride (TBAF) (0.44 
mL of 1M solution in THF, 0.44 mmol). The reaction was closely monitored by TLC. 
In 40 min the primary silyl group was removed. Saturated NaHCO3
 
solution was 
added and the mixture was extracted with EtOAc
 
(2x). The combined organic 
extracts were washed with brine, dried over Na2SO4, filtered, and evaporated in 
vacuo. The residue was purified by gradient flash column chromatography, eluting 
with 5%-10%-40% EtOAc/hexanes, to afford 0.11 g (71 %) of the primary alcohol as 
a viscous oil. 1H NMR (500 MHz, CDCl3) δ ppm 5.02 (d, J = 0.6 Hz, 1H), 4.95 (d, J = 
0.6 Hz, 1H), 4.62 (s, 2H), 4.47 (dd, J = 6.6, 4.8 Hz, 1H), 3.79 (q, J = 5.5 Hz, 2H), 
2.09-1.98 (m, 5H), 1.55 (td, J = 13.30, 6.66 Hz, 1H), 1.37-1.30 (m, 2H), 0.92 (s, 9H), 
0.89 (d, J = 6.6 Hz, 6H), 0.11 (s, 3H), 0.08 (s, 3H).; 13C NMR (126 MHz, CDCl3) δ 
ppm 173.3, 143.9, 112.5, 70.7, 67.3, 59.5, 36.9, 36.6, 31.0, 27.8, 25.7, 22.5, 18.2, -
5.0, -5.6; IR (film) 3436.53, 3030,59, 2923.56, 2854.13, 1716.34, 1496.49, 1454.06, 
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1363.43, 1245.79, 1096.33, 1061.62, 1026.91, 1009.55, 983.518, 802.242, 737.639, 
699.069, 609.396 cm-1; MS calculated for C18H36O4Si [M + Na]+: 367.24, found 
367.2; [α]24D = +29.8 o (c 0.4, CH2Cl2). 
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A solution of the primary alcohol (0.135 g, 0.39 mmol) in THF (10 mL) was cooled to 
0 oC. Ph3P (0.154 g, 0.59 mmol), imidazole (0.080 g, 1.18 mmol), and I2 (0.149 g, 
0.59 mmol) were added. After 2 h, the resulting solution was diluted with ether (20 
mL) and washed with saturated Na2S2O3 (15 mL) solution. The aqueous phase was 
extracted with ether (20 mL). The combined organic extracts were washed with 
brine, dried over Na2SO4, filtered, and evaporated in vacuo. The residue was purified 
by gradient flash column chromatography, eluting with 10%-25%-40% 
EtOAc/hexanes, to afford 0.1 g (81 %) of the iodide. 1H NMR (400 MHz, CDCl3) δ 
5.02 (s, 1H), 4.95 (d, 1H, J = 0.7 Hz), 4.57 (s, 2H), 4.30 (dd, 1H, J = 7.8, 4.3 Hz), 
3.33-3.19 (m, 2H), 2.32-2.13 (m, 2H), 2.06 (t, 2H, J = 8.0 Hz), 1.62-1.48 (m, 1H), 
1.38-1.28 (m, 2H), 0.91 (s, 9H), 0.90 (d, 6H, J = 6.7 Hz), 0.11 (s, 6H). 13C NMR (126 
MHz, CDCl3) δ ppm ; IR (film) 3359.39, 2925.48, 2854.13, 1733.69, 1653.66, 
1633.41, 1463.71, 1428.99, 1376.93, 1256.4, 1077.05, 1004.73, 835.99, 776.208, 
741.496 cm-1; MS calculated for C18H35IO3Si [M + Na]+: 486.14, found 486.1; [α]24D = 
+31.8 o (c 0.67, CH2Cl2). 
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To a solution of the iodide (0.934 g, 0.3219 mmol) in CH3CN (6 mL) was added Ph3P 
(0.17 g, 0.65 mmol). The resulting solution was stirred for 12 h under reflux. The 
solvent was removed in vacuo. The residue was purified by gradient flash column 
chromatography, eluting with 10%-25%-40% EtOAc/hexanes, to afford 0.182 g 
(79%) of phosphonium salt 3-125 1H NMR (400 MHz, CDCl3): δ ppm 7.88-7.21 (m, 
15H), 4.83 (s, 1H), 4.77 (s, 1H), 4.57 (t, 1H, J = 5.4 Hz), 4.44 (s, 2H), 3.85-3.68 (m, 
1H), 3.37-3.20 (m, 1H), 2.05-1.92 (m, 1H), 1.92-1.77 (m, 3H), 1.43-1.30 (m, 1H), 
1.20-1.04 (m, 2H), 0.74 (s, 9H), 0.72 (d, 6H, J = 6.8 Hz), 0.01 (s, 3H), 0.002 (s,3H). 
13C NMR (126 MHz, CDCl3) δ ppm 171.4, 143.3, 135.2, 135.2, 133.3, 133.2, 130.6, 
130.4, 117.8, 116.6, 112.3, 70.2, 67.3, 36.2, 30.7, 27.4, 25.5, 22.2, 17.8, -5.0, -5.1; 
IR (film) 3423.03, 3051.8, 2955.38, 2931.27, 2858.95, 2311.27, 1970.89, 1902.43, 
1825.29, 1749.12, 1651.73, 1616.06, 1588.09, 1484.92, 1470.46, 1437.67, 1391.39, 
1364.39, 1338.36, 1267, 1190.83, 1162.87, 1111.76, 1027.87, 997.017, 949.77, 
856.239, 822.491, 792.6, 727.032, 702.926, 612.288, 541.899 cm-1; MS calculated 
for C36H50O3PSi [M + Na]+: 621.23, found 621.2; [α]24D = +10.5 o (c 0.44, CH2Cl2).  
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B-4. Coupling Silyl-Protected Segments of (-)-lasonolide A: 
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A solution of phosphonium salt 3-125 (88.6 mg, 0.12 mmol) in THF (1 mL) was 
cooled to -78 oC. Potassium bis(trimethylsilyl)amide (KHMDS) (0.25 mL of 0.5M 
solution in toluene, 0.12 mmol) was added and the yellow solution was stirred for 15 
min. A solution of aldehyde 3-58 (21.5 mg, 0.036 mmol) in THF (2 mL + 1 mL rinse) 
was added to the reaction vessel via cannula. The solution was stirred for 12 h while 
warming to ambient temperature. Half-saturated NH4Cl solution was added and the 
resulting mixture was stirred vigorously. The layers were separated and the aqueous 
solution was extracted with EtOAc
 
(2x). The combined organic extracts were 
washed with brine, dried over Na2SO4, filtered, and evaporated in vacuo. The 
residue was purified by gradient flash column chromatography, eluting with hexanes-
5%-15%-60% EtOAc/hexanes, to afford 25.4 mg (74%) of 3-128 as an opaque, 
viscous oil. 1H NMR (500 MHz, CDCl3) δ ppm 7.88-7.84 (m, 1H), 7.77-7.73 (m, 1H), 
7.43-7.38 (m, 1H), 7.32-7.27 (m, 1H), 5.72-5.57 (m, 3H), 5.49-5.40 (m, 1H), 5.01 (s, 
1H), 4.95-4.91 (m, 1H), 4.55 (s, 2H), 4.27-4.18 (m, 2H), 3.82-3.76 (m, 1H), 3.64-3.59 
(m, 1H), 3.50-3.46 (m, 1H), 3.39 (s, 2H), 2.05 (s, 3H), 2.28-2.20 (m, 1H), 2.49-2.41 
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(m, 1H), 2.59-2.52 (m, 2H), 0.05 (dd, J = 18.09, 7.58 Hz, 17H), 0.89 (s, 37H), 1.25 
(s, 22H), 0.94 (d, J = 7.74 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ ppm 196.897, 
172.945, 166.983, 153.332, 144.078, 135.200, 133.905, 130.748, 127.308, 125.974, 
124.583, 124.108, 121.484, 120.898, 112.123, 77.254, 77.137, 77.123, 77.000, 
76.910, 76.746, 72.244, 71.872, 71.213, 66.994, 66.538, 42.269, 36.623, 35.925, 
33.555, 32.953, 32.192, 31.928, 31.068, 30.036, 29.701, 29.660, 29.363, 28.446, 
27.765, 26.058, 26.029, 25.922, 25.751, 22.693, 22.501, 18.333, 18.286, 18.158, 
14.894, 14.119, 7.030, 5.101, -4.368, -4.887, -4.972, -5.172, -5.249, -5.472; IR (film) 
3359.39, 2925.48, 2854.13, 1733.69, 1653.66, 1633.41, 1463.71, 1428.99, 1376.93, 
1256.4, 1077.05, 1004.73, 835.99, 776.208, 741.496 cm-1; MS calculated for 
C50H87NO6S2Si3 [M + Na]+: 968.53, found 968.5; [α]24D = -4.3 o (c 0.76, CH2Cl2). 
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A solution of sulfide 3-128 (4.66 mg, 0.005 mmol) in ethanol (1 mL) at 0 oC was 
treated with ammonium molybdate tetrahydrate (2 mg, 0.001 mmol) in hydrogen 
peroxide (30% in H2O, 6 µL) (mixed in small, conical flask and transferred via micro-
syringe). The resultant suspension was stirred at ambient temperature for 8 h and 
treated with water (10 mL). The resulting solution was diluted with ether (5 mL) and 
washed with saturated Na2S2O3 (15 mL) solution. The aqueous phase was extracted 
with ether (10 mL x2). The combined organic extracts were washed with brine, dried 
over Na2SO4, filtered, and evaporated in vacuo. The residue was purified by gradient 
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flash column chromatography, eluting with 10%-25%-40% EtOAc/hexanes, to afford 
3.8 mg (78 %) of sulfone 3-130. 1H NMR (500 MHz, CDCl3) δ ppm 8.22 (d, J = 8.14 
Hz, 1H), 8.02 (d, J = 8.02 Hz, 1H), 7.62 (td, J = 15.13, 7.35 Hz, 2H), 5.42 (dd, J = 
17.63, 7.45 Hz, 1H), 5.63-5.53 (m, 3H), 5.00 (s, 1H), 4.92 (s, 1H), 4.54 (s, 2H), 4.22 
(t, J = 6.14 Hz, 1H), 4.12 (d, J = 11.68 Hz, 1H), 3.76 (d, J = 10.83 Hz, 1H), 3.58 (dd, 
J = 16.51, 8.44 Hz, 4H), 3.45 (d, J = 9.40 Hz, 1H), 3.35-3.30 (m, 1H), 2.64-2.58 (m, 
2H), 2.53-2.38 (m, 2H), 2.27 (s, 1H), 2.21 (dd, J = 15.13, 7.19 Hz, 1H), 2.07-2.01 (m, 
3H), 1.25 (s, 4H), 0.88 (d, J = 4.69 Hz, 38H), 0.84 (d, J = 4.06 Hz, 4H), 0.03 (m, 
19H); 13C NMR (126 MHz, CDCl3) δ ppm 196.897, 172.909, 165.699, 152.734, 
144.058, 136.791, 134.593, 130.622, 128.009, 127.642, 125.515, 124.656, 124.624, 
122.309, 112.134, 77.253, 77.131, 77.000, 76.878, 76.745, 72.201, 71.512, 71.471, 
71.065, 67.001, 66.454, 54.094, 42.230, 36.609, 35.762, 33.513, 31.924, 31.053, 
29.695, 29.656, 29.359, 28.377, 27.758, 26.038, 26.009, 25.896, 25.733, 25.308, 
22.689, 22.495, 18.338, 18.315, 18.271, 18.133, 14.861, 14.773, 14.116, 7.010, 
5.069, 1.015, -4.401, -4.901, -4.979, -5.194, -5.264, -5.352, -5.490; IR (film) 
3854.04, 3751.83, 3430.74, 2955.38, 2927.41, 2857.02, 1730.8, 1646.91, 1462.74, 
1430.92, 1389.46, 1361.5, 1646.91, 1462.74, 1430.92, 1389.46, 1361.5, 1250.61, 
1231.33, 1154.19, 1120.44, 960.377, 835.99, 775.244, 590.111, 523.579 cm-1; MS 
calculated for CHO [M + Na]+: 1000.51, found 1000.6; [α]24D = -16.2 o (c 0.12, 
CH2Cl2). 
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Lithium bis(trimethylsilyl)amide (LiHMDS) (1M in THF, 11 µL, 0.011 mmol) was 
added dropwise to a solution of sulfone 3-130 (8.7 mg, 0.009 mmol) in dry THF (1 
mL) at –78 oC. Immediately, a solution of aldehyde 3-110 (5.0 mg, 0.009 mmol) in 
dry THF (0.5 mL + 0.5 mL rinse) was added slowly via micro-syringe. The reaction 
mixture was stirred for 12 h at -20 oC. The resulting mixture was partitioned between 
water (10 mL) and Et2O (10 mL), and the aqueous phase was extracted with Et2O 
(10 mL). The combined organic extracts were washed with brine, dried over Na2SO4, 
filtered, and evaporated in vacuo. The residue was purified by gradient flash column 
chromatography, eluting with 5%-10%-25% EtOAc/hexanes, to afford 12.1 mg (89 
%) of 3-135. 1H NMR (500 MHz, CDCl3) δ ppm 7.25-7.18 (m, 2H), 6.26-6.11 (m, 2H), 
6.09-6.03 (m, 1H), 5.83-5.77 (m, 1H), 5.70-5.57 (m, 3H), 5.53-5.49 (m, 1H), 5.49-
5.47 (m, 1H), 5.44-5.40 (m, 1H), 5.15-5.10 (m, 1H), 5.05-5.00 (m, 1H), 4.97-4.91 (m, 
1H), 4.83-4.78 (m, 1H), 4.60-4.53 (m, 2H), 4.27-4.16 (m, 2H), 3.95-3.88 (m, 1H), 
3.86-3.82 (m, 1H), 3.80-3.77 (m, 1H), 3.64-3.58 (m, 1H), 3.50-3.45 (m, 1H), 3.39-
3.33 (m, 1H), 2.85-2.79 (m, 2H), 2.52-2.36 (m, 3H), 2.33-2.22 (m, 2H), 2.04 (s, 3H), 
1.75 (s, 2H), 1.70-1.66 (m, 1H), 0.09-0.01 (m, 15H), 0.89 (t, J = 5.66 Hz, 29H), 1.09 
(d, J = 7.46 Hz, 12H), 1.25 (s, 5H), 1.33 (m, 5H); 13C NMR (126 MHz, CDCl3) δ ppm 
171.152, 145.241, 144.075, 140.296, 135.233, 132.197, 130.842, 130.220, 129.772, 
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128.333, 126.768, 124.488, 121.475, 112.137, 72.247, 71.875, 71.598, 70.835, 
67.004, 60.407, 42.282, 39.900, 39.706, 36.623, 31.073, 29.713, 27.774, 26.071, 
25.941, 25.776, 25.759, 22.519, 21.072, 17.843, 14.215, 12.029, 11.325, 7.049, 
1.039, -4.343, -4.855, -4.888, -4.950, -5.169, -5.235, -5.457; IR (film) 3853.08, 
3837.65, 3801.01, 3749.9, 3734.48, 3710.37, 3688.19, 3674.69, 3647.7, 3565.74, 
2959.23, 2924.52, 2853.17, 2390.33, 2348.87, 1731.76, 1668.12, 1557.24, 1539.88, 
1507.1, 1456.96, 1376.93, 1261.22, 1094.4, 1018.23, 826.989, 800.314, 741.496, 
703.89, 663.393, 581.433, 512.972 cm-1; MS calculated for C74H138O10Si5 [M + Na]+: 
1349.91, found 1349.9; [α]24D = -18.6 o (c 0.2, CH2Cl2). 
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